<SEC-DOCUMENT>0001193125-25-079097.txt : 20250411
<SEC-HEADER>0001193125-25-079097.hdr.sgml : 20250411
<ACCEPTANCE-DATETIME>20250411160532
ACCESSION NUMBER:		0001193125-25-079097
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250520
FILED AS OF DATE:		20250411
DATE AS OF CHANGE:		20250411

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001369568
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33057
		FILM NUMBER:		25831570

	BUSINESS ADDRESS:	
		STREET 1:		355 ALHAMBRA CIRCLE
		STREET 2:		SUITE 801
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134
		BUSINESS PHONE:		(305) 529-2522

	MAIL ADDRESS:	
		STREET 1:		355 ALHAMBRA CIRCLE
		STREET 2:		SUITE 801
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATALYST PHARMACEUTICAL PARTNERS, INC.
		DATE OF NAME CHANGE:	20110215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Catalyst Pharmaceutical Partners, Inc.
		DATE OF NAME CHANGE:	20060719
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d900407ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cprx="http://www.catalystpharma.com/20241231" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>DEF 14A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden137734544" contextRef="P01_01_2024To12_31_2024">DEF 14A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2024To12_31_2024" id="ixv-7190">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2024To12_31_2024" id="ixv-7191">0001369568</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cprx-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="P01_01_2024To12_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_2TypedMemberecdMeasureAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ecd:MeasureAxis"> <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_3TypedMemberecdMeasureAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ecd:MeasureAxis"> <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_4TypedMemberecdMeasureAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ecd:MeasureAxis"> <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_1TypedMemberecdMeasureAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001369568</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ecd:MeasureAxis"> <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">UNITED STATES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Washington, D.C. 20549 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="-sec-ix-hidden:hidden137734544;display:inline;">SCHEDULE 14A</div> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Proxy Statement Pursuant to Section&#160;14(a) of the </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities Exchange Act of 1934 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </div><div style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Preliminary Proxy Statement </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div>&#9744;<div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Confidential, for Use of the Commission Only (as permitted by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-6(e)(2))</div> </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9746;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Proxy Statement </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Additional Materials </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Soliciting Material Pursuant to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">&#167;240.14a-12</div> </div></td></tr></table><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2024To12_31_2024" id="ixv-7467">Catalyst Pharmaceuticals, Inc.</ix:nonNumeric> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Registrant as Specified In Its Charter) </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9746;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">No fee required. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee paid previously with preliminary materials </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-6(i)(1)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11.</div> </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g900407g0404235412721.jpg" alt="LOGO"/>
 </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO BE HELD ON MAY&#160;20, 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CATALYST PHARMACEUTICALS, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FLORIDA 33134 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholder: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cordially invited to our 2025 Annual Meeting of Stockholders. The meeting will be a virtual meeting held via the internet on Tuesday, May&#160;20, 2025, beginning at 9:00 a.m. Eastern Time. The meeting will be held for the following purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect six directors to serve a term of one year or until their successors are duly elected and qualified, or until their earlier death, resignation, or removal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance thereunder by 5,000,000 shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve, on an advisory basis, the 2024 compensation of our named executive officers, as set forth herein; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To transact such other business as may properly come before the meeting. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Annual Meeting will be a virtual meeting of stockholders, which will be conducted exclusively via the internet at a virtual web conference. There will not be a physical meeting location, and stockholders will not be able to attend the Annual Meeting in person. This means that you can attend the Annual Meeting online, vote your shares during the online meeting, and submit questions for consideration at the online meeting. Stockholders of record as of the close of business on Monday, March&#160;31, 2025 are entitled to notice of and to vote at the Annual Meeting. In order to attend the meeting online, vote your shares electronically during the meeting, and submit questions, you must register in advance. Upon completing your registration, you will receive further instructions via email, including your unique links that will allow you access to the meeting and will also permit you to submit questions. Please be sure to follow instructions found on your Notice, proxy card and/or voting instruction form, and subsequent instructions that will be delivered to you via email. We believe that hosting a &#8220;virtual meeting&#8221; will enable greater stockholder attendance and participation from any location around the world. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We encourage all stockholders to attend the Annual Meeting online. Whether or not you plan to attend the Annual Meeting online, we encourage you to read this Proxy Statement and submit your proxy or voting instructions as soon as possible by using the internet as described in the instructions included on your Notice, by calling the toll-free telephone number included in the Proxy Statement, or, if you received a paper copy of the proxy materials, by completing, signing, dating, and returning your proxy card. Further information about how to register for the Annual Meeting, attend the Annual Meeting online, vote your shares, and submit questions for consideration at the meeting is included in the accompanying Proxy Statement. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you for your ongoing support of and your continued interest in Catalyst Pharmaceuticals, Inc. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BY ORDER OF THE BOARD OF DIRECTORS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt">


<img src="g900407g0404235412946.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Patrick J. McEnany </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Chairman of the Board </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coral Gables, Florida </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&#160;10, 2025 </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">TABLE OF CONTENTS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:97%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_1">General Information About the Annual Meeting and Voting</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_2">Proposal One &#8211; Election of Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_3">Information Regarding Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_4">Corporate Governance</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_5">Compensation of Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_6">Proposal Two - Amending our 2018 Stock Incentive Plan</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_7">2018 Stock Incentive Plan</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_8">Proposal Three &#8211; Advisory Approval of the Compensation of Named Executive Officers</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_9">Compensation Discussion and Analysis</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc900407_10">Compensation Committee Report</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_11">Pay Versus Performance</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_12">CEO Pay Ratio</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_13">Proposal Four &#8211; Ratification of Appointment of Independent Public Accounting Firm</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_14">Audit Committee Report</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">41</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_15">Security Ownership of Certain Beneficial Owners and Management</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_16">Certain Relationships and Related Party Transactions</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_17">Other Matters</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_18">Contacting the Board of Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_19">Stockholder Proposals</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_20">Additional Information</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#txa900407_21">Annex A &#8211; Amendment No.&#160;5 to Catalyst Pharmaceuticals, Inc. 2018 Stock Incentive Plan</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g900407g0404235412721.jpg" alt="LOGO" style="width:3.05486in;height:0.827083in"/>
 </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO BE HELD ON TUESDAY, MAY&#160;20, 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INFORMATION REGARDING SOLICITATION AND VOTING </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Proxy Statement contains information about our 2025 Annual Meeting of Stockholders (the &#8220;<span style="font-weight:bold">Annual Meeting</span>&#8221;). The Annual Meeting will be held on Tuesday, May&#160;20, 2025, beginning at 9:00 a.m., Eastern Time. Holders of record of shares of our common stock, par value $0.001 per share (the &#8220;<span style="font-weight:bold">Common Stock</span>&#8221;), as of the close of business on Monday, March&#160;31, 2025 (the &#8220;<span style="font-weight:bold">Record Date</span>&#8221;), will be entitled to notice of and to vote at the Annual Meeting and any continuation, postponement or adjournment thereof. As of the Record Date, there were 121,959,172 shares of our Common Stock outstanding and entitled to notice of and to vote at the Annual Meeting. Each share of Common Stock is entitled to one vote on any matter presented to stockholders at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual Meeting will be a virtual meeting held via the internet. In order to attend the Annual Meeting online, you must register in the manner set forth below under &#8220;How can I attend the Annual Meeting of Stockholders?&#8221;. Upon completing your registration, you will receive further instructions via <span style="white-space:nowrap">e-mail,</span> including your unique links that will allow you access to the meeting. Please be sure to follow instructions found on your proxy card and subsequent instructions that will be delivered to you via <span style="white-space:nowrap">e-mail.</span> There will not be a physical meeting location, and stockholders will not be able to attend the annual meeting of stockholders in person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except where the context otherwise requires, references to &#8220;Catalyst Pharmaceuticals&#8221;, &#8220;Catalyst&#8221;, &#8220;the Company&#8221;, &#8220;we&#8221;, &#8216;us&#8221;, &#8220;our&#8221;, and similar terms refer to Catalyst Pharmaceuticals, Inc. and its subsidiary. References to our website are inactive textual references only and the contents of our website are not incorporated by reference into this Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Proxy Statement and the enclosed proxy card are being furnished in connection with the solicitation of proxies by our board of directors for use at the Annual Meeting and any adjournment thereof. All proxies will be voted in accordance with the instructions they contain. If you do not specify your voting instructions on the proxy, your shares will be voted in accordance with the recommendations of our board of directors. This Proxy Statement, the related proxy card and our annual report to stockholders are being mailed to stockholders on or about Thursday, April&#160;10, 2025. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">FOR THE ANNUAL MEETING OF STOCKHOLDERS: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">This Proxy Statement and our 2024 Annual Report to Stockholders are available at: </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">http://ir.catalystpharma.com/annual-proxy.cfm</span>. </p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_1">G<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ENERAL</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NFORMATION</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">BOUT</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">THE</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NNUAL</small> M<small style="font-weight:inherit;font-style:unset;text-decoration:unset">EETING</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AND</small> V<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OTING</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why did I receive this proxy statement? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have received these proxy materials because the board of directors is soliciting your proxy to vote at the Annual Meeting. This proxy statement contains information that we are required to provide you under the rules of the Securities and Exchange Commission (&#8220;<span style="font-weight:bold">SEC</span>&#8221;). This information is designed to assist you in voting your shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is the purpose of the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, stockholders will consider and vote on the following matters: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect six directors to serve a term of one year or until their successors are duly elected and qualified, or until their earlier death, resignation, or removal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance thereunder by 5,000,000 shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve, on an advisory basis, the 2024 compensation of our named executive officers, as set forth herein; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To transact such other business as may properly come before the meeting. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently know of no other business that will be presented at the Annual Meeting. However, if any other matter properly comes before the stockholders for a vote at the Annual Meeting, the proxy holders named on the Company&#8217;s proxy card will vote your shares in accordance with their best judgement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What are the recommendations of the Board of Directors? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board recommends that you vote your shares as indicated below. If you return a properly completed proxy card, or vote your shares by telephone or internet, your shares of Common Stock will be voted on your behalf as you direct. If not otherwise specified, the shares of common stock represented by the proxies will be voted, and the Board recommends that you vote, as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">FOR</span> the election of six directors to serve a term of one year or until their successors are duly elected and qualified, or until their earlier death, resignation, or removal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">FOR</span> the approval of an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance thereunder by 5,000,000 shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">FOR</span> the approval, on an advisory basis, the 2024 compensation of our named executive officers, as set forth herein; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">FOR</span> the ratification of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any other matter properly comes before the stockholders for a vote at the Annual Meeting, the proxy holders named on our proxy card will vote your shares in accordance with their best judgement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who is entitled to vote on matters presented at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Record Date for the Annual Meeting is the close of business on Monday, March&#160;31, 2025. You are entitled to vote on the matters presented at the Annual Meeting if you owned shares of our common stock as the close of business on the Record Date. Each outstanding share of Common Stock is entitled to one vote for all matters before the Annual Meeting. At the close of business on the Record Date, there were 121,959,172 shares of Common Stock outstanding and entitled to vote at the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is the difference between being a &#8220;Record Holder&#8221; and holding shares in &#8220;Street Name&#8221;? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, on the Record Date, your shares were registered directly in your name with our transfer agent, you are a stockholder of record. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, on the Record Date, your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Am I entitled to vote if my shares are held in &#8220;Street Name&#8221;? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. If your shares are held in street name, these proxy materials, along with instructions on how to vote your shares, are being provided to you by your brokerage firm, bank, dealer, or other similar organization. As the beneficial owner, you have the right to direct your brokerage firm, bank, dealer, or other similar organization how to vote your shares, and the brokerage firm, bank, dealer, or other similar organization is required to vote your shares in accordance with your instructions. If your shares are held in street name, you may not vote your shares in person at the Annual Meeting unless you obtain, and present at the Annual Meeting, a legal proxy from your brokerage firm, bank, dealer, or other organization. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many shares must be present to hold the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum must be present at the Annual Meeting for any business to be conducted. Under Delaware Law and our Bylaws, the presence at the Annual Meeting online, or by proxy, of the holders of a majority in voting power of the Common Stock issued and outstanding entitled to vote on the Record Date, will constitute a quorum for the transaction of business at the Annual Meeting. The inspector of elections will determine whether a quorum is present and will tabulate the votes cast at the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How can I attend the Annual Meeting of Stockholders? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, the Annual Meeting will be held entirely online. You may attend the Annual Meeting only if you are a record holder or beneficial owner of our Common Stock as of the Record Date. The process for attending the Annual Meeting and casting your vote at the Annual Meeting depends on the manner in which you hold your shares: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Registered Stockholders</span></span><span style="font-weight:bold">. </span>If your shares are registered in your name with our transfer agent, Continental Stock Transfer and Trust Company (&#8220;<span style="font-weight:bold">Continental</span>&#8221;) and you wish to attend the online-only virtual Annual Meeting, go to <span style="font-weight:bold"><span style="text-decoration:underline">www.cstproxy.com/catalystpharma/202</span>5</span>, enter the control number you received on your proxy card (printed in the box and marked with an arrow) and click on the &#8220;<span style="font-style:italic">Click Here to Preregister for the Online Meeting</span>&#8221; link at the top of the page. Just prior to the start of the meeting you will need to log back into the meeting site using your control number. <span style="white-space:nowrap">Pre-registration</span> is recommended but is not required to attend. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Street Name Stockholders</span></span><span style="font-weight:bold">. </span>Street name stockholders who wish to attend the online-only virtual Annual Meeting must obtain a legal proxy by contacting their account representative at the bank, broker, or other nominee that holds their shares and email a copy (a legible photograph is sufficient) of their legal proxy to <span style="font-weight:bold"><span style="text-decoration:underline">proxy@continentalstock.com</span></span>. Street name stockholders who email a valid legal proxy will be issued a meeting control number that will allow them to register to attend and participate in the online-only Annual Meeting. After contacting Continental, a street name stockholder will receive an <span style="white-space:nowrap">e-mail</span> prior to the meeting with a link and instructions for entering the virtual Annual Meeting. Street name stockholders should contact Continental at least five (5)&#160;business days prior to the Annual Meeting date. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will there be a question and answer session during the annual meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders participating in the virtual Annual Meeting will be in a listen-only mode and will not be able to speak during the webcast. However, in order to maintain the interactive nature of the virtual meeting, virtual attendees are able to: (i)&#160;vote using the online meeting website, and (ii)&#160;submit questions or comments to our officers during the meeting via <span style="white-space:nowrap">e-mail</span> or the virtual meeting webcast. Starting Tuesday, May&#160;13, 2025 at 9:00 AM eastern time, stockholders may submit questions or comments before or during the meeting through the virtual meeting portal by typing in the &#8220;<span style="font-style:italic">Submit a Question</span>&#8221; box. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Can I listen to the Annual Meeting without attending? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders will have the option to call in to the virtual Annual Meeting by telephone and listen (in listen-only mode) by calling: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:81%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Within the U.S. and Canada (toll free):</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="white-space:nowrap">(800)&#160;450-7155</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside the U.S. and Canada (standard rates apply):</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="white-space:nowrap">(857)&#160;999-9155</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Passcode for telephone access:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">9073787#</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if a quorum is not present at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a quorum is not present at the scheduled time of the Annual Meeting, the Chairperson of the Annual Meeting is authorized by our Bylaws to adjourn the Annual Meeting until a quorum is present or represented. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What does it mean if I receive more than one set of proxy materials? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you receive more than one set of proxy materials, your shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your shares. To ensure that your shares are voted, for each set of proxy materials, please submit your proxy via phone, via the internet or by signing, dating and returning the enclosed proxy card in the enclosed <span style="white-space:nowrap">pre-paid</span> envelope. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I vote? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may vote over the internet, the phone, via mail, or at the Annual Meeting. Your proxy will have specific information on the manner in which you can vote your shares. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Can I change my vote after I submit my proxy? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. If you are a record holder, you may revoke your proxy and change your vote at any time before the proxy is voted at the Annual Meeting: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by submitting a duly executed proxy bearing a later date than your prior proxy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by granting a subsequent proxy through the internet or via telephone; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by giving written notice of revocation to our corporate secretary at or prior to the Annual Meeting; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by voting online at the Annual Meeting. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your most recent proxy is the one that is counted. Your attendance at the Annual Meeting will not, by itself, revoke your proxy. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held in street name, you may change or revoke your voting instructions by following the specific directions provided to you by your bank or broker, or you may vote virtually at the Annual Meeting by obtaining a legal proxy from your bank or broker and submitting the legal proxy along with your ballot at the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who will count the votes? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A representative from Continental will tabulate and certify the votes by proxy, and a representative from the Company will act as inspector of elections. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I do not specify how my shares are to be voted? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a record holder and you indicate when voting on the Internet or by telephone that you wish to vote as recommended by the Board, then your shares will be voted at the Annual Meeting in accordance with the Board&#8217;s recommendation on all matters presented for a vote at the Annual Meeting. Similarly, if you are a record holder and submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote in accordance with the recommendations of the Board. The Board&#8217;s recommendations are indicated on page 2 of this proxy statement, along with the description of each proposal in this proxy statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares held in street name and do not provide the organization that holds your shares with specific voting instructions, then, the organization that holds your shares may generally vote your shares in their discretion on &#8220;routine&#8221; matters but cannot vote your shares on <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> matters. If the organization that holds your shares does not receive instructions from you on how to vote your shares on a <span style="white-space:nowrap">non-routine</span> matter, that organization will inform the inspector of election that it does not have the authority to vote on that matter with respect to your shares. This is generally referred to as a &#8220;broker <span style="white-space:nowrap">non-vote.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What are &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> and do they count for determining the quorum? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares represented by proxies that reflect a &#8220;broker <span style="white-space:nowrap">non-vote&#8221;</span> will be counted as present for purposes of determining the presence of a quorum. As discussed above, &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> occur when shares held by a broker in &#8220;street name&#8221; for a beneficial owner are not voted with respect to a particular proposal because (1)&#160;the broker has not received voting instructions from the beneficial owner and (2)&#160;the broker lacks discretionary voting power to vote those shares on a particular matter. A broker has discretionary power to vote shares without instruction from the beneficial owner on routine matters, such as the ratification of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
appointment of Grant Thornton LLP as our independent registered public accounting firm. Thus, &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> are not expected on that proposal. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on <span style="white-space:nowrap">non-routine</span> matters. &#8220;Broker <span style="white-space:nowrap">non-votes&#8221;</span> on the election of directors, which is considered a <span style="white-space:nowrap">non-routine</span> matter, will have no effect because they are not considered votes cast. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is an abstention and how will votes withheld and abstentions be treated? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares of common stock held by persons attending the Annual Meeting but not voting, and shares represented by proxies that reflect withheld votes or abstentions as to a particular proposal, will be counted as present for purposes of determining the presence of a quorum. A &#8220;vote withheld,&#8221; in the case of the proposal regarding the election of directors, or an &#8220;abstention,&#8221; in the case of the ratification of the appointment of Grant Thornton LLP, represents a stockholder&#8217;s affirmative choice to decline to vote on a proposal. Votes withheld have no effect on the election of directors, and abstentions are not considered to be a vote cast and will have no effect on the ratification of the appointment of Grant Thornton LLP. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many votes are required for the approval of the proposals to be voted on and how will abstentions and &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> be treated? </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Votes Required</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">Effect of Votes</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">Withheld/Abstentions and</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">&#8220;Broker <span style="white-space:nowrap">Non-Votes&#8221;</span></p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Proposal 1: Election of Directors</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of a plurality of the votes cast by the holders of our common stock for each director nominee.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Votes withheld and &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Proposal 2: Amendment to our 2018 Stock Incentive Plan</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of a majority of the votes cast for or against the matter.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Votes withheld and &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Proposal 3: Advisory Approval of the Compensation of Named Executive Officers</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of a majority of the votes cast for or against the matter.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Votes withheld and &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Proposal 4: Ratification of Appointment of our Independent Registered Public Accounting Firm</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of a majority of the votes cast for or against the matter.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions will have no effect. We do not expect any &#8220;broker <span style="white-space:nowrap">non-votes&#8221;</span> on this proposal.</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will any other business be conducted at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently know of no other business that will be presented at the Annual Meeting. If any such business does properly come before the meeting, however, your shares will be voted in accordance with the best judgement of the proxy holders named on your proxy card. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Where can I find the voting results of the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to announce the preliminary voting results at the Annual Meeting and will report the final results in a Current Report on Form <span style="white-space:nowrap">8-K,</span> which we intend to file with the SEC within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form <span style="white-space:nowrap">8-K</span> within four business days after the Annual Meeting, we intend to file a Form <span style="white-space:nowrap">8-K</span> to publish preliminary results and, within four business days after the final results are known to us, file an additional Form <span style="white-space:nowrap">8-K</span> to publish the final results. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSALS</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">TO</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">BE</small> V<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OTED</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">N</small></span><small style="font-weight:inherit;font-style:unset;text-decoration:unset"></small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_2">P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSAL</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NE</small> &#8211; E<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LECTION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRECTORS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following paragraphs provide information as of the date of this Proxy Statement about each director and nominee for director, as furnished to us by the directors and nominees for director. The information presented includes information each such individual has given us about his or her age, all positions he or she holds, his or her principal occupation and business experience for the past five years, and the names of other publicly held companies of which he or she currently serves as a director or has served as a director during the past five years. In addition to the information presented below regarding each such individual&#8217;s specific experience, qualifications, attributes and skills that led our board of directors to the conclusion that he or she should serve as a director, we also believe that each of our directors and director nominees has a reputation for integrity, honesty and adherence to high ethical standards. Each has demonstrated business acumen and an ability to exercise sound judgment, as well as a commitment of service to our company and our board of directors. Finally, we value their significant experience on other public company boards of directors and board committees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information about the number of shares of common stock beneficially owned by each of our directors and nominees for director appears below under the heading &#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between or among any of our executive officers, directors, or nominees for director. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMINEES</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">FOR</small> E<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LECTION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">TO</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">THE</small> B<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OARD</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRECTORS</small> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:22%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:33%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:30%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Age</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Independent</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Committee Membership</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Patrick J. McEnany</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">77</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">Non-Executive</span> Chairman of the Board and <span style="white-space:nowrap">co-founder</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Richard J. Daly</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">64</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director, President, and CEO</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Donald A. Denkhaus</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">79</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Audit (Chair); Corporate Governance and Nominating</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Molly Harper</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">48</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Lead Independent Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Compensation; Corporate Governance and Nominating</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:22%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:27%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:36%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Age</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Independent</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Committee Membership</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Tamar Thompson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">51</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Corporate Governance and Nominating (Chair), Audit</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">David S. Tierney, M.D.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">61</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Compensation (Chair), Corporate Governance and Nominating</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event any of the nominees should become unable to serve, or for good cause will not serve, as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that the nominees named below will be unable to serve if elected. Each of the nominees has consented to being named in this proxy statement and to serve if elected. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the persons whose names and biographies appear below are currently serving as our directors. Each of our directors brings to the Board significant leadership experience derived from their professional experience and service as executives or board members of other corporations and/or private equity and venture capital firms. The process undertaken by the Corporate Governance and Nominating Committee in recommending qualified director candidates is described below under &#8220;Board Diversity&#8221; and &#8220;Director Qualifications and Attributes.&#8221; Certain individual qualifications and skills of our directors that contribute to the Board&#8217;s effectiveness as a whole are described in the following paragraphs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The election of directors requires a plurality of the votes cast by the holders of our common stock. A &#8220;plurality&#8221; means that each director must receive a greater number of votes cast for their retention on the board of directors than those cast against. Consequently, any shares not voted (whether by abstention, broker <span style="white-space:nowrap">non-vote</span> or otherwise) have no impact on the election of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Board of Directors recommends a vote in favor of the six persons listed above who have been nominated for election to the Board of Directors. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Currently Ongoing Search for a Seventh Director to serve on the Board </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors has historically included seven members. On January&#160;17, 2025, Charles B. O&#8217;Keeffe, age 85, who has served as an independent member of our Board since December 2004 and as our lead independent director since July 2011, informed the Board of his intent not to stand for <span style="white-space:nowrap">re-election</span> at the Annual Meeting when his current term expires. Following Mr.&#160;O&#8217;Keeffe&#8217;s retirement, the Board will consist of six directors (and the currently serving remaining six directors will be considered for election at the Annual Meeting). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporate Governance and Nominating Committee of the Board has retained a nationally recognized recruitment firm to assist the committee in its search for a new director to replace Mr.&#160;O&#8217;Keeffe. The committee intends to look at a number of candidates and appropriately consider each candidate&#8217;s business and professional experience, including experience in the pharmaceutical industry, demonstrated leadership ability, integrity and judgement, record of public service, and financial and technological acumen. That search is expected to be completed before the end of the second quarter of 2025. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an effort to ensure that the committee has sufficient time to identify the best candidate, the committee has decided that it is more important to source the right director to serve on the Board even if it means that the decision on locating a new director is deferred until after the Annual Meeting. Once the committee identifies the appropriate candidate to add to the Board, the Board intends to add the new director to the Board (as permitted by the Company&#8217;s bylaws), to serve until the 2026 annual meeting of stockholders. We will announce the appointment of our new director via a press release and the filing of a Form <span style="white-space:nowrap">8-K</span> with the SEC. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Consideration of Future Nominees </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporate Governance and Nominating Committee will consider director candidates recommended by our stockholders. Any stockholder wishing to submit a recommendation with respect to the 2026 Annual Meeting of Stockholders should send a signed letter of recommendation to us at 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, Attention: Corporate Secretary. To be considered, recommendation letters must be received between November&#160;11, 2025 and December&#160;10, 2025, and must include: (i)&#160;all information about the nominee required to be disclosed in solicitations of proxies in an election contest; (ii)&#160;the written consent of the nominee to the nomination and such nominee&#8217;s willingness to serve if elected; and (iii)&#160;the name and address of the stockholder making such recommendation, the class and number of shares of capital stock the stockholder owns, and a representation by the stockholder that such stockholder is a holder of record of stock of the corporation entitled to vote at such meeting and intends to appear, in person or by proxy, to propose such nomination. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_3">I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NFORMATION</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">EGARDING</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRECTORS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth below as to the directors and nominees for director has been furnished to us by the directors and nominees for director. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Nominees for Election to the Board of Directors: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Patrick J. McEnany</span><span style="font-weight:bold"></span>&#160;is <span style="white-space:nowrap">a&#160;co-founder&#160;of</span> our company and currently serves as the <span style="white-space:nowrap">Non-Executive</span> Chairman of our Board. Mr.&#160;McEnany has served as a director since our formation in January 2002 and as Chairman of our Board since March 2006. Mr.&#160;McEnany served as our President and Chief Executive Officer (CEO) from our formation until December&#160;31, 2023 when he retired. Prior to founding our company, (i)&#160;from 1999 until 2002, Mr.&#160;McEnany was a consultant to the pharmaceutical industry, and (ii)&#160;from 1991 to 1997, Mr.&#160;McEnany was Chairman and CEO of Royce Laboratories, Inc., a generic pharmaceutical manufacturer, and after the merger of Royce Laboratories into Watson Pharmaceuticals, Inc. in 1997, Mr.&#160;McEnany served as president of Watson&#8217;s wholly owned Royce Laboratories subsidiary and as vice president of corporate development for Watson Pharmaceuticals, Inc. Finally, Mr.&#160;McEnany serves on the board of directors of the Baptist Health Foundation and is a Council Director for Doctor&#8217;s Hospital and Baptist Health Orthopedic Care in Coral Gables, Florida. The Board believes that the characteristics that qualify Mr.&#160;McEnany as a director to serve on our Board include his long-term experience in the pharmaceutical industry, his intimate knowledge of the Company&#8217;s operations, and his extensive business leadership experience. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Richard J. Daly </span>has been a director since 2015 and became our President and CEO on January&#160;1, 2024. Prior to joining Catalyst, from January 2022 until August 2023, Mr.&#160;Daly served as President of CARsgen Therapeutics Corporation, an emerging oncology company focused on <span style="white-space:nowrap">developing&#160;CAR-T&#160;therapies</span> for both liquid and solid tumors. Further, from July 2018 through January 2022, Mr.&#160;Daly served as Chief Operating Officer of BeyondSpring <span style="white-space:nowrap">Pharmaceuticals,&#160;a&#160;pre-commercial&#160;biotech&#160;company</span> focused on oncology with assets in late Phase 3 clinical trials. Finally, before joining BeyondSpring, (i)&#160;from February </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
2016 until July 2018 Mr.&#160;Daly served as Chairman and CEO of Neuralstem, Inc., a biopharmaceutical company focused on the development of central nervous system therapies based on its neuronal stem cell technology, (ii)&#160;from October 2014 until September 2016, Mr.&#160;Daly served as a partner of RavineRock Partners, a commercial consulting practice focused on biotech and pharmaceuticals, and (iii)&#160;from February 2013 until September 2014, Mr.&#160;Daly served as President of AstraZeneca US Diabetes. Additionally, Mr.&#160;Daly served on the board of directors of Opiant Pharmaceuticals, and as a member of Opiant&#8217;s Compensation and Audit Committees, from 2018 until the sale of that company in 2023. Mr.&#160;Daly received his Bachelor of Science in Microbiology from the University of Notre Dame in 1983 and his MBA from the Kellogg School of Management, Northwestern University in 1998. The Board believes that the characteristics that qualify Mr.&#160;Daly as a director of our company include his significant pharmaceutical industry experience and his experience in launching and managing sales of numerous pharmaceutical products, including several products that are used to treat orphan/rare diseases. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Donald A. Denkhaus</span><span style="font-weight:bold"></span>&#160;joined our Board in February 2015 and currently chairs the Audit Committee of our Board. From 2005 until 2024, Mr.&#160;Denkhaus has been Chairman and Chief Financial Officer of The Kitchen, LLC, a company providing language dubbing and subtitling services to the media and entertainment industry. From 1970 through 2002, Mr.&#160;Denkhaus, who is a retired certified public accountant, worked for Arthur Andersen LLP, a global professional services organization, where he was an audit partner <span style="white-space:nowrap">for&#160;twenty-two&#160;years</span> and held numerous leadership positions, including as head of Andersen&#8217;s South Florida audit practice and, from 1998 through 2002, as Audit Practice Partner responsible for Andersen&#8217;s offices in Florida and Puerto Rico. From 2010 to 2013, Mr.&#160;Denkhaus was Chair of Nuovo Biologics, a privately held biotech company that was developing an antiviral drug for animal use, and, from 2004 until its sale in 2009, Mr.&#160;Denkhaus served on the board of directors and as chair of the audit committee of Noven Pharmaceuticals, a publicly-traded specialty pharmaceutical company focused on women&#8217;s health and psychiatry. Mr.&#160;Denkhaus received a Master&#8217;s in Business Administration degree with a major in finance from the University of Maryland and a Bachelor of Business Administration with a major in accounting from Kent State University. The Board believes that the characteristics that qualify Mr.&#160;Denkhaus to be a member of our Board include his extensive financial experience and his prior experience serving as a director of two pharmaceutical companies, one of which was publicly traded. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Molly Harper</span> joined our Board in June 2021 and will become our Lead Independent Director upon Mr.&#160;O&#8217;Keeffe&#8217;s retirement from the Board at the Annual Meeting. Ms.&#160;Harper has more than two decades of leading biopharma businesses in growth across settings ranging from large biopharmaceutical companies to entrepreneurial <span style="white-space:nowrap">start-ups,</span> with a particular focus on therapeutics for rare diseases. Ms.&#160;Harper is currently Managing Partner for Peacock Hall LLC, an advisory firm focused on life sciences companies. Previously, from September 2021 until March 2024, Ms.&#160;Harper served as Chief Business Officer for Synlogic, Inc. a clinical-stage biotechnology company pioneering therapeutics based on synthetic biology, where her responsibilities spanned business development, investor relations and corporate communications, new product planning, commercial strategy and patient advocacy. Ms.&#160;Harper joined Synlogic from Relmada Therapeutics, Inc., where she was Executive Vice President of Operations from May 2020 to September 2021. Prior to Relmada she served in positions of increasing responsibility with Akcea Therapeutics, most recently as Senior Vice President and Global Franchise General Manager, with responsibility for a <span style="white-space:nowrap">six-drug</span> portfolio, including the global commercialization of two rare disease drugs, having designed and built a scalable, global commercial organization. Ms.&#160;Harper previously served as Head of US Endocrinology in the Rare Disease division of Sanofi Genzyme, in commercial leadership roles with Merck&#160;&amp; Co, and began her career in equity research at UBS Warburg and strategy consulting at The Wilkerson Group/IBM. Ms.&#160;Harper received her Bachelor of Arts from Cornell University and her Master of Business Administration from The Wharton School of the University of Pennsylvania. Ms.&#160;Harper also serves on the Board of Directors of PreciseDx, a privately held AI oncology pathology company. The Board believes that the characteristics that qualify Ms.&#160;Harper to be a director of our company include her significant pharmaceutical industry experience and her experience in pharmaceutical company operations overseeing the development, launch, and commercialization of several pharmaceutical products, including several products that are used to treat orphan/rare diseases, as well as business development and investor relations in the biopharma space. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Tamar Thompson</span><span style="font-weight:bold"></span>&#160;joined our Board on May&#160;25, 2023 and is currently Chair of our Board&#8217;s Corporate Governance and Nominating Committee. Ms.&#160;Thompson has served as Vice President/Head of Global Corporate Affairs for Alexion Pharmaceuticals/AstraZeneca Rare Disease since 2021, when Alexion was acquired by AstraZeneca. Prior thereto, from 2019 to 2021, Ms.&#160;Thompson was Vice President, Global Corporate Affairs for Alexion Pharmaceuticals. Further, prior to joining Alexion, from February 2015 to November 2019 when she joined Alexion, Ms.&#160;Thompson served in several capacities for Bristol-Myers Squibb Company, most recently as executive director of State Government Affairs and Federal Policy. Prior to joining Bristol-Myers Squibb, Ms.&#160;Thompson was a strategic policy advisor and consultant for premiere Washington, DC based governmental affairs firms, including ADVI, Kimbell and Associates, and Avalere Health. Finally, since 2020, Ms.&#160;Thompson has served as an independent director of Avidity Biosciences, Inc., where she serves on the Nominating and Governance Committee and on the Compensation Committee of that board. She also serves as the Chair of the board of directors of MassBio, a premier state level trade association representing the biotech sector in Massachusetts. Ms.&#160;Thompson holds an M.S. in Health Sciences with a concentration in Public Health from Trident University in Cypress, California. The Board believes that the characteristics that qualify Ms.&#160;Thompson to serve as a member of our Board include her extensive health policy and government affairs experience, as well as her focus on rare diseases in her current position at Alexion Pharmaceuticals/AstraZeneca Rare Diseases. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">David S. Tierney, M.D.</span> has served as a member of our Board since October 2002 and currently chairs the Compensation Committee of our Board. Dr.&#160;Tierney currently serves as Chief Executive Officer and Director of Aramis Biosciences, a privately held clinical stage ophthalmology pharmaceutical company. From February 2020 until December 2020, Dr.&#160;Tierney served as CEO of Pharma Two B, a CNS specialty pharmaceutical company. From September 2018 until January 2020, Dr.&#160;Tierney served as President&#160;&amp; CEO of BioPharmX Corporation, a dermatology specialty pharmaceutical company. He also served on the Board of Directors of BioPharmX from September 2018 until May 2020. From January 2014 until March 2018, he served as President&#160;&amp; CEO of Icon Bioscience, Inc., a privately held ophthalmic drug delivery company. Dr.&#160;Tierney served as President and Chief Operating Officer (and a member of the board of directors) of Oceana Therapeutics, Inc., a private specialty pharmaceutical company between the organization of that company in 2008 and the sale of that company to Salix Pharmaceuticals, Ltd. in December 2011. Dr.&#160;Tierney also served as the President and CEO (and as a member of the board of directors) of Valera Pharmaceuticals, Inc. a specialty pharmaceutical company, between August 2000 and April 2007, when Valera completed a merger with Indevus Pharmaceuticals, Inc. Further, from January 2000 until August 2000, Dr.&#160;Tierney served as President of Biovail Technologies, a division of Biovail Corporation, a Canadian drug delivery company, where he was responsible for all of Biovail&#8217;s research and development, regulatory and clinical activities. Finally, from March 1997 until January 2000, Dr.&#160;Tierney was Senior Vice President of Drug Development at Roberts Pharmaceutical Corporation, where he was responsible for all research and development activities, and for drug development, medical affairs, worldwide regulatory affairs and chemical process development, as well as being part of the executive management team, and from December 1989 until March 1997, Dr.&#160;Tierney was employed by &#201;lan Corporation, a pharmaceutical company, in a variety of management positions. Dr.&#160;Tierney is currently a director of Bimeda, Inc. Dr.&#160;Tierney received his medical degree from the Royal College of Surgeons in Dublin, Ireland and was subsequently trained in internal medicine. The Board believes the characteristics that qualify Dr.&#160;Tierney to serve on our Board include his business leadership experience and his pharmaceutical industry experience. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_4">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ORPORATE</small> G<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OVERNANCE</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;16(a) Beneficial Ownership Reporting Compliance </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;16(a) of the Securities Exchange Act of 1934 (the &#8220;<span style="font-weight:bold">Exchange Act</span>&#8221;) requires our officers and directors and persons who own more than 10% of our outstanding common stock to file with the Securities and Exchange Commission reports of changes in their ownership of common stock. Officers, directors, and greater than 10% stockholders are also required to furnish us with copies of all forms they file under this regulation. To our knowledge, based solely on a review of the copies of such reports furnished to us and representations made to us that no other reports were required, during the year ended December&#160;31, 2024 all Section&#160;16(a) filings required to be filed by our officers, directors, and greater than 10% stockholders were timely filed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Independent Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As required under applicable NASDAQ listing standards, a majority of the members of a listed company&#8217;s board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the listed company&#8217;s board of directors. The Board consults with our counsel to ensure that its determinations are consistent with all relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent NASDAQ listing standards, as in effect from time to time. Consistent with these considerations, the Board has affirmatively determined that all of our directors (other than Mr.&#160;McEnany, who was our CEO until December&#160;31, 2023, and Mr.&#160;Daly, who has been our CEO since January&#160;1, 2024) are &#8220;independent directors&#8221; within the meaning of the applicable NASDAQ listing standards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Governance </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board and management are committed to utilizing good corporate governance practices to ensure we are managed for the long-term benefit of our stockholders. We have in place a variety of policies and practices to promote good corporate governance. A majority of our Board is independent, in accordance with applicable NASDAQ listing standards, and all members of the Audit Committee, Compensation Committee, and Nominating&#160;&amp; Corporate Governance Committee of our Board also meet applicable NASDAQ listing standards for independence. We have also established: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">written charters for the Audit, Compensation, and Corporate Governance and Nominating Committees that address corporate governance practices in accordance with the Sarbanes-Oxley Act, current NASDAQ corporate governance guidelines, and other applicable rules and regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Corporate Governance Guidelines that describe our Board&#8217;s policies with respect to corporate governance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a Code of Business Conduct and Ethics applicable to our officers, directors, and employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a procedure for receipt and treatment of anonymous and confidential complaints or concerns on any matter, including audit or accounting matters; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">disclosure control policies and procedures. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporate Governance and Nominating Committee is responsible for establishing and reviewing our corporate governance guidelines from time to time and reporting and making recommendations to the Board concerning corporate governance matters. Among the matters addressed by our corporate governance guidelines are: </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="text-decoration:underline">Director Independence</span> &#8211; Independent directors shall constitute at least a majority of our Board and of our Board committees in accordance with the independence standards set forth in the applicable NASDAQ listing standards. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="text-decoration:underline">Executive Sessions of Independent Directors</span> &#8211; Our independent directors regularly meet in executive session without management present. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of our Code of Business Conduct and Ethics can be found on the corporate governance page of the Investor Relations section of our website, which is located at <span style="text-decoration:underline">http://ir.catalystpharma.com/governance.cfm</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Composition </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In making determinations about the composition of our Board, the Corporate Governance and Nominating Committee considers many factors, including, but not limited to, gender, age, race and ethnicity. As a result, the Corporate Governance and Nominating Committee strives to ensure when recommending nominations to our Board that our Board is represented by individuals with a variety of different opinions, perspectives, personal, professional, and industry experience and backgrounds, skills, and expertise. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Qualifications and Attributes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have concluded that all of our directors have the skills, experience, knowledge, and personal attributes that are necessary to effectively serve on our Board and to contribute to the overall success of the Company. We believe that the diverse professional background of each of our directors ensures that we have a Board that has a broad range of industry-related knowledge, experience, and business acumen. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Leadership Structure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patrick J. McEnany serves as the <span style="white-space:nowrap">Non-Executive</span> Chairman of our Board of Directors. The Board does not currently have a policy on whether the roles of Chair and CEO should be combined. Mr.&#160;McEnany served as the Company&#8217;s CEO and Chairman until December&#160;31, 2023. Richard J. Daly became the Company&#8217;s President and CEO on January&#160;1, 2024 and remains a member of the Board. Further, on Mr.&#160;O&#8217;Keeffe&#8217;s retirement from the Board at the Annual Meeting, Ms.&#160;Harper will become the lead independent director of our Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that independent oversight of management is an important component of an effective board of directors. The Board believes that, for the reasons set forth below, our existing corporate governance practices achieve independent oversight and management accountability. Our governance practices provide for strong independent leadership, independent discussion among directors and for independent evaluation of, and communication with, our officers. These governance practices are reflected in our various committee charters, which are available on our website at <span style="text-decoration:underline">www.catalystpharma.com</span>. Some of the relevant processes and other corporate governance practices include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">At each regularly scheduled Board meeting, all of our independent directors meet in an executive session without Mr.&#160;McEnany and Mr.&#160;Daly. In these executive sessions, the independent directors deliberate on matters such as those involving the performance of our Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Each of our directors is elected annually by our stockholders. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">All of our directors, except for Mr.&#160;McEnany and Mr.&#160;Daly, are independent directors. Each director is an equal participant in decisions made by the full Board. All of the committees of the Board are comprised of only independent directors. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Lead Independent Director </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has appointed a <span style="white-space:nowrap">non-management</span> independent director to serve in a lead capacity (the &#8220;<span style="font-weight:bold">Lead Independent Director</span>&#8221;) to perform such duties and responsibilities as the Board may determine. Charles B. O&#8217;Keeffe currently serves as our Board&#8217;s Lead Independent Director, and, following this Annual Meeting, Molly Harper will fill this role. The role of the Lead Independent Director includes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in consultation with the Chairman, determining the length and timing of Board meetings, including regular and special meetings; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">determining the agenda and materials to be provided to directors in advance of each meeting of the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">serving as chair of executive sessions of the Board and other meetings of the Board in the absence of the Chairman of the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">serving as liaison between the Chairman of the Board and the independent directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing the Board&#8217;s stockholder communication policies and procedures; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">calling meetings of independent directors. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Meetings and Attendance at Board and Board Committee Meetings </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2024, our Board held eight meetings and took actions by unanimous written consent on five occasions. For 2024, all of our directors attended at least 75% or more of the aggregate number of meetings held by our Board and the Board committees on which they served. Further, all of our directors attended the 2024 Annual Meeting of Stockholders which was held virtually on May&#160;21, 2024. Directors are encouraged, but not required, to attend the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee assists the Board in fulfilling its responsibility for oversight of the quality and integrity of the accounting, auditing, and reporting practices of our company, and such other duties as directed by the Board. The committee&#8217;s purpose is to oversee our accounting and financial reporting processes, the audits of our financial statements, the qualifications of the independent registered public accounting firm engaged as our independent auditor to prepare or issue an audit report on our financial statements, and the performance of our internal and independent auditors. The committee&#8217;s role includes a particular focus on the qualitative aspects of financial reporting to stockholders, our processes to manage business and financial risk, and compliance with applicable legal, ethical, and regulatory requirements. The Audit Committee is directly responsible for the appointment, compensation, retention and oversight of our independent auditor. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has determined that Donald A. Denkhaus, the current chair of the Audit Committee, is an &#8220;audit committee financial expert&#8221; as defined in Regulation <span style="white-space:nowrap">S-K</span> under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee held four meetings in 2024 and took one action by unanimous written consent. The Audit Committee operates under a written charter which describes the role, responsibilities, and functioning of the Audit Committee. The Audit Committee&#8217;s charter can be found at <span style="text-decoration:underline">http://ir.catalystpharma.com/governance.cfm</span>. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="cprx-20241231.xsd"/></ix:references></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Compensation Committee </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The role of the Compensation Committee is to discharge the Board&#8217;s responsibilities related to compensation of our executive officers, to produce an annual report on executive compensation for inclusion in our Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> or proxy statement, and to oversee and advise the Board on the adoption of policies that govern our compensation programs, including our stock incentive plans and our benefit plans. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee held three meetings in 2024 and took two actions by unanimous written consent. The Compensation Committee operates under a written charter which describes the role, responsibilities, and functioning of the Compensation Committee. A copy of this charter can be found on our website at <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">http://ir.catalystpharma.com/governance.cfm</div>. Pursuant to its charter, the Compensation Committee has authority to retain compensation consultants to assist in its evaluation of executive and director compensation. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Corporate Governance and Nominating Committee </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The role of the Corporate Governance and Nominating Committee (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">CG&amp;N Committee</div></div>&#8221;) is to appoint nominees for election to our Board, to identify and recommend candidates to fill vacancies between annual stockholder meetings, to review, evaluate and recommend changes to our corporate governance policies, and to review our policies and programs that relate to matters of corporate responsibility, including public issues of significance to our company and our stockholders. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CG&amp;N Committee held one meeting in 2024. The CG&amp;N Committee operates under a written charter which describes the role, responsibilities, and functioning of the CG&amp;N Committee. A copy of the CG&amp;N Committee&#8217;s charter can be found on our website at <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">http://ir.catalystpharma.com/governance.cfm</div>. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Corporate Governance Guidelines </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a set of Corporate Governance Guidelines that provide a framework for the Company&#8217;s governance. The Board believes that these Guidelines reflect the Board&#8217;s commitment to govern the Company with high standards of integrity and increased stockholder value. A copy of the Guidelines can be found on our website at <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">http://ir.catalystpharma.com/governance.cfm</div>. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Insider Trading Policy </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="ecd:InsiderTrdPoliciesProcAdoptedFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-true" id="ixv-1252">Our Insider Trading Policy applies to transactions in our securities, including common stock, derivative securities, and any other securities that we may issue, unless the transaction is specifically exempted. The Insider Trading Policy applies to our directors, officers, employees, agents and consultants. If a covered person has material nonpublic information relating to us or our securities, it is our policy that neither that person nor any related person may buy, sell, gift or recommend our securities. We believe that our Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and NASDAQ listing standards. A copy of our Insider Trading Policy was filed as Exhibit 19.1 to our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> for the fiscal year ended December&#160;31, 2024.</ix:nonNumeric> </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risk Oversight </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risk oversight is administered through the Board as a whole. The Board does not believe that risk management issues have an effect on our leadership structure. The Board provides feedback to management at regularly held Board meetings. The independent directors meet in executive session at each regular meeting of the Board and provide insight to our management on a variety of topics, including risk oversight. </div><div style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_5">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMPENSATION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRECTORS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding compensation earned by our <span style="white-space:nowrap">non-employee</span> directors for the year ended December&#160;31, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Fees&#160;Earned&#160;or&#160;Paid<br/>in Cash ($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="white-space:nowrap">Stock-Based&#160;Awards&#160;(1)</span><br/>(2) ($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Total ($)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick J. McEnany</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">282,211</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">562,548</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">844,759</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald A. Denkhaus</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">86,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">300,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">386,269</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Molly Harper (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">139,125</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">300,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">439,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles B. O&#8217;Keeffe (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">108,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">300,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">408,644</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tamar Thompson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">81,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">300,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">381,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David S. Tierney, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">81,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">300,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">381,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts reported in this column represent the grant date fair value of stock-based compensation awards granted in accordance with FASB ASC Topic 718 for 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The aggregate number of stock options and restricted stock units held by each <span style="white-space:nowrap">non-employee</span> director as of December&#160;31, 2024 is indicated in the table below: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number&#160;of&#160;Stock<br/>Options</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number&#160;of&#160;Unvested<br/>Restricted&#160;Stock&#160;Units</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick J. McEnany</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,799,401</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">38,729</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald A. Denkhaus</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">201,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Molly Harper</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">120,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles B. O&#8217;Keeffe (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">201,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tamar Thompson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">92,772</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,668</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David S. Tierney</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">201,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes $66,000 for consulting services in connection with a project in which Ms.&#160;Harper assisted the Company. The Board, independent of Ms.&#160;Harper, reviewed the consulting assignment and concluded that it did not affect Ms.&#160;Harper&#8217;s ability to serve as an independent member of the Board. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;O&#8217;Keeffe is not standing for <span style="white-space:nowrap">re-election</span> to the Board and his term will end at the conclusion of the Annual Meeting. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2024 Compensation of Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2024, <span style="white-space:nowrap">non-employee</span> directors received an annual retainer of $60,000. Mr.&#160;McEnany, as <span style="white-space:nowrap">Non-Executive</span> Chairman of the Board, received cash compensation of $250,000 for his service in that role. The chairs of the Audit, Compensation and Corporate Governance and Nominating Committees received an additional retainer of $21,000, $15,750 and $10,500, respectively, and members of the Audit, Compensation and CG&amp;N Committees received an additional retainer of $10,500, $7,875 and $5,250, respectively. Additionally, the Lead Director received an additional fee of $25,000 for his services as lead director. No meeting fees were paid. Further, directors received a grant of stock options and RSUs for their service. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Hedging and Pledging Policies </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Insider Trading Policy prohibits our executive officers, other <span style="white-space:nowrap">employees,&#160;non-employee&#160;directors</span> and consultants from engaging in short sales, transactions in put or call options, hedging transactions or other inherently speculative transactions with respect to our ordinary shares at any time. In addition, no officer, director, other employee or consultant of Catalyst may margin or pledge, or make any offer to margin or pledge, any of our ordinary shares, including without limitation, borrowing against the value of such ordinary shares, at any time. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_6">P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSAL</small> T<small style="font-weight:inherit;font-style:unset;text-decoration:unset">WO</small> - A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">MENDING</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OUR</small> 2018 S<small style="font-weight:inherit;font-style:unset;text-decoration:unset">TOCK</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NCENTIVE</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LAN</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation is a fundamental component of our compensation program. Our equity compensation program is designed to attract and retain key employees, directors and consultants, many of whom view equity incentives as a key component of their compensation. Stock-based compensation encourages and rewards employee performance and helps align employee interests with those of our stockholders. We currently award stock options on an annual basis to our employees and to members of our Board of Directors as part of our overall compensation package for each year. The amendment will add additional shares into our 2018 Stock Incentive Plan (the &#8220;<span style="font-weight:bold">2018 Plan</span>&#8221;) so that we are able to continue to grant stock-based awards in order to continue to motivate existing key employees, consultants and members of our Board of Directors and align their financial interests with those of our stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon recommendation from the Compensation Committee, on April&#160;4, 2025 the Board of Directors approved Amendment No.&#160;5 to our 2018 Stock Incentive Plan (the &#8220;<span style="font-weight:bold">Amendment</span>&#8221;). The Board of Directors believes that the Amendment serves a critical role in attracting and retaining the high-caliber employees, consultants and directors that are essential to our success and in motivating these individuals to strive to reach our goals. By approving the Amendment, stockholders will be approving the addition of 5,000,000 shares to the 2018 Plan, representing approximately 4.1% of our outstanding common stock as of the close of business on the Record Date on a fully diluted basis. The 2018 Plan, as amended previously, has reserved 21&#160;million shares of common stock for issuance, 1,774,678 of which currently remain available for future issuance. This Amendment will increase the number of shares available for issuance to 6,774,678 shares available for future issuance. Such terms are described in &#8220;2018 Stock Incentive Plan&#8221; below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proposal requires the affirmative vote of the holders of a majority in voting power of the votes cast affirmatively or negatively. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Board unanimously recommends a vote FOR the proposal to amend our 2018 Stock Incentive Plan to add an additional 5,000,000 shares to the Plan. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_7">2018 S<small style="font-weight:inherit;font-style:unset;text-decoration:unset">TOCK</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NCENTIVE</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LAN</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2018 Plan was approved by our board of directors in February 2018 and became effective in May 2018 after its approval by our stockholders at our 2018 annual meeting of stockholders. Amendments adding additional shares to the 2018 Plan were approved by our stockholders at the 2020 annual meeting of stockholders, the 2021 annual meeting of stockholders, the 2023 annual meeting of stockholders and the 2024 annual meeting of stockholders. However, as the Company has continued to grow, there has been a need to add additional shares to the 2018 Plan so that the Company can continue to use stock-based compensation as part of the overall compensation package required to bring necessary talent to the Company. The Board believes that based on the current configuration of the company, with this grant adding additional shares to the 2018 Plan the Company should have sufficient shares available for the next two to three years. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Administration </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee of the Board administers the 2018 Plan and determines which persons will receive grants of awards and the type of award to be granted to such persons. The Compensation Committee will also interpret the provisions of the 2018 Plan and make all other determinations that it deems necessary or advisable for the administration of the 2018 Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Eligibility to Participate in the 2018 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All eligible individuals are able to participate in the 2018 Plan. Eligible individuals include our directors, officers, employees, independent contractors and consultants, as well as individuals who have accepted an offer of employment from us. As of the date of this proxy statement, six <span style="white-space:nowrap">non-employee</span> directors, eight executive officers, approximately 173 other employees, and one consultant are eligible to receive grants under the 2018 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because benefits under the 2018 Plan will require future actions by the Compensation Committee and the fair market value of our common stock at various dates, it is not possible to determine the benefits that will be received by eligible individuals under the 2018 Plan, if any. The securities that are underlying grants of awards under the 2018 Plan is our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Form of Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards under the 2018 Plan may be granted in any one or all of the following forms: (i)&#160;Incentive Stock Options within the meaning of Section&#160;422 of the Internal Revenue Code of 1986, as amended (the &#8220;<span style="font-weight:bold">Code</span>&#8221;), (ii)&#160;stock options that are not Incentive Stock Options (&#8220;<span style="font-weight:bold"><span style="white-space:nowrap">Non-Qualified</span> Stock Options</span>&#8221;, unless otherwise noted herein, &#8220;<span style="font-weight:bold">Options</span>&#8221; refers to both Incentive Stock Options and <span style="white-space:nowrap">Non-Qualified</span> Stock Options), (iii)&#160;the right to receive all or some portion of the increase in value of a fixed number of shares of the Company&#8217;s common stock (&#8220;<span style="font-weight:bold">Stock Appreciation Rights</span>&#8221; or &#8220;<span style="font-weight:bold">SARs</span>&#8221;), which may be awarded either in tandem with Options or on a stand-alone basis, (iv)&#160;shares of Common Stock that are restricted (&#8220;<span style="font-weight:bold">Restricted Shares</span>&#8221;), (v)&#160;the right to receive shares of the Company&#8217;s common stock at the end of a specified period (&#8220;<span style="font-weight:bold">RSU</span>s&#8221;), (vi)&#160;the right to receive a fixed number of shares of the Company&#8217;s common stock, or the cash equivalent, which is contingent on the achievement of certain performance goals (&#8220;<span style="font-weight:bold">Performance Shares</span>&#8221;), and (vii)&#160;the right to receive a designated dollar value, or shares of the Company&#8217;s common stock of the equivalent value, which is contingent on the achievement of certain performance goals (&#8220;<span style="font-weight:bold">Performance Units</span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, the Company has only granted stock options and RSUs to its officers, directors, employees, and consultants, and has not utilized any of the other forms of stock-based compensation that are available for grant under the 2018 Plan. However, the Compensation Committee reserves the right to grant in the future stock-based compensation in the other forms available under the 2018 Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stock Options </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options may be granted under the 2018 Plan for the purchase of shares of our common stock. The Compensation Committee may designate Options as either Incentive Stock Options or <span style="white-space:nowrap">Non-Qualified</span> Stock Options. The term of each Option granted will be determined by the Compensation Committee. However, no Incentive Stock Option will be exercisable more than ten years after the date it is granted, or in the case of an Incentive Stock Option granted to an employee owning more than 10% of the total combined voting power of all classes of stock of the Company (a &#8220;<span style="font-weight:bold">10% Stockholder</span>&#8221;), more than five years after the date it is granted. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price per share under each Incentive Stock Option will be specified by the Compensation Committee, but in no event may it be less than 100% of the market price per share of our common stock on the date the Incentive Stock Option is granted. In the case of an Incentive Stock Option granted to a 10% Stockholder, the purchase price per share must not be less than 110% of the market price of our common stock on the date of grant. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options may be exercised in whole or in part. Payment for such exercise must be made in cash or through the delivery to the Company of shares of common stock previously owned by the Option holder. The Compensation Committee, in its sole and absolute discretion, may allow other forms of payment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stock Appreciation Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock Appreciation Rights may be awarded by the Compensation Committee in such amounts and on such terms and conditions as the Compensation Committee shall determine, in its sole and absolute discretion. The terms and conditions of any Stock Appreciation Right shall be substantially identical to the terms and conditions that would apply if the grant of such Stock Appreciation Right had been the grant of an Option. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon exercise of a Stock Appreciation Right, the owner of such Stock Appreciation Right shall be entitled to receive payment in cash, in shares of common stock, or a combination thereof, as determined by the Compensation Committee in its sole and absolute discretion. The amount of such payment shall be determined by multiplying the excess, if any, of the fair market value of a share of common stock on the date of exercise over the fair market value of the common stock on the grant date, by the number of shares of common stock with respect to which the Stock Appreciation Rights are being exercised. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Restricted Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares of Restricted Stock may be granted, in such amounts and on such terms and conditions as the Compensation Committee may determine, in its sole and absolute discretion. The Compensation Committee shall impose such restrictions on any Restricted Stock granted under the 2018 Plan as it may deem advisable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as provided by the Compensation Committee in its sole and absolute discretion, Restricted Stock granted under the 2018 Plan will vest over a four-year period after the grant date in equal annual increments. Shares of Restricted Stock may also be granted subject to performance goals, and such shares will be released from restrictions only after the attainment of such performance goals has been certified by the Compensation Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by the Compensation Committee, until the expiration of all applicable restrictions, and subject to the terms of the Plan, (i)&#160;the Restricted Stock is treated as outstanding common stock in the Company, (ii)&#160;the participant holding shares of Restricted Stock may exercise full voting rights with respect to such shares, and (iii)&#160;the participant holding shares of Restricted Stock is entitled to all dividends and other distributions paid with respect to such shares while they are so held. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Restricted Stock Units (RSUs) </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RSUs may be granted, in such amounts and on such terms and conditions as the Compensation Committee may determine, in its sole and absolute discretion. The Compensation Committee shall impose such restrictions on any RSUs granted under the 2018 Plan as it may deem advisable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by the Compensation Committee in an award agreement, upon the expiration of all applicable restrictions, shares of the Company&#8217;s common stock will be paid within 60 days following the date the restrictions lapse. Participant&#8217;s holding RSUs will not have any rights of a stockholder until the underlying shares of the Company&#8217;s common stock are delivered. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Performance Shares and Performance Units </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Shares and Performance Units may be granted, in such amounts and on such terms and conditions as the Compensation Committee may determine, in its sole and absolute discretion. Performance Shares and Performance Units will be subject to the attainment of one or more <span style="white-space:nowrap">pre-established</span> performance goals. Such performance goals shall be established by the Committee in writing (other than options and SARs) and shall be based on one or more of the following business criteria: (i)&#160;the attainment of certain target levels of, or a specified increase in, the Company&#8217;s enterprise value or value creation targets; (ii)&#160;the attainment of certain target levels of, or a percentage increase in, the Company&#8217;s <span style="white-space:nowrap">after-tax</span> or <span style="white-space:nowrap">pre-tax</span> profits including, without limitation, that attributable to the Company&#8217;s continuing and/or other operations; (iii)&#160;the attainment of certain target levels of, or a specified increase relating to, the Company&#8217;s operational cash flow or working capital, or a component thereof; (iv)&#160;the attainment of certain target levels of, or a specified decrease relating to, the Company&#8217;s operational costs, or a component thereof; (v)&#160;the attainment of a certain level of reduction of, or other specified objectives with regard to limiting the level of increase in all or a portion of bank debt or other of the Company&#8217;s long-term or short-term public or private debt or other similar financial obligations of the Company, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee; (vi)&#160;the attainment of a specified percentage increase in earnings per share or earnings per share from the Company&#8217;s continuing operations; (vii)&#160;the attainment of certain target levels of, or a specified percentage increase in, the Company&#8217;s net sales, revenues, net income or earnings before income tax or other exclusions; (viii)&#160;the attainment of certain target levels of, or a specified increase in, the Company&#8217;s return on capital employed or return on invested capital; (ix)&#160;the attainment of certain target levels of, or a percentage increase in, the Company&#8217;s <span style="white-space:nowrap">after-tax</span> or <span style="white-space:nowrap">pre-tax</span> return on stockholder equity; (x)&#160;the attainment of certain target levels in the fair market value of the Company&#8217;s common stock; (xi)&#160;the growth in the value of an investment in the common stock assuming the reinvestment of dividends; (xii)&#160;the attainment of certain target levels of, or a specified increase in, EBITDA (earnings before income tax, depreciation and amortization); and/or attainment of synergies and cost reductions in connection with mergers, acquisitions and similar corporate transactions involving the Company. As soon as practicable after the end of a performance period (as set forth by the Compensation Committee), the Compensation Committee shall determine to what extent the Performance Shares or Performance Units have been earned on the basis of the Company&#8217;s performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Transferability of Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards are <span style="white-space:nowrap">non-transferable</span> other than by will or by the laws of descent and distribution or as otherwise expressly allowed by the Compensation Committee pursuant to a gift to members of an eligible person&#8217;s immediate family. The gift may be directly or indirectly transferred, by means of a trust, partnership, or otherwise. Stock options and SARs may be exercised only by the optionee, any such permitted transferee or a guardian, legal representative or beneficiary. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Treatment of Awards upon a Change in Control </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there is a change in control of Catalyst Pharmaceuticals, Inc., any award that is not exercisable and vested may immediately become exercisable and vested in the sole and absolute discretion of the Compensation Committee. Vested awards will be deemed earned and payable in full. The Compensation Committee may also terminate the awards, entitling participants to a cash payment. If we are liquidated or dissolved, awards may also be converted into the right to receive liquidation proceeds. In the event that the Compensation Committee does not terminate or convert an award upon a change of control, then the award will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amendments, Modifications and Termination </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board may, at any time, amend, suspend or terminate the 2018 Plan, but the Board may not impair the rights of holders of outstanding awards without the holder&#8217;s consent. No amendment to the 2018 Plan may be made without consent of our stockholders. In the event that an award is granted to a person residing outside of the United States, the Board may, at its discretion, modify the terms of the agreement to comply with the laws of the country of which the eligible individual is a resident. The 2018 Plan will terminate 10&#160;years after its effective date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Material Federal Income Tax Consequences </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a brief description of the principal federal income tax consequences, as of the date of this proxy statement, associated with the grant of awards under the 2018 Plan. This summary is based on our understanding of present United States federal income tax law and regulations. The summary does not purport to be complete or applicable to every specific situation. Furthermore, the following discussion does not address foreign, state or local tax consequences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Grant</span>. There is generally no United States federal income tax consequence to the participant solely by reason of the grant of incentive stock options or nonqualified stock options under the 2018 Plan, assuming the exercise price of the option is not less than the fair market value of the shares on the date of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Exercise</span>. The exercise of an incentive stock option is not a taxable event for regular federal income tax purposes if certain requirements are satisfied, including the requirement that the participant generally must exercise the incentive stock option no later than three months following the termination of the participant&#8217;s employment with us. However, such exercise may give rise to alternative minimum tax liability (see &#8220;<span style="font-weight:bold">Alternative Minimum Tax</span>&#8221; below). Upon the exercise of a nonqualified stock option, the participant will generally recognize ordinary income in an amount equal to the excess of the fair market value of the shares at the time of exercise over the amount paid by the participant as the exercise price. The ordinary income recognized in connection with the exercise by a participant of a nonqualified stock option will be subject to both wage and employment tax withholding, and we generally will be entitled to a corresponding deduction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The participant&#8217;s tax basis in the shares acquired pursuant to the exercise of an option will be the amount paid upon exercise plus, in the case of a nonqualified stock option, the amount of ordinary income, if any, recognized by the participant upon exercise thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Disqualifying Disposition</span>. If the participant disposes of shares of our common stock acquired upon the exercise of an incentive stock option (other than in certain tax free transactions) within two years from the date on which the incentive stock option was granted or within one year after the transfer of shares to the participant pursuant to the exercise of the incentive stock option, at the time of disposition the participant will generally recognize ordinary income equal to the lesser of: (i)&#160;the excess of each such share&#8217;s fair market value on the date of exercise over the exercise price paid by the participant, or (ii)&#160;the participant&#8217;s actual gain. If the total amount realized on a taxable disposition (including return on capital and capital gain) exceeds the fair market value on the date of exercise of the shares of our common stock purchased by the participant under the option, the participant will recognize a capital gain in the amount of the excess. If the participant incurs a loss on the disposition (the total amount realized is less than the exercise price paid by the participant), the loss will be a capital loss. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Disposition</span>. If a participant disposes of shares of our common stock acquired upon exercise of a nonqualified stock option in a taxable transaction, the participant will recognize capital gain or loss in an amount equal to the difference between the participant&#8217;s basis (as discussed above) in the shares sold and the total amount realized upon disposition. Any such capital gain or loss (and any capital gain or loss recognized on a disqualifying disposition of shares of our common stock acquired upon exercise of incentive stock options as discussed above) will be short-term or long-term depending on whether the shares of our common stock were held for more than one year from the date such shares were transferred to the participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Alternative Minimum Tax</span>. Alternative minimum tax is payable if and to the extent the amount thereof exceeds the amount of the taxpayer&#8217;s regular tax liability, and any alternative minimum tax paid generally may be credited against future regular tax liability (but not future alternative minimum tax liability). Alternative minimum tax applies to alternative minimum taxable income. Generally, regular taxable income as adjusted for tax preferences and other items is treated differently under the alternative minimum tax. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For alternative minimum tax purposes, the spread upon exercise of an incentive stock option (but not a nonqualified stock option) will be included in alternative minimum taxable income, and the taxpayer will receive a tax basis equal to the fair market value of the shares of our common stock at such time for subsequent alternative minimum tax purposes. However, if the participant disposes of the incentive stock option shares in the year of exercise, the alternative minimum tax income cannot exceed the gain recognized for regular tax purposes, provided that the disposition meets certain third-party requirements for limiting the gain on a disqualifying disposition. If there is a disqualifying disposition in a year other than the year of exercise, the income on the disqualifying disposition is not considered alternative minimum taxable income. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no federal income tax consequences to us by reason of the grant of incentive stock options or nonqualified stock options or the exercise of an incentive stock option (other than disqualifying dispositions). At the time the participant recognizes ordinary income from the exercise of a nonqualified stock option, we will be entitled to a federal income tax deduction in the amount of the ordinary income so recognized (as described above), provided that we satisfy our reporting obligations described below. To the extent the participant recognizes ordinary income by reason of a disqualifying disposition of the stock acquired upon exercise of an incentive stock option, and subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we generally will be entitled to a corresponding deduction in the year in which the disposition occurs. We are required to report to the Internal Revenue Service any ordinary income recognized by any participant by reason of the exercise of a nonqualified stock option. We are required to withhold income and employment taxes (and pay the employer&#8217;s share of the employment taxes) with respect to ordinary income recognized by the participant upon exercise of nonqualified stock options. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stock Appreciation Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are generally no tax consequences to the participant or us by reason of the grant of stock appreciation rights. In general, upon exercise of a stock appreciation rights award, the participant will recognize taxable ordinary income equal to the excess of the stock&#8217;s fair market value on the date of exercise over the stock appreciation rights&#8217; base price, or the amount payable. Generally, with respect to employees, we are required to withhold from regular wages or supplemental wage payments an amount based on the ordinary income recognized. Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we generally will be entitled to a business expense deduction equal to the taxable ordinary income realized by the participant. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Restricted Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless a participant makes a Section&#160;83(b) election, as described below, with respect to restricted stock granted under the 2018 Plan, a participant receiving such an award will not recognize U.S. taxable ordinary income and we will not be allowed a deduction at the time such award is granted. While an award remains unvested or otherwise subject to a substantial risk of forfeiture, a participant will recognize compensation income equal to the amount of any dividends received and we will be allowed a deduction in a like amount. When an award vests or otherwise ceases to be subject to a substantial risk of forfeiture, the excess of the fair market value of the award on the date of vesting or the cessation of the substantial risk of forfeiture over the amount paid, if any, by the participant for the award will be ordinary income to the participant and will be claimed as a deduction for federal income tax purposes by us. Upon disposition of the shares received, the gain or loss recognized by the participant will be treated as capital gain or loss, and the capital gain or loss will be short-term or long-term depending upon whether the participant held the shares for more than one year following the vesting or cessation of the substantial risk of forfeiture. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, by filing a Section&#160;83(b) election with the Internal Revenue Service within 30 days after the date of grant, a participant&#8217;s ordinary income and commencement of holding period and the deduction will be determined as of the date of grant. In such a case, the amount of ordinary income recognized by such a participant and deductible by us will be equal to the excess of the fair market value of the award as of the date of grant over the amount paid, if any, by the participant for the award. If such election is made and a participant thereafter forfeits his or her award, no refund or deduction will be allowed for the amount previously included in such participant&#8217;s income. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, with respect to employees, we are required to withhold from regular wages or supplemental wage payments an amount based on the ordinary income recognized. Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code the satisfaction of a tax reporting obligation and any tax withholding condition, we generally will be entitled to a business expense deduction equal to the taxable ordinary income realized by the recipient. Upon disposition of stock, the recipient will recognize a capital gain or loss equal to the difference between the selling price and the sum of the amount paid for such stock, if any, plus any amount recognized as ordinary income upon acquisition (or vesting) of the stock. Such gain or loss will be long- or short-term depending on whether the stock was held for more than one year from the date ordinary income is measured. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Restricted Stock Units (RSUs) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the recipient of a restricted stock unit award structured to conform to the requirements of Section&#160;409A of the Code or an exception to Section&#160;409A of the Code will recognize ordinary income at the time the shares are delivered to the participant in an amount equal to the excess, if any, of the fair market value of the shares received over any amount paid by the recipient in exchange for the shares. If a restricted stock unit award is subject to Section&#160;409A of the Code, the shares subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability, or a change in control. If delivery occurs on another date, unless the restricted stock unit awards otherwise comply with or qualify for an exception to the requirements of Section&#160;409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid, if any, for shares plus any ordinary income recognized when the stock is delivered. Subject to the requirement of reasonableness, the provisions and limitations of Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to an income tax deduction equal to the amount of ordinary income realized by the participant. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Section&#160;409A </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an award under the 2018 Plan is subject to Section&#160;409A of the Code, but does not comply with the requirements of Section&#160;409A of the Code, the taxable events as described above could apply earlier than described, and could result in the imposition of additional taxes and penalties. Participants are urged to consult with their tax advisors regarding the applicability of Section&#160;409A of the Code to their awards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Potential Limitation on Company Deductions </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;162(m) of the Code generally disallows a tax deduction for compensation in excess of $1&#160;million paid in a taxable year by a publicly held corporation to its chief executive officer and certain other &#8220;covered employees&#8221;. Our board of directors and Compensation Committee intend to consider the potential impact of Section&#160;162(m) on grants made under the 2018 Plan but reserve the right to approve grants of options and other awards for an executive officer that exceeds the deduction limit of Section&#160;162(m). </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_8">P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSAL</small> T<small style="font-weight:inherit;font-style:unset;text-decoration:unset">HREE</small> &#8211; A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">DVISORY</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">PPROVAL</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">THE</small> C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMPENSATION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> N<small style="font-weight:inherit;font-style:unset;text-decoration:unset">AMED</small> E<small style="font-weight:inherit;font-style:unset;text-decoration:unset">XECUTIVE</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">FFICERS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;<span style="font-weight:bold">Dodd-Frank Act</span>&#8221;), our stockholders are entitled to vote at the Annual Meeting to provide advisory approval of the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the SEC. Pursuant to the Dodd-Frank Act, the stockholder vote on executive compensation is an advisory vote only, and it is not binding on us or our Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the result of the vote is <span style="white-space:nowrap">non-binding,</span> our Compensation Committee and Board value the opinions of the stockholders and will consider the outcome of the vote when making future compensation decisions. As described more fully in the &#8220;Compensation Discussion and Analysis&#8221; section of this proxy statement, our executive compensation program is designed to attract, retain and motivate individuals with superior ability, experience and leadership capability to deliver on our annual and long-term business objectives necessary to create stockholder value. We urge stockholders to read the &#8220;Compensation Discussion and Analysis&#8221; section of this proxy statement, which describes in detail how our executive compensation policies and procedures operate and are intended to operate in the future. The Compensation Committee and the Board believe that our executive compensation program fulfills these goals and is reasonable, competitive and aligned with our performance and the performance of our executives. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking our stockholders to indicate their support for our named executive officer compensation as described in this proxy statement. This proposal, commonly known as a <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;say-on-pay&#8221;</span></span> proposal, gives our stockholders the opportunity to express their views on our named executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we ask that our stockholders vote &#8220;<span style="font-weight:bold">FOR</span>&#8221; the following resolution: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">RESOLVED</span>, that Catalyst Pharmaceuticals, Inc.&#8217;s stockholders approve, on an advisory basis, the 2024 compensation of the named executive officers, as disclosed in Catalyst Pharmaceuticals, Inc.&#8217;s Proxy Statement for the 2025 Annual Meeting. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the voting power of the votes cast affirmatively or negatively on the proposal will be required to approve the advisory vote regarding the compensation of the named executive officers. Abstentions will not be counted toward the tabulation of votes cast on this proposal and will have no effect on the proposal. Broker <span style="white-space:nowrap">non-votes</span> will have no effect on this proposal as brokers or other nominees are not entitled to vote on such proposal in the absence of voting instructions from the beneficial owner. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">The Board unanimously recommends a vote FOR the approval of the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the SEC</span>. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">E<small style="font-weight:inherit;font-style:unset;text-decoration:unset">XECUTIVE</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">FFICERS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following list reflects our executive officers as of the date of this Proxy Statement, the capacity in which they serve us, and when they assumed office: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:40%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:37%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position(s)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Age</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Executive</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Officer Since</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Richard J. Daly</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director, President, and Chief Executive Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">64</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">January 2024</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Steven R. Miller, Ph.D.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Executive Vice President, Chief Operating Officer, and Chief Scientific Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">63</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">April 2007</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Michael W. Kalb, CPA</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Executive Vice President, Treasurer, and Chief Financial Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">54</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">January 2024</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Gary Ingenito, M.D., Ph.D.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Medical and Regulatory Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">69</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">June 2015</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Brian Elsbernd, J.D.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Compliance Officer and Chief Legal Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">61</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">February 2016</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Jeffrey Del Carmen</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Executive Vice President, Chief Commercial Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">54</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">June 2020</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Preethi Sundaram, Ph.D.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Strategy Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">49</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">July 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Gregg Russo</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Human Resources Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">62</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">February 2025</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officers&#8217; Business Experience </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Richard J. Daly.</span> The business experience of Richard J. Daly is included above in &#8220;Board of Directors.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Steven R. Miller, Ph.D.</span>, has served as our Executive Vice President since January&#160;1, 2024, as our Chief Operating Officer since January 2011, and as our Chief Scientific Officer since October 2009. Previously, commencing in April 2007, Dr.&#160;Miller was our Vice President of Pharmaceutical Development and Project Management. Dr.&#160;Miller has worked in the healthcare industry for over 30 years. Prior to joining us, Dr.&#160;Miller spent 15 years with various divisions of Watson Laboratories, a subsidiary of Watson </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Pharmaceuticals, Inc., most recently as Executive Director of R&amp;D Operations. In this capacity, Dr.&#160;Miller managed a team of 75 in the testing of all R&amp;D products for clinical trials, including method valuation, stability testing, operation of the R&amp;D pilot plant, and assembly of the CMC section of drug applications, in addition to other responsibilities. Prior to holding this position, Dr.&#160;Miller was Director of Technology Transfer for Watson Laboratories, and Vice President of Research and Product Development for Royce Laboratories, which was subsequently acquired by Watson Laboratories. Prior to joining Royce Laboratories, Dr.&#160;Miller was Group Leader and Senior Scientist at Dade Behring. Prior to that, he served as an Analytical Chemist at the U.S. Food&#160;&amp; Drug Administration. Dr.&#160;Miller received his Bachelor of Science Degree in Chemistry from the University of Maryland and his Ph.D. from the University of Miami. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Michael W. Kalb</span> joined us as our Executive Vice President, Treasurer, and Chief Financial Officer on January&#160;1, 2024. Mr.&#160;Kalb has more than 30 years of experience in the pharmaceutical and financial service industries. Prior to joining us, (i)&#160;from May 2023 until December 2023, Mr.&#160;Kalb served as Chief Financial Officer of Impel Pharmaceuticals, a commercial-stage biopharmaceutical company developing therapies for people suffering from diseases with high unmet medical needs, (ii)&#160;from November 2022 until March 2023, Mr.&#160;Kalb served as Executive Vice President and Chief Financial Officer of CinCor Pharma, Inc., a clinical stage biopharmaceutical company focused on developing treatments for cardiovascular diseases, which was acquired by AstraZeneca in February 2023, (iii) from June 2016 until June 2022, Mr.&#160;Kalb served as Senior Vice President and Chief Financial Officer of Amarin Corporation plc, a multinational biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, and (iv)&#160;from June 2009 until June 2016, Mr.&#160;Kalb served in several financial senior management positions at Taro Pharmaceutical Industries, Ltd., including as Group Vice President and Chief Financial Officer. Prior to that, Mr.&#160;Kalb served as a Director in the Accounting and Financial Consulting Group of Huron Consulting Group Inc. His experience also includes over ten years of public accounting experience, principally at Ernst and Young. In December 2023, Impel Pharmaceuticals filed for Chapter 11 bankruptcy. Mr.&#160;Kalb holds a B.S. in Accounting from the State University of New York at Albany, School of Business. Mr.&#160;Kalb is a certified public accountant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Gary Ingenito, M.D., Ph.D., </span>is our Chief Medical and Regulatory Officer. He joined us as our Chief Medical Officer in June 2015 and took over our regulatory operations in February 2016. Prior to joining Catalyst, Dr.&#160;Ingenito spent more than 25 years in the field of pharmaceutical development; including drugs, biologics, and combination products. During this time, Dr.&#160;Ingenito has held executive responsibilities for clinical research, regulatory, drug safety, and medical affairs at pharmaceutical companies and contract research organizations. Dr.&#160;Ingenito initially joined Sandoz Pharmaceuticals in the neuroendocrine group and progressed to become head of medical affairs. He spent 8 years at Otsuka Pharmaceuticals, overseeing the approval of anti-infective, cardiovascular, and central nervous system products. Dr.&#160;Ingenito has also held positions at Corning-Besselaar, SFBC International, Angiotech Pharmaceuticals, Biotest Pharmaceuticals, and, most recently at Boehringer-Ingelheim Pharmaceuticals, where he served as head of regulatory affairs North America for biosimilars. After obtaining his Bachelor of Arts degree from The Johns Hopkins University, Dr.&#160;Ingenito earned his medical degree at Jefferson Medical College, and a Ph.D. in&#160;philosophy from Thomas Jefferson University. He completed a post-graduate residency in neurology at the University of Miami, Jackson Memorial Hospital. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Brian Elsbernd, J.D.</span>&#160;joined us in February 2016 as our Senior Vice President of Legal and Compliance and became our Chief Compliance Officer and Chief Legal Officer on January&#160;1, 2019. Prior to joining Catalyst, Mr.&#160;Elsbernd was, from 2004 until February 2016, employed in various capacities with Mallinckrodt Pharmaceuticals and its predecessors, including as Senior Director of U.S. Healthcare Compliance. At Mallinckrodt, he was involved in the building of their formal compliance program including providing leadership and vision on ethics and business conduct while also managing multiple other legal and business functions. Before joining Mallinckrodt, Mr.&#160;Elsbernd was an associate at Proskauer Rose LLP, within its Health Care practice group, representing health care providers nationwide in matters pertaining to regulatory and administrative law, transactional matters, litigation, and reimbursement issues. Mr.&#160;Elsbernd holds a Bachelor of Arts degree in history from the University of Illinois-Urbana and a law degree from the Saint Louis University School of Law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Jeffrey Del Carmen</span>&#160;has been our Executive Vice President since January&#160;1, 2024 and our Chief Commercial Officer since June&#160;23, 2020. Previously, since July 2018, Mr.&#160;Del Carmen served as our Senior Vice President of Sales and Marketing. Mr.&#160;Del Carmen has over 25 years of experience in pharmaceutical sales and project management. Prior to joining Catalyst, from January 2018 until July 2018, Mr.&#160;Del Carmen served as Vice President of Business Development of Paragon Biosciences evaluating commercial assets to expand Paragon&#8217;s portfolio. From September 2016 until June 2017 (when it was acquired by PTC Therapeutics), Mr.&#160;Del Carmen was Senior Director, Rare Disease Marketing for Marathon Pharmaceuticals, leading Marathon&#8217;s marketing efforts for the commercialization of Emflaza. From January 2016 until August 2016, Mr.&#160;Del Carmen served as Vice President of Sales at Insys Therapeutics. From August 2011 until January 2016, Mr.&#160;Del Carmen was employed by Lundbeck Inc., where for the last two years of his tenure at Lundbeck he was the Movement Disorder National Sales Director. Prior to joining Lundbeck, Mr.&#160;Del Carmen spent 16 years at Abbott Laboratories in various sales and marketing leadership roles, with increasing responsibility. Mr.&#160;Del Carmen holds a Bachelor of Arts degree in Economics from the University of Dayton and an Executive MBA degree from the University of Wisconsin. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Preethi</span><span style="font-weight:bold"> </span><span style="font-weight:bold">Sundaram</span><span style="font-weight:bold">, Ph.D., </span>has been our Chief Strategy Officer since January&#160;1, 2022. Previously, since July 2021, Dr.&#160;Sundaram served as our Chief Product Development Officer. Dr.&#160;Sundaram has more than 20 years&#8217; experience managing and mentoring teams delivering lifesaving medicines to patients. Prior to her employment with Catalyst, since 2005 Dr.&#160;Sundaram was employed in various positions with Sanofi, including as Global Clinical Research Director, International Development from 2005-2010, Global Project Head, Multiple Therapeutic Area Programs from 2010 until 2017, Global Head and VP, Medical Operations, Primary Care Business Unit from 2017 until 2020, and since October 2020, as Sanofi&#8217;s Global Head and VP, Medical Operations, General Medicines Business Unit. In that last position, Dr.&#160;Sundaram was accountable for leadership of critical global medical operational functions, including the oversight of portfolio financials and delivery of strategic milestones, as well as being responsible for the leadership of multiple portfolio management functions across all therapeutic areas in Sanofi&#8217;s General Medicines Business Unit. Prior to joining Sanofi in 2005, Dr.&#160;Sundaram served as a Project Lead, Immunoscience Development Center for Abbott Laboratories; between 2003 until 2005, Dr.&#160;Sundaram served as a medical writer and project lead at Covance; between 2001 until 2003, Dr.&#160;Sundaram served as a Clinical Director with Neurovision&#160;&amp; Medical Services; between 1997 until 2001, Dr.&#160;Sundaram was a Graduate Teaching Assistant and Clinical Supervisor at West Norwich Hospital in Cambridge, UK; and between 1995 to 1997, Dr.&#160;Sundaram was on the clinical faculty at the Sankara Nethralaya Eye Hospital in Chennai, India. Additionally, since December 2024, Dr.&#160;Sundaram serves on the board of directors of Cilcare, a privately owned biotechnology company specializing in auditory sciences. Dr.&#160;Sundaram holds a Bachelor of Arts in Psychology from the University of Madras (India), a Bachelor of Science in Optometry from the Elite School of Optometry&#160;&amp; Bits (India), a Doctor of Philosophy in Optometry from Anglia Ruskin University (United Kingdom), and an Executive Business Masters from the London Business School. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Gregg Russo</span> joined us as our Vice President of Human Resources on April&#160;8, 2024 and became our Chief Human Resources Officer on February&#160;13, 2025. From 2021 until joining Catalyst, Mr.&#160;Russo served as Managing Director of Kavod Consulting, a human resource consultancy focused on emerging pharmaceutical and biotech organizations. From 2019 to 2021, Mr.&#160;Russo served as Chief Human Resources Officer of BeyondSpring Pharmaceuticals, a <span style="white-space:nowrap">pre-commercial</span> oncology organization, and from 2015 to 2019, Mr.&#160;Russo served as Head of Human Resources for Chugai Pharma, a translational/early-stage clinical research division of F. <span style="white-space:nowrap">Hoffman-La</span> Roche AG (commonly known as Roche). From 2014-2015, Mr.&#160;Russo served as a Business Development Partner with ExxPharma Therapeutics, LLC and from 2013 to 2014, he served as the Human Resources Lead for NeuroStem. Prior to NeuroStem, he served in varying lead human resources roles since 1996. Mr.&#160;Russo holds a Bachelor of Arts degree in Communication and a Master of Arts degree in Organizational Communication from the State University of New York at Buffalo. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Family Relationships </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between or among any of our directors and/or executive officers. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_9">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMPENSATION</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ISCUSSION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AND</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NALYSIS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The role of the compensation committee in setting executive officer compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee establishes and regularly reviews our compensation philosophy and programs, exercises authority with respect to the determination and payment of base and incentive compensation to our executive officers and administers our 2018 Stock Incentive Plan (the &#8220;<span style="font-weight:bold">2018 Plan</span>&#8221;). Our Compensation Committee consists of three members of our Board, each of whom is independent as that term is defined in the Sarbanes-Oxley Act of 2002 and the rules and regulations that have been promulgated thereunder and under the Exchange Act, and in the applicable NASDAQ listing standards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Executive officers </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2024, our Board designated that our &#8220;executive officers&#8221; (as that term is defined in the rules and regulations under the Exchange Act) were our Chief Executive Officer (Richard J. Daly), our Chief Operating Officer and Chief Scientific Officer (Dr.&#160;Steven R. Miller), our Chief Financial Officer (Michael W. Kalb), our Chief Medical and Regulatory Officer (Dr.&#160;Gary Ingenito), our Chief Commercial Officer (Jeffrey Del Carmen), our Chief Compliance Officer and Chief Legal Officer (Brian Elsbernd), and our Chief Strategy Officer (Dr.&#160;Preethi Sundaram). Each of these executive officers were employed by us for all of fiscal 2024. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Overview of executive officer compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In evaluating executive compensation, our Compensation Committee receives third-party data and analysis on market trends and competitive practices from its independent compensation consultant. The Compensation Committee also receives and considers the recommendations of our Chief Executive Officer with respect to goals and compensation of executive officers. Our Compensation Committee assesses the information it receives in accordance with its business judgment. Our Chief Executive Officer is not present when his compensation is discussed by the Compensation Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Compensation Committee believes that our executive officers are instrumental to our success. To that end, our compensation program is designed around the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:31%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:54%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="text-decoration:underline">Pay Element</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="text-decoration:underline">Form</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="text-decoration:underline">Purpose</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Base Salary</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cash (Fixed)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Provides a competitive level of compensation that reflects position responsibilities, strategic importance of the position, and individual experience.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Short-Term Incentive (Annual Bonus)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash Bonus</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Percent Fixed)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Provides a cash-based award that recognizes the achievement of annual goals and objectives supporting an annual business plan.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Long-Term Incentive</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Equity (Variable)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Provides incentives for management to execute goals supporting long-term stockholder value creation and our ability to recruit, retain and motivate key executives.</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also offer health and other insurance benefits to each of our employees, including our executive officers, and the benefits available to our executive officers are equal to the benefits available to all employees. No other perquisite benefits are available to our executive officers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Process of setting 2024 executive officer compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the fall of 2023, the Compensation Committee engaged Mercer LLC (a business of Marsh McLennan), an independent compensation consultant, to provide advice and recommendations relating to our executive officer and director compensation arrangements for the 2024 fiscal year. Initially, Mercer assisted the Compensation Committee in determining an appropriate peer group to evaluate the Company&#8217;s executive officer and director compensation for alignment with governance and market best practices, and to provide recommendations as to an appropriate compensation philosophy to guide the Compensation Committee in determining executive officer base, bonus and equity compensation for 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An updated peer group was selected by the Compensation Committee, with the advice of Mercer, in October 2023. The criteria used in determining the peer group were U.S. publicly traded biopharmaceutical companies with projected 2024 product revenues of $480&#160;million. The peer group selected was as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:50%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Acadia Pharmaceuticals Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Amicus Therapeutics, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Amphastar Pharmaceuticals, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Ani Pharmaceuticals, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Collegium Pharmaceutical, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Corcept Therapeutics Incorporated</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dynavax Technologies Corporation</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Halozyme Therapeutics, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Harmony Biosciences Holdings, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Insmed Incorporated</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Ionis Pharmaceuticals, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Ironwood Pharmaceuticals, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Pacira BioSciences, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">PTC Therapeutics, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Supernus Pharmaceutials, Inc.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Ultragenyx Pharmaceutical, Inc.</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2023, Mercer presented their report to the Compensation Committee of the compensation payable to the executive officers in Company&#8217;s peer group. Based on that information, in December 2023, the Compensation Committee set base compensation and a bonus target for 2024 for each executive officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, in January 2024, the Compensation Committee established the corporate goals and objectives for the payment of 2024 cash bonuses to executive officers, as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:91%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Objective</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Weight</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Achievement of total revenues in 2024 of at least $475&#160;million, including FIRDAPSE<sup style="font-size:75%; vertical-align:top">&#174;</sup> net product revenues for 2024 of at least $301.6&#160;million and AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> net product revenues for 2024 of at least $20&#160;million</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">40%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of a significant company or a <span style="white-space:nowrap">de-risked</span> late-stage orphan asset (CNS/adjacent orphan) before the end of 2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Global expansion &#8211; Entering into an agreement to <span style="white-space:nowrap">out-license</span> AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> or FIRDAPSE<sup style="font-size:75%; vertical-align:top">&#174;</sup> (in the APAC or LATAM regions)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating to the 2024 budget</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of an AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> life cycle management strategy plan by the Board of Directors by the August 2024 regular Board meeting</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">10%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">100%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thereafter, in December 2024, the Compensation Committee considered cash bonus compensation for the Company&#8217;s executive officers for 2024 services based on the previously established corporate goals and objectives. In reaching a determination as to the cash bonuses to grant for 2024 performance, the Compensation Committee considered the following factors: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company achieved total revenues in 2024 of approximately $492&#160;million, exceeding the 2024 goal by $17&#160;million. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s net product revenues in 2024 for FIRDAPSE<sup style="font-size:75%; vertical-align:top">&#174;</sup> were approximately $306&#160;million, exceeding the 2024 goal of $301.6&#160;million. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s net product revenues in 2024 for AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> were approximately $46&#160;million, exceeding the 2024 goal of $20&#160;million. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company entered into an agreement in July 2024 to <span style="white-space:nowrap">out-license</span> AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> in Canada with KYE Pharmaceuticals, Inc. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company operated to the 2024 budget, with approximately $32&#160;million of favorable net income over budget. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Management presented an AGAMREE<sup style="font-size:75%; vertical-align:top">&#174;</sup> life-cycle plan to the Board at the August 2024 Board meeting, which plan was approved by the Board at that meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">While the Company did not achieve its goal of acquiring a significant company or a <span style="white-space:nowrap">de-risked,</span> late-stage orphan asset by the end of 2024, management evaluated over 100 opportunities and entered into three term sheets for acquisition (none of which were ultimately determined, after diligence, to be in the best interest of the company) during 2024. Further, several potential acquisition transactions for which diligence was performed during 2024 are still being actively considered. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After considering these factors, none of which was, in and of itself dispositive, but all of which were considered, the Compensation Committee determined that cash bonuses would be paid to executive officers for their 2024 services at 105% of each respective executive officer&#8217;s previously established bonus target. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finally, in November 2024, the Compensation Committee granted stock options and RSUs to each of the Company&#8217;s executive officers who will serve in 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The base and bonus compensation for our Principal Executive Officer, Principal Financial Officer, and our three most highly compensated officers for services during the fiscal years ended December&#160;31, 2024, 2023 and 2022, as applicable, as well as the value of the option and RSU grants made to each such executive officer in 2024, 2023, and 2022, as applicable, are described in the following summary compensation table: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">[Table on Next Page] </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Awards ($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name and Principal Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Year</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Salary<br/>($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Cash<br/>Bonus<br/>($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">RSU Stock<br/>Grants (1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Stock<br/>Options<br/>(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="white-space:nowrap">Non-Equity</span><br/>Incentive<br/>Compensation</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">All Other<br/>Compensation<br/>($) (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Totals ($)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly, President and CEO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">590,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,267,601</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,070,830</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">95,104</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,774,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb, EVP and CFO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">350,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,036,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,147,345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">121,163</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,180,936</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller, COO and CSO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2023</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2022</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">560,000<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">525,000</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">496,827</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">352,800<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">346,500</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">300,000</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">523,797<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">503,995</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">1,091,560</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,095,377<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,016,003</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">1,574,196</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,800<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">13,200</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">12,200</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,545,774<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">3,404,698</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">3,474,783</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen, CCO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2023</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2022</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">475,000</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">449,000</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">275,625<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">256,500</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">211,200</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">355,006<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">341,256</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">725,900</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,420,124<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">1,364,991</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">948,830</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62,372<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">68,319</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">51,502</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,638,127<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,506,066</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,386,432</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram, Chief Strategy Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2023</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2022</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">485,000<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">440,000</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">415,674</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">254,625<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">237,600</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">226,600</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">355,006<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">290,995</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">750,800</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,420,124<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">1,164,003</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">733,187</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">&#8212;&#8194;</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,800<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">13,200</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">12,200</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,528,555<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,145,798</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">2,138,461</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&#160;</p></td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts reported are based on the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 for restricted stock unit grants to the executive officers in the listed fiscal year. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts reported represent the grant date fair value of stock option awards granted in accordance with FASB ASC Topic 718 for the listed year. For additional information on the valuation assumptions used in the calculation of these amounts, see Note 16 to &#8220;Notes to Consolidated Financial Statements&#8221; contained in our 2024 Form <span style="white-space:nowrap">10-K.</span> </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes, for Mr.&#160;Daly, Mr.&#160;Kalb and Mr.&#160;Del Carmen, a housing allowance, and for Mr.&#160;Kalb, a travel allowance. All other compensation consists of 401(k) employer match. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Employment Agreements and Potential Payments upon Termination or Change in Control </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a severance and change in control plan in place that provides for severance if those of our executive officers designated to participate in the benefits under the plan are terminated for other than &#8220;cause&#8221; or if they terminate their employment with us for &#8220;good reason&#8221;, and for severance compensation in the event of a &#8220;change in control&#8221; (as all of those terms are defined in the plan). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our severance and change in control plan, </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">on a termination without &#8220;cause&#8221; or a termination for &#8220;good reason&#8221; of a designated executive, the executive will receive one year&#8217;s base salary, any accrued bonus prior to termination, 12 month accelerated vesting of stock options, and benefits continuation for one year; provided that the terminated executive agrees to not compete with the company during the period in which severance is paid; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon a &#8220;change in control,&#8221; all outstanding stock options and other equity awards held by each designated executive that have not yet vested shall automatically vest; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon termination of a designated executive within one year of a &#8220;change in control,&#8221; the terminated executive will receive one year&#8217;s base salary, payment in full of any target bonus previously granted for the severance period, and benefits continuation for the severance period, again subject to the terminated executive agreeing not to compete with the company during the period in which severance is paid. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this Proxy Statement, the Compensation Committee has designated that Mr.&#160;Daly, Mr.&#160;Kalb, Mr.&#160;Del Carmen, Mr.&#160;Elsbernd, Dr.&#160;Ingenito, Dr.&#160;Miller, Dr.&#160;Sundaram, and Mr.&#160;Russo will receive benefits under the severance and change in control plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the plan, once an executive has been designated to participate in the severance benefits afforded by the plan, the Compensation Committee cannot modify the plan as to that designated executive to eliminate any benefits or to modify the definitions used in the policy to the detriment of the designated executive, unless otherwise agreed to by the designated executive. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following chart sets forth the amounts payable to our CEO, CFO, and our three most highly compensated employees assuming the enumerated events had occurred on December&#160;31, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:46%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">Name</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Payment&#160;Due&#160;Upon<br/>Termination either<br/>by&#160;company&#160;without<br/>Cause or Officer for<br/>Good Reason (1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Payment&#160;Due<br/>Upon Death<br/>or&#160;Permanent<br/>Disability</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Payment&#160;Due&#160;Upon&#160;a<br/>Termination by<br/>company&#160;with&#160;Cause&#160;or<br/>Resignation or<br/>Retirement</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Payment&#160;Due<br/>upon&#160;a&#160;Change<br/>in Control (1)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">560,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">560,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">485,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">485,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Excludes the value of any bonus due for services prior to termination, the value of health benefits for the term of the </p></td></tr></table> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">severance and the value of any accelerated vesting of stock options. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Grants of Plan-Based Awards for 2024 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information relating to stock options granted to our CEO, CFO, and our three most highly compensated employees during the fiscal year ended December&#160;31, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:57%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Grant Date</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center">Number of<br/>Securities<br/>Underlying<br/>Options&#160;(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Exercise&#160;Price&#160;of<br/>Option Awards<br/>($/share)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Grant&#160;Date&#160;Fair<br/>Value of<br/>Option<br/>Awards</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">491,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,070,830</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/01/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">257,214</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16.81</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,399,996</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">169,248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,747,349</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">202,958</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,095,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">137,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,420,124</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">137,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,420,124</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Except as otherwise indicated in footnote 3 below, all options vest <span style="white-space:nowrap">one-third</span> on the first anniversary of the grant date, <span style="white-space:nowrap">one-third</span> on the second anniversary of the grant date, and <span style="white-space:nowrap">one-third</span> on the third anniversary of the grant date and expire on the seventh anniversary of the grant date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Stock options granted to Mr.&#160;Daly in October 2023 in anticipation of his joining the Company as CEO effective January&#160;1, 2024 were reported in the Company&#8217;s proxy statement for the 2024 annual meeting of stockholders as part of the table reporting &#8220;Compensation of Directors.&#8221; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Options were awarded to Mr.&#160;Kalb on January&#160;1, 2024 upon commencement of employment as our CFO. These options vest <span style="white-space:nowrap">one-fifth</span> on the first anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the second anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the third anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the fourth anniversary of the grant date, and <span style="white-space:nowrap">one-fifth</span> on the fifth anniversary of the grant date, and expire on the seventh anniversary of the grant date. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the following table provides information relating to restricted stock units granted to our CEO, CFO and our three most highly compensated employees during 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Grant Date</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number&#160;of&#160;RSUs<br/>Granted (1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Grant&#160;Date&#160;Fair&#160;Value&#160;of<br/>RSU Awards</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">60,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,267,601</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/01/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"> 599,999</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">20,682</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"> 436,804</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24,801</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"> 523,797</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,809</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"> 355,006</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,809</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"> 355,006</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Except as otherwise indicated in footnote 3 below, RSUs vest <span style="white-space:nowrap">one-third</span> on the first anniversary of the grant date, <span style="white-space:nowrap">one-third</span> on the second anniversary of the grant date, and <span style="white-space:nowrap">one-third</span> on the third anniversary of the grant date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">RSUs granted to Mr.&#160;Daly in October 2023 in anticipation of his joining the Company as CEO effective January&#160;1, 2024 were reported in the Company&#8217;s proxy statement for the 2024 annual meeting of stockholders as part of the table reporting &#8220;Compensation of Directors.&#8221; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">RSUs were awarded to Mr.&#160;Kalb on January&#160;1, 2024 upon commencement of employment as CFO. These options vest <span style="white-space:nowrap">one-fifth</span> on the first anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the second anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the third anniversary of the grant date, <span style="white-space:nowrap">one-fifth</span> on the fourth anniversary of the grant date, and <span style="white-space:nowrap">one-fifth</span> on the fifth anniversary of the grant date, and expire on the seventh anniversary of the grant date. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Outstanding Stock Options and Restricted Stock Units </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently have one stock incentive plan: our 2018 Plan. Our 2014 Stock Incentive Plan has been fully terminated, with the last options granted under that plan having been exercised in early 2025. As of the Record Date, the following derivative securities were outstanding under our 2018 Plan: (i)&#160;stock options to purchase an aggregate of 12,577,619 shares of our common stock, at exercise prices ranging from $2.11 to $24.25 per share (7,079,684 of which are currently exercisable); and (ii)&#160;restricted stock units for 578,488 shares of common stock (none of which are currently vested). On the same date, 1,774,678 shares of common stock remained eligible for grant under the 2018 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the close of business on the Record Date, the market price of our common stock on the NASDAQ Stock Market was $24.25 per share. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Outstanding Equity Awards at Fiscal Year End </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information regarding equity-based awards held by our CEO, CFO and our three other most highly compensated employees as of December&#160;31, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:30%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="30">OUTSTANDING EQUITY AWARDS AT DECEMBER&#160;31, 2024</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Option Awards</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Stock Awards</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Unexercisable</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Unearned<br/>Options (#)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Option<br/>Exercise<br/>Price&#160;($)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Option&#160;Expiration<br/>Date</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number<br/>of&#160;Shares<br/>or Units<br/>of Stock<br/>that&#160;Have<br/>Not<br/>Vested</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Market<br/>Value<br/>of<br/>Shares<br/>or<br/>Units<br/>of<br/>Stock<br/>that<br/>Have<br/>Not<br/>Vested</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Number&#160;of<br/>Unearned<br/>Shares,<br/>Units, or<br/>Other<br/>Rights<br/>That Have<br/>Not&#160;Vested</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Market&#160;or<br/>Payout<br/>Value of<br/>Unearned<br/>Shares,<br/>Units, or<br/>Other<br/>Rights&#160;That<br/>Have Not<br/>Vested</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.24</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/19/2025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">33,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.64</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/02/2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3.42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/30/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">20,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/28/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18.59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/27/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,365,319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10/18/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">491,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,334</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">210,526</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">60,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">257,214</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16.81</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/01/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">169,248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">20,682</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">225,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.24</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/19/2025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">180,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.64</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/02/2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">275,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3.42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/30/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">185,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/28/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">97,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">48,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18.59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/27/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">82,668</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">165,336</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14.15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/08/3030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">202,958</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">23,746</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24,801</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,983</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.21</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/06/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.70</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">06/23/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">200,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3.42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/30/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">135,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/28/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58,666</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">29,334</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18.59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/27/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55,972</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">111,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14.15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/08/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">137,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,078</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,809</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">150,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">75,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5.49</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">07/06/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">67,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/28/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">45,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">22,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18.59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/27/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">47,731</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">95,462</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14.15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/08/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">137,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">21.12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,710</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16,809</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Option Exercises </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the exercise of stock options by our CEO, CFO, and our three most highly compensated employees during 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:61%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Grant Date</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Exercise&#160;Date</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number of<br/>Securities<br/>Underlying<br/>Options<br/>(#)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Exercise<br/>Price of<br/>Option<br/>Awards<br/>($/share)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/02/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">06/04/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">40,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.01</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/02/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/10/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.01</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/02/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/13/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">235,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.01</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">08/06/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">08/09/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.86</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc900407_10">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMPENSATION</small> C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMMITTEE</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">EPORT</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee has reviewed the Compensation &#8211; Discussion and Analysis required by Item 402(b) of Regulation <span style="white-space:nowrap">S-K</span> of the SEC&#8217;s rules and regulations with management and based on such review and discussions the Compensation Committee recommended to the Board of Directors that the Compensation &#8211; Discussion and Analysis be included in this Proxy Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Compensation Committee </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David S. Tierney, Chair </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles B. O&#8217;Keeffe </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Molly Harper </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Notwithstanding anything to the contrary set forth in any of our previous filings under the Securities Act of 1933, or the Securities Exchange Act of 1934 that might incorporate future filings, including this Proxy Statement, in whole or in part, the Compensation Committee Report above shall not be incorporated by reference into any such filings</span>. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="cprx-20241231.xsd"/></ix:references></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="txa900407_11" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">P<div style="font-weight: inherit; font-style: unset; text-decoration: unset; display: inline; font-size: smaller">AY</div> V<div style="font-weight: inherit; font-style: unset; text-decoration: unset; display: inline; font-size: smaller">ERSUS</div> P<div style="font-weight: inherit; font-style: unset; text-decoration: unset; display: inline; font-size: smaller">ERFORMANCE</div> </div></div><ix:nonNumeric name="ecd:NamedExecutiveOfficersFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-5271"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s principal executive officer (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div>&#8221;) and our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> named executive officers (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">NEO</div></div>s&#8221;) were as follows for the fiscal years ended December&#160;31, 2024, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:19%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:26%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:53%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PEO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="2" style="height:6pt"/>
<td colspan="2" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2024</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2024To12_31_2024" id="ixv-7474">Richard J. Daly</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Michael W. Kalb, Steven R. Miller, Jeffrey Del Carmen, Preethi Sundaram</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="2" style="height:6pt"/>
<td colspan="2" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Patrick J. McEnany</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="2" style="height:6pt"/>
<td colspan="2" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2022</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Patrick J. McEnany</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen</td></tr></table></ix:nonNumeric><ix:nonNumeric name="ecd:PvpTableTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" continuedAt="TextSelection_137734548" id="ixv-5326"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for the fiscal years ended December&#160;31, <div style="display:inline;">2024</div>, 2023 and 2022, and our financial performance for each such fiscal year: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value of Initial $100</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Fixed Investment Based</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">on (3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Table Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">for PEO ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Actually Paid</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">to PEO ($)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(1)(2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Table Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">for <div style="white-space:nowrap;display:inline;">non-PEO</div></div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="font-weight:bold;display:inline;">Average</div><br/><div style="font-weight:bold;display:inline;">Compensation</div><br/><div style="font-weight:bold;display:inline;">Actually Paid</div><br/><div style="font-weight:bold;display:inline;">to <div style="white-space:nowrap;display:inline;">non-PEO</div></div><br/><div style="font-weight:bold;display:inline;">NEOs (1)(2)</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Shareholder</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Return ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Peer Group</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Shareholder</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Return ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Income</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div><ix:nonNumeric name="ecd:CoSelectedMeasureName" contextRef="P01_01_2024To12_31_2024" id="ixv-5513"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Product</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Revenue</div></div></ix:nonNumeric><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7475">7,774,160</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7476">12,896,544</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7477">3,723,348</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7478">5,024,539</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7479">557</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7480">88</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7481">163,889</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7482">489,327</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7483">2,146,499</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7484">1,007,034</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7485">2,256,711</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7486">1,952,842</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7487">448</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7488">54</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7489">71,410</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7490">396,502</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7491">6,923,782</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7492">17,549,684</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7493">2,674,788</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7494">7,393,846</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7495">496</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7496">69</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7497">83,079</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="ixv-7498">213,938</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Amounts represent compensation actually paid (&#8220;CAP&#8221;) to our PEO and the average compensation actually paid to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for the relevant fiscal year, as determined under SEC rules (and described below). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fair value or change in fair value, as applicable, of stock options in the &#8220;Compensation Actually Paid&#8221; columns was estimated using a Black-Scholes option pricing model for the purposes of this disclosure in accordance with SEC rules and do not reflect compensation actually earned, realized or received during each applicable year. The calculation of CAP for purposes of this table includes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><div style="white-space:nowrap;display:inline;">point-in-time</div></div> fair values of equity awards and those values will fluctuate based on our stock price and various accounting valuation assumptions. See the Summary Compensation Table for certain other compensation of our PEO and our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for each applicable fiscal year. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><ix:nonNumeric name="ecd:PeerGroupIssuersFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-7499">For the relevant fiscal year, represents our cumulative TSR or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future.</ix:nonNumeric> </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>36</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_137734548" continuedAt="TextSelectionAppend_137734548_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_137734548_1" continuedAt="TextSelectionAppend_137734548_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_137734548_2" continuedAt="TextSelectionAppend_137734548_3"><ix:exclude><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_137734548_3"><ix:nonNumeric name="ecd:AdjToPeoCompFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-5678"><ix:nonNumeric name="ecd:AdjToNonPeoNeoCompFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-5679"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the table immediately above, the columns &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs&#8221; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT</div></div>&#8221;), as adjusted based on the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:38%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT&#160;Total&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Minus&#160;SCT</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">New&#160;Unvested</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">12/31 ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Annual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Prior</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">that Remain</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Unvested ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vested and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Granted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">During Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Change</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">in Value of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Prior Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards that</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vest During</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;CAP&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7501">7,774,160</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7502">6,338,431</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7503">6,922,548</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7504">4,488,419</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7505">49,848</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7506">12,896,544</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7507">2,146,499</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7508">749,999</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7509">943,365</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7510">736,903</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7511">595,928</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7512">1,007,034</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7513">6,923,782</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7514">5,727,859</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7515">7,659,348</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7516">3,460,212</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7517">5,234,201</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7518">17,549,684</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></div></td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7519">3,723,348</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7520">2,838,396</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7521">3,237,565</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7522">572,615</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7523">329,407</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7524">5,024,539</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7525">2,256,711</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7526">1,446,560</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7527">1,819,515</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7528">326,149</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7529">350,675</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7530">1,952,842</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7531">2,674,788</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-7532">1,939,664</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7533">2,316,864</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7534">2,394,265</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7535">1,947,593</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-7536">7,393,846</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables illustrate the valuation assumptions as of the vesting date for awards that vested in each of 2024, 2023 and 2022. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">
<tr>
<td style="width:55%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">For Stock Options Vesting in</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">3.85%&#160;-&#8201;4.52%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">3.75%&#160;-&#8201;4.65%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">1.30%&#160;-&#8201;4.00%</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">1.6&#160;-5.0&#160;years</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">4.5&#160;years</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">4.5&#160;years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">54.1% - 60.4%</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">68.0% - 71.0%</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">68.4% - 69.5%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected forfeiture rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">
<tr>
<td style="width:74%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="vertical-align:bottom;text-align:center"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted&#160;Average&#160;Fair&#160;Value&#160;of&#160;Full&#160;Value</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Awards Vesting in</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For Restricted Stock Units</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">11.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">11.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">4.65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table></ix:continuation><ix:nonNumeric name="ecd:TabularListTableTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-6196"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2024 Performance <div style="display:inline;">Measures</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following list represents the financial and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-financial</div> performance measures that we consider to have been the most important in linking Compensation Actually Paid to our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs to company performance. The measures in this list are not ranked. Of these measures, we have identified Net Product Revenue as our most important of our financial performance measures used to link Compensation Actually Paid to our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs to company performance: </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:nonNumeric name="ecd:MeasureName" contextRef="P01_01_2024To12_31_2024_1TypedMemberecdMeasureAxis" id="ixv-7537">Net Product Revenue</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:nonNumeric name="ecd:MeasureName" contextRef="P01_01_2024To12_31_2024_2TypedMemberecdMeasureAxis" id="ixv-7538">Net Income</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:nonNumeric name="ecd:MeasureName" contextRef="P01_01_2024To12_31_2024_3TypedMemberecdMeasureAxis" id="ixv-7539">Completion of a transformational acquisition</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:nonNumeric name="ecd:MeasureName" contextRef="P01_01_2024To12_31_2024_4TypedMemberecdMeasureAxis" id="ixv-7540">Quality and Compliance</ix:nonNumeric> </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Narrative Disclosure to Pay Versus Performance Table </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The graphs below compare the compensation actually paid to our PEO and the average of the compensation actually paid to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs with (i)&#160;our cumulative TSR, (ii)&#160;our Peer Group TSR, (iii)&#160;our net income, and (iv)&#160;our net product revenue, in each case for the fiscal years ended December&#160;31, 2024, 2023 and 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TSR amounts reported in the graph assume an initial fixed investment of $100 on January&#160;1, 2022 and, with respect to our cumulative TSR, based on the opening trading price on such date. </div><ix:nonNumeric name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-6222"><ix:nonNumeric name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-6223"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413317.jpg"/> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><ix:nonNumeric name="ecd:CompActuallyPaidVsNetIncomeTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-6230"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413608.jpg"/> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="display:inline;">38</div> </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-6244"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413831.jpg"/> </div></ix:nonNumeric><div id="txa900407_12" style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CEO P<div style="font-weight: inherit; font-style: unset; text-decoration: unset; display: inline; font-size: smaller">AY</div> R<div style="font-weight: inherit; font-style: unset; text-decoration: unset; display: inline; font-size: smaller">ATIO</div> </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As required by Item 402(u) of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Regulation&#160;S-K,&#160;the</div> Compensation Committee reviewed a comparison of our CEO&#8217;s annual total compensation in fiscal year 2024 to that of all of our other employees for 2024. We identified our median employee by reviewing the base salary, on an annualized basis, for all of our employees as of December&#160;31, 2024, for the period from January&#160;1, 2024 through December&#160;31, 2024, excluding our CEO. After identifying our median employee, we calculated total compensation for such employee using the same methodology we use for our named executive officers as set forth in the 2024 Summary Compensation Table above. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total annual compensation for fiscal year 2024 for our CEO was $7,774,160, as noted in the 2024 Summary Compensation table above. The median of the 2024 annual total compensation of all employees (other than our CEO) was $370,800. The resulting ratio of our CEO&#8217;s pay to the pay of our median employee for fiscal year 2024 was 21 to 1. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SEC rules for identifying the median of the total annual compensation of our employees and calculating the pay ratio based on that employee&#8217;s total annual compensation allows companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices. The pay ratio reported by other companies may not be comparable to the pay ratio for our company, as other companies have headquarters offices in different countries, have different employee populations and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their pay ratios. We believe that the pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our internal records and the methodology described above. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We invest in our employees at all levels in our company by rewarding performance that balances risk and reward, empowering professional growth and development and by offering affordable benefits and programs that meet the diverse needs of our employees. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_13">P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSAL</small> F<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OUR</small> &#8211; R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ATIFICATION</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">PPOINTMENT</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NDEPENDENT</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">UBLIC</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">CCOUNTING</small> F<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRM</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Audit Committee has appointed Grant Thornton, LLP (&#8220;Grant Thornton&#8221;) as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. The Board has directed that this appointment be submitted to our stockholders for ratification. Although ratification of our appointment of Grant Thornton is not required, we value the opinions of our stockholders and believe that stockholder ratification of our appointment is a good corporate governance practice. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Grant Thornton also served as our independent registered public accounting firm for the fiscal years ended December&#160;31, 2024, 2023, and 2022. Neither the accounting firm nor any of its members has any direct or indirect financial interest in or any connection with us in any capacity other than as our auditors, providing audit and <span style="white-space:nowrap">non-audit</span> services. A representative of Grant Thornton is expected to attend the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the appointment of Grant Thornton is not ratified by the stockholders, the Audit Committee will consider this fact when it appoints the independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. Even if the appointment of Grant Thornton is ratified, the Audit Committee retains the discretion to appoint a different independent registered public accounting firm at any time if it determines that such a change is in the interest of the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proposal requires the affirmative vote of the holders of a majority in voting power of the votes cast affirmatively or negatively. Abstentions are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. Because brokers have discretionary authority to vote on the ratification of the appointment of Grant Thornton, we do not expect any broker <span style="white-space:nowrap">non-votes</span> in connection with this proposal. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Board unanimously recommends a vote FOR the Ratification of the Appointment of Grant Thornton as our Independent Registered Public Accounting Firm. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Independent Auditor Fees </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table represents fees for professional audit and other services rendered by Grant Thornton for the fiscal years ended December&#160;31, 2024 and 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:78%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2024</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit fees (1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">613,923</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">489,779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-related fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total audit fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">613,923</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">489,779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All other fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">613,923</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">489,779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents aggregate fees billed for professional services rendered by Grant Thornton LLP for the audit of our financial statements included in our 2024 and 2023 Forms <span style="white-space:nowrap">10-K,</span> for their reviews of our quarterly reports during 2024 and 2023, and for their report on the effectiveness of our internal controls over financial reporting as of December&#160;31, 2024 and 2023. Includes for 2024, $70,384 in fees in connection with comfort letter and <span style="white-space:nowrap">S-8</span> Registration Statements and for 2023, $15,900 in fees in connection with <span style="white-space:nowrap">S-3&#160;and</span> <span style="white-space:nowrap">S-8</span> Registration Statements. Includes, for 2024 and 2023, $13,539 and $12,779, respectively, for the audit of the financial statements of our wholly owned subsidiary, Catalyst Pharmaceuticals Ireland, Ltd., a corporation organized in the Republic of Ireland. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Pre-Approval</span> of Audit Functions </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to its written charter, the Audit Committee is responsible for <span style="white-space:nowrap">pre-approving</span> all audit and permitted <span style="white-space:nowrap">non-audit</span> services to be performed for us by our independent registered public accounting firm or any other auditing or accounting firm. 100% of the services provided to us by Grant Thornton in 2024 and 2023 were <span style="white-space:nowrap">pre-approved</span> by the Audit Committee. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_14">A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">UDIT</small> C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OMMITTEE</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">EPORT</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management has the primary responsibility for our internal control over financial reporting, the financial reporting process and preparation of our financial statements. Grant Thornton LLP, our independent registered public accounting firm, is responsible for performing an independent audit of our financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) and to issue a report thereon. Grant Thornton LLP is also responsible for auditing our internal control over financial reporting in accordance with the standards of the PCAOB. The Audit Committee&#8217;s responsibility is to select the independent auditors and to monitor and oversee these processes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has met and held discussions with management and the independent auditors. Management represented to the Audit Committee that our financial statements were prepared in accordance with accounting principles generally accepted in the United States. The Audit Committee reviewed and discussed the audited financial statements with management and the independent auditors. In fulfilling its responsibilities, the Audit Committee discussed with the independent auditors the matters that are required to be discussed by Auditing Standard No.&#160;1301 (Communication with Audit Committees). In addition, the Audit Committee received from the independent auditors the written disclosures and letter required by PCAOB Ethics and Independence Rule 3526, Communications with Audit Committees Concerning Independence, and the Audit Committee discussed with the independent auditors that firm&#8217;s independence. In connection with this discussion, the Audit Committee also considered whether the provision of services by the independent auditors not related to the audit of our financial statements is compatible with maintaining the independent auditors&#8217; independence. During such discussions, the independent auditors confirmed that, as of December&#160;31, 2024, they were independent accountants with respect to our company within the meaning of applicable federal securities laws and the requirements of the PCAOB. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the Audit Committee&#8217;s discussions with management and the independent auditors and the Audit Committee&#8217;s review of the representations of management and the reports and letter of the independent auditors provided to the Audit Committee, the Audit Committee recommended to the Board that our audited financial statements for fiscal 2024 be included in our 2024 Form <span style="white-space:nowrap">10-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has also reviewed all <span style="white-space:nowrap">non-audit</span> services being provided by the independent auditors and has concluded that the provision of such services has been compatible with the maintenance of that firm&#8217;s independence in the conduct of its auditing functions. The Audit Committee has discussed these matters with representatives of the independent auditors and our management and will monitor our compliance with any new restrictions as they are put in place to continue to ensure that the services provided by our independent accountants are compatible with the maintenance of that firm&#8217;s independence in the conduct of its auditing functions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Donald A. Denkhaus (Chair) </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles B. O&#8217;Keeffe </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tamar Thompson </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Notwithstanding anything to the contrary set forth in any of our previous filings under the Securities Act of 1933, or the Securities Exchange Act of 1934 that might incorporate future filings, including this Proxy Statement, in whole or in part, the Audit Committee Report above shall not be incorporated by reference into any such filings. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_15">S<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ECURITY</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">WNERSHIP</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ERTAIN</small> B<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ENEFICIAL</small> O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">WNERS</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AND</small> M<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ANAGEMENT</small> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the close of business on the Record Date, we had 121,959,172 shares of our common stock outstanding. The following table sets forth, as of such date, certain information regarding the shares of common stock owned of record or beneficially by (i)&#160;each person who owns beneficially more than 5% of our outstanding common stock; (ii)&#160;each of our directors and executive officers; and (iii)&#160;all executive officers and directors as a group. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:75%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Shares&#160;Beneficially&#160;Owned&#160;(1)</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Number</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Percentage</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc. (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">19,016,873</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">15.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,120,417</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5.8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard J. Daly (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">686,327</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Kalb (5)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55,639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven R. Miller (6)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,994,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary Ingenito (7)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">561,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Elsbernd (8)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">913,246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Del Carmen (9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">580,621</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preethi Sundaram (10)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">355,569</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gregg Russo (11)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick J. McEnany (12)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,097,638</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4.9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald A. Denkhaus (13)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">598,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Molly Harper (14)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">79,087</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles B. O&#8217;Keeffe (15)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">885,811</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tamar Thompson (16)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24,587</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David S. Tierney, M.D. (15)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">508,961</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All officers and directors as a group (14 persons) (17)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,341,618</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10.4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Less than one percent </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Unless otherwise indicated, each person named in the table has the sole voting and investment power with respect to the shares beneficially owned. Further, unless otherwise indicated, the address for each person named in this table is c/o Catalyst Pharmaceuticals, Inc. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reported in a Schedule 13G filed by BlackRock on November&#160;8, 2024. According to the Schedule 13G, BlackRock&#8217;s address is 55 East 52<sup style="font-size:75%; vertical-align:top">nd</sup> Street, New York, NY 10055. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reported in a Schedule 13G filed by Vanguard on February&#160;13, 2025. According to the Schedule 13G, Vanguard&#8217;s address is 100 Vanguard Blvd., Malvern, PA 19355. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 416,563 shares of our common stock, of which (i) 50,000 shares are exercisable at a price of $2.24 per share, (ii) 33,500 shares are exercisable at a price of $4.64 per share, (iii) 30,000 shares are exercisable at a price of $3.42 per share, (iv) 20,000 shares are exercisable at a price of $7.07 per share, (v) 10,000 shares are exercisable at a price of $18.59 per share, and (vi) 273,063 shares are exercisable at a price of $13.30 per share. Excludes (i)&#160;unvested stock options to purchase 5,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 1,092,256 shares of our common stock at a price of $13.30 per share that will vest in four annual tranches beginning on January&#160;1, 2026, (iii) unvested stock options to purchase 491,160 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 1,334 restricted stock units that will vest on December&#160;27, 2025, (v) 168,421 restricted stock units that will vest in four annual tranches beginning on January&#160;1, 2026, and (vi) 60,019 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 51,442 shares of our common stock at a price of $16.81 per share. Excludes (i)&#160;unvested stock options to purchase 205,772 shares of our common stock at a price of $16.81 per share that will vest in four annual tranches beginning on January&#160;1, 2026, (ii) unvested stock options to purchase 169,248 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iii) 28,555 restricted stock units that will vest in four annual tranches beginning on January&#160;1, 2026, and (iv) 20,682 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 1,045,001 shares of our common stock, of which (i) 225,000 shares are exercisable at a price of $2.24 per share, (ii) 180,000 shares are exercisable at a price of $4.64 per share, (iii) 275,000 shares are exercisable at a price of $3.42 per share, (iv) 185,000 shares are exercisable at a price of $7.07 per share, (v) 97,333 shares are exercisable at a price of $18.59 per share, and (vi) 82,668 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 48,667 shares of our common stock at an exercise price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 165,336 shares of our common stock at an exercise price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 202,958 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 14,000 restricted stock units that will vest on December&#160;27, 2025, (v) 23,746 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 24,801 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 492,175 shares of our common stock, of which (i) 44,000 shares are exercisable at a price of $4.64 per share, (ii) 200,000 shares are exercisable at a price of $3.42 per share, (iii) 135,000 shares are exercisable at a price of $7.07 per share, (iv) 62,000 shares are exercisable at a price of $18.59 per share, and (v) 51,175 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 31,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 102,351 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 125,696 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 9,000 restricted stock units that will vest on December&#160;27, 2025, (v) 14,700 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 15,360 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 724,682 shares of our common stock, of which (i) 162,475 shares are exercisable at a price of $2.24 per share, (ii) 132,000 shares are exercisable at a price of $4.64 per share, (iii) 200,000 shares are exercisable at a price of $3.42 per share, (iv) 135,000 shares are exercisable at a price of $7.07 per share, (v) 46,000 shares are exercisable at a price of $18.59 per share, and (vi) 49,207 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 23,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 98,414 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 126,704 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 6,667 restricted stock units that will vest on December&#160;27, 2025, (v) 14,134 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 15,483 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(9)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 580,621 shares of our common stock, of which (i) 10,983 shares are exercisable at a price of $4.21 per share, (ii) 120,000 shares are exercisable at a price of $4.70 per share, (iii) 200,000 shares are exercisable at a price of $3.42 per share, (iv) 135,000 shares are exercisable at a price of $7.07 per share, (v) 58,666 shares are exercisable at a price of $18.59 per share, and (vi) 55,972 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 30,000 shares of our common stock at a price of $4.70 per share that will vest on June&#160;23, 2025, (ii) unvested stock options to purchase 29,334 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (iii) unvested stock options to purchase 111,946 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iv) unvested stock options to purchase 137,553 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (v) 8,667 restricted stock units that will vest on December&#160;27, 2025, (vi) 16,078 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vii) 16,809 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(10)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 310,564 shares of our common stock, of which (i) 150,000 shares are exercisable at a price of $5.49 per share, (ii) 67,500 shares are exercisable at a price of $7.07 per share, (iii) 45,333 shares are exercisable at a price of $18.59 per share, and (iv) 47,731 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 75,000 shares of our common stock at a price of $5.49 per share that will vest on July&#160;6, 2025, (ii) unvested stock options to purchase 22,667 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (iii) unvested stock options to purchase 95,462 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iv) unvested stock options to purchase 137,553 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (v) 6,667 restricted stock units that will vest on December&#160;27, 2025, (vi) 13,710 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vii) 16,809 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(11)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Excludes (i)&#160;unvested stock options to purchase 15,000 shares of our common stock at a price of $15.51 per share that will vest in three annual tranches beginning on April&#160;8, 2025, (ii) unvested stock options to purchase 6,957 shares of our common stock at a price of $22.90 per share that will vest in three annual tranches beginning on February&#160;7, 2026, (iii) unvested stock options to purchase 20,349 shares of our common stock at a price of $23.26 per share that will vest in five annual tranches beginning on February&#160;13, 2026, and (iv) 3,439 restricted stock units that will vest in five annual tranches beginning on February&#160;13, 2026. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(12)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 1,615,936 shares of our common stock, of which (i) 740,000 shares are exercisable at a price of $4.64 per share, (ii) 400,000 shares are exercisable at a price of $3.42 per share, (iii) 270,000 shares are exercisable at a price of $7.07 per share, (iv) 181,333 shares are exercisable at a price of $18.59 per share, and (v) 24,603 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 90,667 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 49,207 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 43,591 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 26,334 restricted stock units that will vest on December&#160;27, 2025, (v) 7,068 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 5,327 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(13)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 103,341 shares of our common stock, of which (i) 33,500 shares are exercisable at a price of $4.64 per share, (ii) 30,000 shares are exercisable at a price of $3.42 per share, (iii) 20,000 shares are exercisable at a price of $7.07 per share, (iv) 10,000 shares are exercisable at a price of $18.59 per share, and (v) 9,841 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 5,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 19,683 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 23,248 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 1,334 restricted stock units that will vest on December&#160;27, 2025, (v) 2,827 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 2,841 restricted stock units that will vest in three annual tranches beginning November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(14)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 72,341 shares of our common stock, of which (i) 32,500 shares are exercisable at a price of $5.78 per share, (ii) 20,000 shares are exercisable at a price of $7.07 per share, (iii) 10,000 shares are exercisable at a price of $18.59 per share, and (iv) 9,841 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 5,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 19,683 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 23,248 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 1,334 restricted stock units that will vest on December&#160;27, 2025, (v) 2,827 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 2,841 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(15)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 153,341 shares of our common stock, of which (i) 50,000 shares are exercisable at a price of $2.24 per share, (ii) 33,500 shares are exercisable at a price of $4.64 per share, (iii) 30,000 shares are exercisable at a price of $3.42 per share, (iv) 20,000 shares are exercisable at a price of $7.07 per share, (v) 10,000 shares are exercisable at a price of $18.59 per share, and (vi) 9,841 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 5,000 shares of our common stock at a price of $18.59 per share that will vest on December&#160;27, 2025, (ii) unvested stock options to purchase 19,683 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 23,248 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 1,334 restricted stock units that will vest on December&#160;27, 2025, (v) 2,827 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (vi) 2,841 restricted stock units that will vest in three annual tranches beginning November&#160;21, 2025. </p></td></tr></table> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(16)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 23,174 shares of our common stock, of which (i) 13,333 shares are exercisable at a price of $11.59 per share, and (ii) 9,841 shares are exercisable at a price of $14.15 per share. Excludes (i)&#160;unvested stock options to purchase 26,667 shares of our common stock at a price of $11.59 per share that will vest in two annual tranches beginning on May&#160;25, 2025, (ii) unvested stock options to purchase 19,683 shares of our common stock at a price of $14.15 per share that will vest in two annual tranches beginning on December&#160;8, 2025, (iii) unvested stock options to purchase 23,248 shares of our common stock at a price of $21.12 per share that will vest in three annual tranches beginning on November&#160;21, 2025, (iv) 2,827 restricted stock units that will vest in two annual tranches beginning on December&#160;8, 2025, and (v) 2,841 restricted stock units that will vest in three annual tranches beginning on November&#160;21, 2025. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(17)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes options to purchase 5,742,522 shares of our common stock at prices ranging from $2.24 per share to $18.59 per share. Excludes (i)&#160;unvested stock options to purchase 4,014,170 shares of our common stock at prices ranging from $4.70 per share to $23.26 per share, and (ii) 571,486 unvested restricted stock units. </p></td></tr></table> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_16">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ERTAIN</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ELATIONSHIPS</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AND</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ELATED</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ARTY</small> T<small style="font-weight:inherit;font-style:unset;text-decoration:unset">RANSACTIONS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Related Person Transaction Parties and Procedures </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2017, we adopted our Code of Business Conduct and Ethics, including a <span style="white-space:nowrap"><span style="white-space:nowrap">conflict-of-interest</span></span> transaction policy that identifies our procedures for the identification, review, consideration and approval or ratification of conflict of interest transactions. The policy applies where one&#8217;s private life or interest interferes, or even appears to interfere, with the interests of our company. Under the policy, a conflict can arise when any of our personnel (or a member of their family) acts or has interests that make it difficult, or makes it appear difficult, to perform their duties for us objectively and effectively. Conflicts can also arise under the policy when our personnel (or a member of their family) receives significant personal benefits as a result of their position in the Company. Any such determination regarding the approval of such a transaction will be made by the Audit Committee or the Board of Directors, with any interested directors abstaining. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Related Party Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since 2023, we have had no transactions or proposed transactions in which we were or are to be participants and in which any related person had or will have a direct or indirect material interest. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_17">O<small style="font-weight:inherit;font-style:unset;text-decoration:unset">THER</small> M<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ATTERS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board is not aware of any other business that may come before the meeting. However, if additional matters properly come before the meeting, proxies will be voted at the discretion of proxy holders. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_18">C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ONTACTING</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">THE</small> B<small style="font-weight:inherit;font-style:unset;text-decoration:unset">OARD</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">OF</small> D<small style="font-weight:inherit;font-style:unset;text-decoration:unset">IRECTORS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders may communicate with the board of directors by directing their communications in a hard copy <span style="white-space:nowrap">(i.e.&#160;non-electronic)&#160;written</span> form to the attention of one or more members of the Board of Directors, or to the Board of Directors collectively, at our principal executive office located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, Attention: Corporate Secretary. A stockholder communication must include a statement that the author of such communication is a beneficial or record owner of shares of our common stock. Our corporate secretary will review all communications meeting the requirements discussed above and will remove any communications relating to (i)&#160;the purchase or sale of our products or services; (ii)&#160;communications from suppliers or vendors relating to our obligations to such supplier or vendor; (iii)&#160;communications from pending or threatened opposing parties in legal or administrative proceedings regarding matters not related to securities law matters or fiduciary duty matters, and (iv)&#160;any other communications that the corporate secretary deems, in his reasonable discretion, to be unrelated to our business. The corporate secretary will compile all communications not removed in accordance with the procedure described above and will distribute such qualifying communications to the intended recipient(s). A copy of any qualifying communications that relate to our accounting and auditing practices will also be automatically sent directly to the chair of the Audit Committee, whether or not it was directed to such person. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_19">S<small style="font-weight:inherit;font-style:unset;text-decoration:unset">TOCKHOLDER</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ROPOSALS</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder proposals intended to be presented at the 2026 Annual Meeting of Stockholders must be received by our corporate secretary not later than December&#160;10, 2025 at our principal executive offices, 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, Attention: Corporate Secretary, for inclusion in the proxy statement and proxy relating to the 2025 Annual Meeting of Stockholders. The persons named in the proxies solicited by management may exercise discretionary voting authority with respect to such proposal. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_20">A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">DDITIONAL</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NFORMATION</small> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are delivering our Annual Report to our stockholders with this Proxy Statement. We will furnish without charge to any stockholder submitting a written request, our 2024 Annual Report on <span style="white-space:nowrap">Form&#160;10-K&#160;as</span> filed with the Securities and Exchange Commission, including the financial statements and any schedules thereto. Such written requests should be directed to our Corporate Secretary at the address set forth above </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="txa900407_21">A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NNEX</small> A &#8211; A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">MENDMENT</small> N<small style="font-weight:inherit;font-style:unset;text-decoration:unset">O</small>.&#160;5 <small style="font-weight:inherit;font-style:unset;text-decoration:unset">TO</small> C<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ATALYST</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">HARMACEUTICALS</small>, I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NC</small>. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2018 S<small style="font-weight:inherit;font-style:unset;text-decoration:unset">TOCK</small> I<small style="font-weight:inherit;font-style:unset;text-decoration:unset">NCENTIVE</small> P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LAN</small> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">WHEREAS</span>, the Board of Directors of Catalyst Pharmaceuticals, Inc. (the &#8220;Company&#8221;) has determined that it is in the Company&#8217;s best interest to amend the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;). </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOW, THEREFORE, <small style="font-weight:inherit;font-style:unset;text-decoration:unset">THE</small> 2018 P<small style="font-weight:inherit;font-style:unset;text-decoration:unset">LAN</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">IS</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">HEREBY</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AMENDED</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AS</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">FOLLOWS</small>: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top;text-align:left">1.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The first sentence of Section&#160;5(a) of the 2018 Plan is amended in its entirety and restated as follows: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<span style="text-decoration:underline">Shares Available for Rewards</span>. The Common Stock that may be issued pursuant to Awards granted under the 2018 Plan shall be treasury shares or authorized but unissued shares of the Common Stock. The total number of shares of Common Stock that may be issued pursuant to Awards granted under the 2018 Plan shall be <span style="white-space:nowrap">Twenty-Six</span> Million (26,000,000) shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&#8195;In all other respects, the 2018 Plan shall remain in full force and effect. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CATALYST PHARMACEUTICALS, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">355 Alhambra Circle, Suite 801 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Coral Gables, Florida 33134 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby appoints Richard J. Daly and Michael W. Kalb, and each of them, with full power of substitution, proxies of the undersigned, to attend and vote all the shares of common stock, $0.001 par value per share, of Catalyst Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;) which the undersigned would be entitled to vote at the 2025 Annual Meeting of Stockholders to be held at 9:00 a.m. local time, on Tuesday, May&#160;20, 2025, or any adjournment thereof, according to the number of votes the undersigned would be entitled to vote if personally present upon the matters referred to in this proxy. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EACH OF THE PROPOSALS. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:1%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:34%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom"/>
<td style="width:30%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">1.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PROPOSAL ONE &#8212; Election of Directors</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">Richard J. Daly</span> as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">Patrick J. McEnany</span> as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">Donald A. Denkhaus</span> as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">Molly Harper</span> as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">Tamar Thompson</span> as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">To elect <span style="font-weight:bold">David S. Tierney, M.D. </span>as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">2.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="5">PROPOSAL TWO &#8211; To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 5&#160;million shares.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:1%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">3.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="5">PROPOSAL THREE &#8212; To approve, on an advisory basis, the 2024 compensation of our named executive officers.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">4.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="5">PROPOSAL FOUR &#8212; To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="5">PROPOSAL FIVE &#8212; To transact such other business as may properly come before the meeting.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; FOR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; AGAINST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#9744; ABSTAIN</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Proxy when properly executed will be voted in the manner directed herein by the undersigned stockholder. If no direction is made, this proxy will be voted FOR the proposals as set forth herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges receipt of Notice of Annual Meeting of Stockholders dated April&#160;10, 2025, and the accompanying Proxy Statement. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: ____________, 2025.</td></tr>
<tr style="font-size:1pt">
<td style="height:24pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Signature</p></td></tr>
<tr style="font-size:1pt">
<td style="height:18pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Name(s) (typed or printed)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:18pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address(es)</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign exactly as name appears on this Proxy. When shares are held by joint tenants, both should sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. If a corporation, please sign in full corporate name by the President or other authorized officer. If a partnership, please sign in partnership name by authorized person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED. </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>cprx-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 10-April-2025 [06:10:12] {PM}-->
<schema targetNamespace="http://www.catalystpharma.com/20241231" elementFormDefault="qualified" xmlns:cprx="http://www.catalystpharma.com/20241231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2024">
<annotation>
<appinfo />
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
<import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
<import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
<import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" />
<import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
<import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g900407g0404235412721.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g900407g0404235412721.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. 2$# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g900407g0404235412946.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g900407g0404235412946.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] .8# 2(  A$! Q$!_\0
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MU3:@.YF)RSL>K,>Y/K6#=6WB%EGO-4\20Z19PEF":?;HQ"=B\DRN"?8*/QH
MZFBN \+:]K^J"^-E]HU*T,@6TO-15(551U),:+NR>@"_4BFKJ6H+XIAU"XU^
M>33+96AFBC@"0W,YZ) @!=L=R6:@#T&L/7/%FE:#%,;B5IIH4WO;VXWNH]6[
M*/=B!4-RU_>VLEUJD[:1IL8+-#%(/.D7_;<?<!]$Y_VATJGH^AQ7<B7MQ81V
M6F0MYEG8; N6_P">TPQR_< ].IYZ &SX?U.]UC2DOKW3&T[S3NB@DEWR;.Q<
M8 4G^[DX]:U:CAGBN(5E@E26-ONNC!@?H14E !5>\O[/3H?.O;N"VCS@/-($
M!/IDURO]LS:G=7,5_=WFE00RL@MH+2599%4D9:4IC:PY'EX(X^;L+5IJ'AO3
MYC+:V%Y]H90&G72[F65Q_M/Y99OQ- &I_;:R$K9V%_=D$9*0^6N#W#2%58?[
MI-*TFM3"X58K"S4 &"9Y&G/OOC 0#\'--&N"50;;3=3GSV-L8?\ T;LI@U+6
M9E/D: T3=OMMW&@/XQ^8?TH P9-7U&^:..RNM:NY#PTVEZ?##;GW#W.0P_W6
M:JFEZ7\2AXFAN+S7[0:$LF6M9DCDN&3T+)$B@GV/'OWVM7U+6].T]KZ[O=&T
MN), JT,MX78]%7#1$L>@ !)-6/"<WB*YL9[KQ"D$+S2[K:"./8T<6.-XW-AC
MUQDXSC)H WZ*** "J6JZI;:-ITE[=LWEI@!4&6=B<*JCN2>!5VO/_P#A'+_Q
MCXPN-1\1P2P:)IDS0Z;I[' N".&GD'=3T4'J.V#R 3Z;'J/BFZ&H2X@@(/EW
M4; ^6A_AMR1W'WIN_P#!Q@CH)[RTT*&/3;"U\R<1F1(5.%5><R2.?NC.<DY)
MYP"<UL    # '0"L>[\,:9?ZC->722R^<J"6$RD1/L^[N4?>^AR/;- '%:IJ
M6IZKJ$-O:VXU"6:0^1-< ):)C!W0Q,?WVW@^:V0,_+G.VJ4FF:-H,,OB"6UF
M\5Z\76,ZA=,1 9'8*L<><KC)P @;&""17I=]H>EZG+#)?6$%PT*E4$BY !P2
M,=",@'![@5+J&F66J61L[VW66W)!V9(P0<@@CD$$=10!R"Z'HFG7=K?^)YH+
M[6"I:UM1%N6'H2+>W7)X_O8+>];YGUS4E*VL":5 1Q-= 23'Z1@[5]BS'W6K
MNG:/IND(ZZ?8V]MYAS(8D 9SZL>K'W-7J .,TWPW9:KKHU:Y,EZEF[+!/=/Y
MC2R=&<=D4$<*@"]3BNSHK!\1^)HM#-M:00->:K>DK:6:$ N1U9B>%4=S^5 &
MW-+%! \L\B1Q(I9W<@*H[DD]JY;7=1L->T2>UM[2]O+5P&^U0(J11XY#AY&1
M6 QG*DBJ]BANKA9=0(UO68VR8H3_ *)9MZ XV@CU.Y_;%;\>DR74BSZO*ERZ
MMNC@0$0QGM\I^\1ZG\ * .9T2_\ &>M0+::CID=C9@[3J%O<!9)T]51@2F?7
M)]O6NUM;6"RMDM[:)8HD& JC'^34U% %>^O$L+.2Y>*>54&=D$32.WL%')KE
MQX?NO%<T5[XGB,=E&V^VT@-\H]&F(^^W^S]T>]=A10!S7B&#6YVM=*TBPMAI
M\B%;B>2;RUC7H%"K\Q_#'ID5=TCP[::65G;_ $B]";//=0-B_P!V-1PB^P_'
M-;%% &)]EGU;6?.NXF33[1OW$,BC$TG_ #T(]!V]^>PK:(!!! (/4&EHH @M
M+*TT^#R+*UAMH<EO+AC"+D]3@=S4]%% !1110 54U#4(=.MQ)+N9W8)%$G+2
M.>BJ/7_]=)J6HQ:;;J[@O+(PCAA7[TKGHH_QZ <GBJFDV%T7.HZKL.H2#Y8U
M.Y+93_ AP,^[=S[ 4 5=,T6YN;]=:UUA)?#FWM5;=%9 ]E[,Y[N1GD@8'7H:
M** "BBB@ HHHH **** "BBB@ HHHH *R-2\,:1J^IV^HWMJ9+JW0QHPE=05/
M56 (##V.:UZ* &0PQ6\*PPQI'&@PJ(H 4>@ I]%% !1110 4444 %%%% !11
M10 4444 %4M5U2VT;39KZ[?;%&.@^\Y/ 51W)/ 'J:NUF7FAV]_K%GJ-S+/)
M]D!,5L2#"'/\97&2P['/&: *NB:?=33'6=60K?S+B*W8AA:1G^ $?Q'@L>>>
1,X%;M%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g900407g0404235413317.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g900407g0404235413317.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ B0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHJCJVLZ=H5BU[JEW';6ZD#<YZD]  .2?8<T 7J*R[#Q#I
MFI31P02RI/(I=8+BWD@D*C&6V2*K;>1SC%:E !1110 4444 %%%% !169?>(
M-*TVSNKN[O%2&T<).RJ7\MCC (4$YY'YUI*P= RG*L,@T +1145S<PV=K+<W
M$BQPQ*7=VZ*!U- $M%5M/U"TU73X+^QF$UK.F^.0 @,/QYJ2YN8;.WDN+B58
MH8QEW<X % $M%(K!U#*<@C(I: "BN<N?'7AVS:\6XO94-E,D-QFTF_=NWW?X
M.A]1Q[UT2L&4,IR",B@!:*P=9\8Z+H%_!9:C-=1W%Q_J4CL9Y?,/HI1""?;K
M5W1M>TOQ#9F[TJ\2YB5BC8!5D8=0RD J?8B@#1HJC<:O86NJ6NFSS[;R[#&&
M/8QW!>O(&!^)J"7Q'I<'B"'0I9Y$U&>,R11&"3:ZCJ0^W;Q]: -6BBB@ HJI
MJ6IV6D6,E[J-U%;6T8RTDC8 _P#K^U4K#Q1I.I/#'!/,DD^?)2XMI8&E Y)4
M2*I8>XXH V**** "BBB@ HHHH **** "BJU_?0:9837MT76"!2\A2)I" .IV
MJ"3^ JK;:_IU[H*ZW:S23:>\?FK)'!(S%?4(%W?AB@#3HKEM.^(OA;5;BVAM
M=2<-=,5@:>TFA25AU"LZ!2?8'-=30 4444 %%8U[XJT>PU+^SI;F22]"AGAM
MK:6X:-3T+B-6V#W;%7]/U*SU6T6[L+A+BW8E5D3H2#@X_&@"U1110 445GZK
MK5EHR1->&X/FL51;>UEG8D#)^6-6./?% &A17,Z9X_\ #>KJ)+.\G,)#D3RV
M,\47R EOWCH%R,'(SVJU%XOT:>%I8YKD[8S*$^Q3"1T& 61-FYUY'*@B@#<H
MKE+7XD>%;M;62/4)TANY/*@GGL;B*&1^FT2.@7.>V:ZN@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KS7XBP75MXP\):[.DDFAV%PWVO
M:I80LV-LC =ASSV_&O2J* .4UCQ##J'AW4KGPM/!J6H06DCV\UKB95?' ##(
MW?[/4XZ5Y[::W>_8-3^PZU>W.GKX>\^]N'O9'-O>XZ"0G,;=?D!&,=!7MM%
M'S@/%-V;.11XLOCN\-"Z9O[2;/VI6..=V0WJHQG'.>:V=5UYI-4>6Z\2W]M#
M)X7CNHVAU"2-&NLX! 5@-Q/&!U/&#7NU8(\+6Z^,SXG%_>BZ:V^RM!F/R3'G
M.,;-W7G.[].* /,=3U[Q/)>Z%::K=)I\=SI"R1S7&HRV"-='J6=$.Y@,'RS@
M')^E5/%^O:EI^LW$-UXBFANT\/>:Z6]_)%&;D=&5,K@GKC SZ5[O10!X]J>L
M7,UMHVK3:U//#+8VXDL[2_DM)_-;DO%@[)F.#E#GI5;6_$UU_P +(M5LM1U2
M"./58+2YBFN6\LHZ$D",815Z<G+9/48KVJB@#Y\6Y71_"'BZ>/5+^SU*/6BH
M(OYD(7S%QD;L9(]>2/4"MC6]?U@:CJSKJEW'J<<MK_8UK%<,$N(6 WL(Q\LH
M/.6(./45[710!\_:3XKO8=?L0?$-R[-XB:W>&34'D7R".1M9B"N>A/3M7K'B
MS4X9GB\.V\FFS7]Z/FL[N\\G?%WZ(YYZ8VUU-% 'AGA#Q-?Z-X3\3>$[2>"3
M6]),K6,=M,)MR=2$) W%?H#UXIWB/[#J'PJDU"PU[5=0,CVSW22WLDBP,& D
MZ\KWRI.!U %>XT4 >%^*]8DTB^UF&UUK5(+5]"26PW7\_P TH;ED);)./3M[
M5!XE\67BIIKV&KZHEW;VEE+(XNV\I][ -\B\,3SDN6^G>O>Z* /G_P 4:E8M
M<>-E^VV^Y[VS('FKDX(SCFNSL=.OX?&,ND-?:O=:5J,,=];W(U*;]QM/S("'
M^Z<C _I7IM9NFZ.NG7%S-]MO;IIW+C[5+O\ *!_A3CA?;F@#SSXGZC!#XO\
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MMG_YZ1_]^S_C1MG_ .>D?_?L_P"- $M%1;9_^>D?_?L_XT;9_P#GI'_W[/\
MC0!+146V?_GI'_W[/^-&V?\ YZ1_]^S_ (T 2T5%MG_YZ1_]^S_C1MG_ .>D
M?_?L_P"- $M%1;9_^>D?_?L_XT;9_P#GI'_W[/\ C0!+146V?_GI'_W[/^-&
MV?\ YZ1_]^S_ (T 2T5%MG_YZ1_]^S_C1MG_ .>D?_?L_P"- $M%1;9_^>D?
M_?L_XT;9_P#GI'_W[/\ C0!+146V?_GI'_W[/^-&V?\ YZ1_]^S_ (T 2T5%
MMG_YZ1_]^S_C1MG_ .>D?_?L_P"- $M%1;9_^>D?_?L_XT;9_P#GI'_W[/\
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MD9_Y;:FQ4_41QAB?H2M<5X_^&>K^.ULC=:]"LEN6.5T]T49QPJY)QQU))YH
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MT; X*G!(R#Z$CT)%6Z "BBB@ K!\0ZU<Z3) L"1,) 2?,!/3'H16]7(>-?\
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M-=&^%XS)@ I_JRN=V_=[8QWSQ4*Z/K,QM]0ETUHY],C@BCMO-C)NMC9=E.[
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M=1^9;WWG)_>C9&'Z"IY(HYD*2HKH>JL,@UCS^#_#5S)YDN@Z:9?^>BVR*_\
MWT!G]: -;RG_ .?B3\E_PH\I_P#GXD_)?\*Q/^$.TR/_ (];C5+0]A!J<X4?
M\!+E?TH_X1_4X?\ CU\5ZH!V2XBMY5_]%AO_ !Z@#;\I_P#GXD_)?\*/*?\
MY^)/R7_"L3[+XM@^YJND72_W9;"2)O\ OI92/_':\6'B;XAM\3OL'VO45THW
MFS/V<M"%_P![ )7/N/K0!]">4_\ S\2?DO\ A69J.NZ7I4@AO-75)V^[ NUY
M6^B*I8_@*K_\(U-><ZQK=_> ]887^RP_E'AB/9F:M/3M(TW28S'IUA;VJM][
MR8PN[W)'4_6@#'_M?6+[C2M'O-IZ3ZBZ6R?]\[6D_ J*<-$UR]!_M/Q'+&AZ
MPZ;"L(^A=MSGZ@K71T4 8MCX5TG3I_M$$&ZZ[W,V)9C_ -M'!;]:U?*?_GXD
M_)?\*EHH B\I_P#GXD_)?\*/*?\ Y^)/R7_"I:* (O*?_GXD_)?\*/*?_GXD
M_)?\*EHH B\I_P#GXD_)?\*/*?\ Y^)/R7_"I:* (O*?_GXD_)?\*/*?_GXD
M_)?\*EHH B\I_P#GXD_)?\*/*?\ Y^)/R7_"I:* (O*?_GXD_)?\*/*?_GXD
M_)?\*EHH B\I_P#GXD_)?\*/*?\ Y^)/R7_"I:* (O*?_GXD_)?\*D' QG/N
M:6B@ IJ(D:[4554=E&!3J* "BBB@ KS_ ,8I92>)$@D\&Z?JMW-:+Y-[>VID
MC3#,6#MY;!551GKDEE '<>@5YSX]?Q!;>(K._P!.*+8VD&Z1KRZDAM0S"13N
MV [NJDEL;=HP1N- '<Z/(TNC64CVJ6C- A-O&05B.!\H(XP.G%<KXPN?%%CK
M]C>:-8W-]8+&5N(+5H49FVO]]G^8#+(1C@8;(/%=-HGG#P]8>?>QWTPMDWW4
M1RLS;1E@>X/6O"+339I[&S%OX<\8I8WT?G:V;7!_M.3@J06?*H<OG&,@@8[@
M ]WT"YN+WP]IUU=R0R7$UM&\KP,"C,5!)4CJ,UHUD>%9XKGPEI$\%F+.*2SB
M9+93Q$"HPOX=*UZ "BBB@ HHHH X+XBZ-_:]QI8_X1*Z\0^6DQVQ:E]C6+)3
MEFR-Q/89['CTQOA_IEKI_C+,7@]M#D:QE_>MK8O?,&^/C;N;;VYXKT+Q*EM)
MX6U9+RX:WMFLY1+,JEC&NPY8 <G YQ7FOPVC\/1>-91H<T+[M.)D5-&>U(.Y
M,G>W.TG.%&>N"3M% 'K<JNT3K&^QRI"MC.#ZUP.B1W%KH.OZ9/?ZA!JT,;/+
M,+EI0QP?WL329VY(.5P-I' Z,?0&574JP!4C!![UAVOA'1[.VOH(X[DK?#;,
M[7<IDV\X17W;E49. ".IH YWQ+XI@T[PQI]M)KD%C?2VL,[/+<JDKK\N0NXY
M)8YR1G@-T.*WM=?[==Z38)=31VEVSN\EM.T;.%0LH#H00"<'@\@>F:TAH]B-
M(32C&[V:($5))G9L#IEB=Q_$U6G\.VU]]K6^EGFCFF$T86XE0PD*!\C!\KGG
M.TJ"#C'7(!Q\&KW]W92ZI+>3_:--C@$,:2LJ3;G(9G0'#[P !D''5<&M;0KJ
MY.IV%R]U/*VI_:?/B>9F1-C';L4G"8 VG &<Y.36\_A[2I+JTN3:X>T54B"2
M,J +]T% =K;>HW X/(Q44OAJQ'VZ6T$EO=7:,IE$TN$SR2@#C9DX)V%<GD\T
M <Y>ZE>6UU<ZO'<SM.E^UF+8RMY7EA,X\O.W=D[MV,]LXJL+BZ@>RTU=1O)(
M=4BMI;B9KERZ-(V'V-G,88' "D 8^7%=E'H&G1ZDNH&)WNPFPN\KE2<;=Q3.
MW?CC=C..,XJ*+PMH\-G<VB6KB&Y(+YGD+#'*A&+90*?NA2 O;% ">&YI9-/G
MADD>46US)!')(Q9F13QECDDC.,GDXYYK9J"RLK?3[..UM4V0QC"@L6/J22<D
MDGDDG)-3T 1>:_\ SPD_-?\ &CS7_P"?>3\U_P :EHH B\U_^?>3\U_QKDO&
M3%IK3,;)\K?>Q[>AKLJY#QK_ *ZS_P!UOZ4 <K1110!L>&"5UR(A2WRMP,>G
MO7>>:_\ S[R?FO\ C7"^%O\ D/1?[K?RKOZ (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\
M:EHH B\U_P#GWD_-?\:D!R,XQ[&EHH :[I%&TDCJB("S,QP !U)-5+#5].U6
MQ^W6%];W-H"09HI R#'7D>E&KP6MSH]Y!?,RVLD3+*RYRJXY/'I7GMGJT][X
M3O[2SLGUFT1WBEO;%X1Y\83(WEG12>0K;<C"D8&<  ]$?5=.CFM89+^U26[S
M]F1IE#38&3L&?FXYXIT6HV4][/90WEO)=VX!F@252\8/3<H.1GMFO.8[D?V<
MD-Q&]M?7UC9)IT,K+O<HV2$VDCY3\QP> 036IH,@;6=/LD<'4;.6[?4$!^9%
M=L@O[,=I7/4#(Z4 =W7E/Q#&F)XWM9[G0M+U2Z6Q4JNJZI';PJN]_NQL#O;D
MY)X'&.]>JGH<5Y*WPZ\7:M%;W.L:IH5S=+ L6+_2$NGC R=N]B<G).2.M 'I
M'AV=[KPWIMQ)#:PO);1LT=HZM$A*CA"I(*^A!Q4QU*,:T-,,,_F&#SQ+M'EX
MW8VYSG=WQCI53PGI]QI/A'2-.ND"7%K9Q12*#D!E4 \BN!^)8\(+XMTT^*-*
MM94EMBGVRZNY(PB@2, B)]X[@ 3G(WK@'/ !ZI'(DT:R1.KQN-RLIR"/4&G5
ME>&/LP\*Z3]BMI+:U^R1>3!*26C3:,*<\Y ]:U: "BBB@ HHHH PO&5Y<V/A
M'5)[.VO9YQ;2!!9$"5#M.&&3V/ID^QKD/ ">9XD><Q>.)2+-E\_Q'\D<>60[
M8UVC);&2>VWWKT+4K>>[TN[MK:X:VN)872.9>L;$$!A]#S7$^%M5U=O&*Z-J
MMYIB/::<5^R6EY)=2R;60>9*S ;3Z9^8[CUH [V5_*B>3:S;5)VJ,D_2N7TC
MQ7?:CX9O=:;2HG2)6DMX[6Z#F0 <JQ8+M<$8(Y ]21BNJ;=M.T@-C@D9&:XV
MQT/7D_X2&YF@T^&XOTV1V\=RYCD< CS7;9\I((& I.%&2<# !I:IXBO;#18-
M7ATI9[,0+<71-SM>-" 3L&T[R!DX)4<=:N:OJLUD+6&RM4NKRZ8B**24Q)@
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M_OXW^-'D)_>D_P"_C?XT <+XJ_Y#TO\ NK_*L6MCQ0H37)0,_=7J2>WO6/0
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M6BHOM,'_ #VC_P"^Q1]I@_Y[1_\ ?8H EHJ+[3!_SVC_ .^Q4@((R#D'H10
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M9B,<*>S'@^M7:XK3/^0G;?\ 'U]\?ZO_ %O_  +_ *=O[M=K0 4444 %%%%
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MZ "K= $7GIZ2?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  KDO&3AYK3
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M\* /-?$<FL2:VQGMK&!LC>$N'E&S'!!*+S[=O4UD+'J1V;[JU7#DL$@;YE[
M9?@^_-=+XH!77)06+?*O)QZ>U8] %);.Z_=F34YR58L0D<8#CT.5)P/8@UGZ
M[\/O$WC+0XK#2=4MUM(;AI9?MUPZEW(&.$0@@#I]36[79>#T9M/N")&3][T
M'H/44 8%G::M86%K9ZY-I<VH00K')+"[-"^!@&Z) .W'W>.M3?Y_TW_VZ_Z9
M_P#//\*T=;!75) 6M&X7EL;.G_+WC^#^[[UG?Y_TW_VZ_P"F?_//\* #_/\
MIO\ [=_],_\ GG^%;WAG_67/W>B_\?'_ !]]_P#6?[/]WVK!_P _Z;_[=_\
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MB@ K)'AO3/[=&LF*4W:CY0T[F-3C!81YVAL<9 S6M10 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 AZ&O*M*O/&&N6%J/"OAJR\,V&P!;
MR]G+EATRL2XW'C@N.1Z5ZM10!#:I.EI$EW*DUP$ EDC38KMCDA<G ]LFJUKH
MNF6=I%:P6$"PQ($12@. !@<GDU?HH @LK.WT^Q@LK2,16\$8CB0$G:H& .:G
MHHH **** "BBB@ HHHH **** "BBB@ HHHH X.]\1:K#?W$276$25E4>6O !
M/M4'_"3:O_S]_P#D)/\ "O0Z* ///^$FU?\ Y^__ "$G^%'_  DVK_\ /W_Y
M"3_"O0Z* .*U+5]8;X<ZQ?VDC/J$44GE.JC<N%'( ')'-)X:T?PS%H>BZG:M
M$EQ+&DYNDDQ)=/MRQD/60_>)SG&.V*[:LR/PWH437+1Z+IR-=*5N"MJ@\X'J
M'X^8?6@#@]/NIAX^U!-2LYX]/UZR8PK=&)XYFCSC:%=OE*'.& /7BJGPI\+W
M,)LM=BBLK&R6*>%DM6.^[)E;!E&T ;<8'+?45Z)-X6\/7 A$^@Z7+Y">7#OL
MXV\M?[JY' ]A5O3M+T[2+8VVF6%K90%MQBMH5C7/KA0!F@#AO$7BS5]%\5ZO
MLD@DL;#2UN%MS$<L[/C);=VQZ=,CWK7T#6;CQ%IFM66K06DSVCF"1H8R(I@4
M#?=8MCKC&3713:9I]Q=?:IK&VDN#&8O->%2^P]5R1G!]*2'2--MM.;3H-.M(
MK%@0ULD"K&0>OR@8YH \.T?P<TG@6\UE[/38+!;"YC\F(;FNG$C;7D4J%!7'
M&-Q]Q76VEK-H?PKO[K2M+L]-UB6P63;IXR74(,28 &6Y/.,_6N\7PWH2:8VF
M)HFFKI[MO:U%J@B9O4IC&>!SBI--T+1]&61=+TJQL1+_ *P6MND6_P"NT#-
M'FT]CIVDV?@R_P##<<:ZI>3PB26$_O+M"N9#*1RXZDDYQ[5ZS6?9Z#H^G7<E
MW9:38VUS+_K)H+9$=_JP&36A0 4444 %%%% !1110 4444 %%%% #)F9(9&4
MH&"D@N?E!]_:N2_MO4>UQMQROGHHVG^]+@?+$?X6&">YKL** ./_ +;U'M<;
M<?=\]%&P_P!Z; ^6(_PL,$]S1_;>H]KC;C[OGHJ[#_>FP/EB/\+#!/<UV%%
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M'WRTY968'N22.HK,USP'K5[K%P\L>HWUNMDJ63)<6WR.$*E)&D7=R?[F >]
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M''UYH G_ .$P00VH;1=42\NV80V3"$2NJ@$L#YFS&"/XL^U49OB+;1WQM(]
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MV:MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g900407g0404235413608.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g900407g0404235413608.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ B0# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)/J%I>V+R[K1K>_DO=BD#*F9U4OSGUQT[5U]% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/J>W3KT33_ _AC2;T7MAHEG;W(!'FQQX8YZY]:V[>WAM+>.WMXUCBC&U448
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M\VT=AEBN%,3%N2#T'0<]: .J?Q%I:2V<9N6+7BJ\16%RNUN%+$#" G@;L9/
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M''0X/(SRP!Z.UU;I;"Y>>)8" PE+@+@]#GI3+V_L]-M6NK^[@M;=2 TL\@1
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M^_9_QH EHJ+;/_STC_[]G_&C;/\ \](_^_9_QH EHJ+;/_STC_[]G_&C;/\
M\](_^_9_QH EHJ+;/_STC_[]G_&C;/\ \](_^_9_QH EHJ+;/_STC_[]G_&C
M;/\ \](_^_9_QH EHJ+;/_STC_[]G_&C;/\ \](_^_9_QH EHJ+;/_STC_[]
MG_&C;/\ \](_^_9_QH EHJ+;/_STC_[]G_&C;/\ \](_^_9_QH EHJ+;/_ST
MC_[]G_&C;/\ \](_^_9_QH EHJ+;/_STC_[]G_&C;/\ \](_^_9_QH EHS@9
M-1$3 9,L0 ZGRS_C6$QNO$;M''*J:0IP\@0@W1[J.?N>I[_3J 2/))XCD:&W
M<II*G;+,O6Y/=5/]SU/?H..NW'&D,2Q1($1!A548 %1I%)%&L<;0JBC"J(R
M!^=.VS_\](_^_9_QH EHJ+;/_P ](_\ OV?\:-L__/2/_OV?\: ):*BVS_\
M/2/_ +]G_&C;/_STC_[]G_&@"6BHML__ #TC_P"_9_QHVS_\](_^_9_QH EH
MJ+;/_P ](_\ OV?\:-L__/2/_OV?\: ):*BVS_\ /2/_ +]G_&C;/_STC_[]
MG_&@"6BFJ' ^=E)]AC^M.H **R;3Q)I=]J-U8PS2>9; EW>%TC..&VN1M;!Z
MX)Q3'\5:.FC1ZLMR\UE+DI);V\DI8#J0J*6P,<G&* -FHXH(K="D,21J6+%4
M4 $DY)X[DDFL]_$6E)-9Q_:]YNU5X6CC9TVMPI9E!503P"Q&3P,FI=3UFPT@
M1&]E9/-)"A(GD.!U8A0=JCNQP!GDB@"_16?_ &WI_P#:PTSSV^U$9P(GV9QD
M+OQMW8YVYSCG&*73=:L-6:9;*9I#$<-NB=,CG#+N W*<'#+D'!P>* +]>*>.
M9A#XKU=K6]\31S-L5OL5Y%!;J^Q< [N3P021_2O:Z\Z\37GVG6-2TX>#[2^=
M?+E:>ZC(29% ()?;C=EMJC/J3@4 >@P9^SQY))VC))SVJ2FQ_P"J3Y=ORCY1
MVIU !1110 4444 4-9CNCI5Y+IPC&I+;2+:R,!\KD<<GC&0O7CBN'\'V_B"#
MQEC6[W4+I/[/9H6N9[8J"S1EEVQ\[AP">0,=3N%=5XSO;.Q\':M)?26JPM:2
MILN9"B2$H?D)!!Y_V>?2N!^&VCVFG^+GFC?PC%(]@ZK#H5Q+,[C>F6<N<*!P
M/4Y]J /6Z:J(F=BJN3DX&,GUI)7\J)Y-K-M4G:HR3]*Y?2/%=]J/AF]UIM*B
M=(E:2WCM;H.9 !RK%@NUP1@CD#U)&* .KJ**VBAEFD0-OF;<Y9BW;'&3P/8<
M=?4UAZIXBO;#18-7ATI9[,0+<71-SM>-" 3L&T[R!DX)4<=:N:OJLUD+6&RM
M4NKRZ8B**24Q)@ LQ9@K$  >AR2![T :M1SP)<P/#)NV.-K;'*G'L001^%<V
M/&*RF.:WL]UBB1M>3/+M: N2H 7:=Q!!W<C Z9Z5;TWQ$]_J*PR6BPVUQYGV
M.82EFE\LX;<NT;.Y'+9 SQTH W%544*H 51@ =A2USLOBD0:C(LMJJZ;'*;8
MW?FG=YP7=C9M^[VW;LYXQWJNGBZX\C;+IB1WLXC>R@^T$B99#A2[;/D(_B #
M8!X)H ZJBJ.DZC_:5EYKQ"*:-VBFB#;@CJ<$ X&1W!P.".!TJ]0 4444 %<A
MXU_UUG_NM_2NOKD/&O\ KK/_ '6_I0!RM%%% '2^#/\ D(7'_7+^HKM*XOP9
M_P A"X_ZY?U%=I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4C,%4LQ 4#))/2AW6-&=V"JHRS$X 'K6$ _B1\G?'HZG@8P;L^_<)_/Z
M4 !+^)7VC<FCJ>3T-V?0>D?_ *%].NZB+&BHBA548  P *%4*H50 H&  .!2
MT %1S3PVZ;YI4C3.-SL /UJ2L'Q=_P @3_MJO]: -/\ M73O^?\ M?\ O\O^
M-']JZ=_S_P!K_P!_E_QKS&B@#T]=3L&8*M];%B< "5<G]:M5Y=8_\A"V_P"N
MJ_S%>HT %%%% !1110 4444 %%%% '%:3*UGXWOX-/M+Z*Q=&EO(Y;=Q&DG!
M#1L>#NRWRH2.,\'.4TW7#I?@^)CINJO-)/)&L?\ 9EP67+D[F0)N"X.<XYZ"
MNVHH \[:Q,%L]A8Z??\ D:A:VT%F[VT@\L1L<^9D?N\#YAOP3G &>*T=9NO,
MO6O(+.\NXVM)].V1VDA99B1@$%<A&_OGY> 2<$5V=1Q016Z%(8DC4L6*HH )
M)R3QW))- 'GZ:/?QQ_V 8)_M+W:70O!$WE",1!23)C&[(V[<[N^,5K>&(IY;
M^WD:RN+5;'3TLI1-"T8:4')"9 W*,?>&5.[@]:ZZB@ KQ?Q_#>77B^ZL(8M2
M\R[V);YU]+6)_E .V$\LOKC.3FO:*\;^($FB6_B>^%QJ%N6E1#=1MH[7,T.%
M&!'*.$)&",]"<]Z /885*0QH>JJ :?3(2#!&5SM*C&>O2GT %%%% !1110!G
M:] ;GP_J,*V45ZSVT@6VF&4E.TX4^Q/%<?X'O=,?65MM*\+III%CF]NUTG["
M&E!7Y%S\S#ECCG&!R<UO^+#XL^RP)X5730[OMN)+S<6C4XYC48!(Y/S'MT.:
MY7P/IDT7BK[?KGB:^O\ Q ]O=1&TN8O*585F4"1(\#RP=JG'\6[CH: /2VW;
M3M(#8X)&1FN-L=#UY/\ A(;F:#3X;B_39';QW+F.1P"/-=MGRD@@8"DX49)P
M,=G10!RL]IXF73-*LK>RTF6*&)5O$EOI$#E1@*I\ELKQDY ST]ZDO(=9OKE;
MFWM;1;S3I2L?FRR)%<*\>'Y\LE<$Y& PXQGKCIJ* .,7PA>V\8L89K=[*Z2(
M7TCLRR*R,6)C4*00V2.2-O7GI4L6DZII+&X,=M<6^FI,UBB22;YC(<X<",[=
MH)'RAL]>.E==10!R4GAJ^O+IX)S FERSF\;$A,RR%,&/&W&T'YMV<]L=ZA3P
MSJ[I'=3O9?;K%8H[-4D;RY5C.<R'9E2W ( ;;V)KLZ* ,W1+";3[%A<M&;F>
M5IYO+)**S'HI(!( P,X&<9P.E:5%% $7V>#_ )XQ_P#?(H^S0?\ /&/_ +X%
M2T4 1?9H/^>,?_? KDO&4:1S6FQ%7*MG:,>E=E7(>-?]=9_[K?TH Y6BBB@#
MH_!\:27]P'16 B[C/<5V/V:#_GC'_P!\"N0\&?\ (0N/^N7]17:4 1?9H/\
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M(,J_S%>F?9H/^>,?_? KS.Q_Y"%M_P!=5_F*]1H B^S0?\\8_P#O@4?9H/\
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M](_^_9_QH EKD/&O^NL_]UOZ5U6V?_GI'_W[/^-<EXR#B:TWLI^5L;5QZ>]
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M6\V/^_Q>G+HOB.'_ %/BQY?^OS3XG_\ 1>R@#HZBN+B&TMWN+B18XHQEG8\
M5RFN-XPLM$O9?MNE3!(6(>WMI890<<;07<$YKSCX3:MXP\0^(YX/%;WLMO%$
M)8%O;8J@<'J.!DB@#UN"WFUN=+V^0QV2'=;6C#ECV>3W]%[5N5%MG_YZ1_\
M?L_XT;9_^>D?_?L_XT 2T5%MG_YZ1_\ ?L_XT;9_^>D?_?L_XT 2T5%MG_YZ
M1_\ ?L_XT;9_^>D?_?L_XT 2T5%MG_YZ1_\ ?L_XT;9_^>D?_?L_XT 2U@^+
MO^0)_P!M5_K6SMG_ .>D?_?L_P"-8?BL2C1OG="/-7@(1Z^] '#T444 6+'_
M )"%M_UU7^8KU&O+K'/]H6V.OFK_ #%>F;9_^>D?_?L_XT 2T5%MG_YZ1_\
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M'=D'[P!8 'UZX@.DZS!+/JD6F/)<:BD\<EKYL8:V\PC8S-NP0 /FVECSQNH
MZ)?$MF^JK9)%,\;,(_M@V^2)2N\1YW;MQ7G.W';.>*V:XJS\/ZA9W,.E"W9[
M)+N.\-]O0* J ;-N=V[</3&T]<\5VM !7CGCK2VG\97+G3D:60)Y$7]B"Z6]
M^4#YI^L?(V\$8QFO8Z\O\9:W?Z)KFI0V_B#1X%O8XS_IM\RR68 Y*1#J3RP[
MDT >FQ#$* J%PH^4=J?3(3F",[M^5'S8Z^]/H **** "BBB@"AKD33Z!J$2V
MB7;/;2*+=SA9<J?E/L>E><?"_5-*U76)#IWA^RMKFUAGBO;RSTW[&BMYPV1X
MSDDJ 2#DKCKR:[_Q4CR>$=92.2.-VLI@KRR;$4[#R6R,#WS7C'A:XUB;7)!X
M/?P$NH)82))%IJW";UW)\YR@4D$#&X]S0![]5'5TO7TN=-/C@EN&4A8YW**_
MJ-P!Q]<&KJYVC=UQS2T <!#X-U:#2[:)8]-D>2UFLYX)I'V6\4C9 C;:2VP9
M&TA00>J@ 5K366JRM";*W@\_27\F W,SJERACVL6/EY4C.?E# XQGKCJ:* .
M,7PA>V\8L89K=[*Z2(7TCLRR*R,6)C4*00V2.2-O7GI4L6DZII+&X,=M<6^F
MI,UBB22;YC(<X<",[=H)'RAL]>.E==10!R4GAJ^O+IX)S FERSF\;$A,RR%,
M&/&W&T'YMV<]L=ZA3PSJ[I'=3O9?;K%8H[-4D;RY5C.<R'9E2W ( ;;V)KLZ
M* ,W1+";3[%A<M&;F>5IYO+)**S'HI(!( P,X&<9P.E:5%% $7V>#_GC'_WR
M*/LT'_/&/_O@5+10!%]F@_YXQ_\ ? KDO&4:1S6FQ%7*MG:,>E=E7(>-?]=9
M_P"ZW]* .5HHHH Z/P?&DE_<!T5@(NXSW%:/B.-(Y;?8D:Y4YXPG;_7?],?7
MWQ5#P9_R$+C_ *Y?U%:/B;_6V_W?NMU^YV_UW_3'U]\4 87^?WW_ +5_Z=?[
MM'^?WW_M7_IU_NT?Y_??^U?^G7^[1_G]]_[5_P"G7^[0!HZ&JOJB*ZEAM/#C
M,G3O_P!,/[GO75?9H/\ GC'_ -\"N7T'_D*I]_[K?>_UG3O_ -,/[GO76T 1
M?9H/^>,?_? H^S0?\\8_^^!4M% $7V:#_GC'_P!\"C[-!_SQC_[X%2T4 1?9
MH/\ GC'_ -\"C[-!_P \8_\ O@5+10!%]F@_YXQ_]\"C[-!_SQC_ .^!4M%
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M6LEH^9<J.%4CD'..<?E0!VML2UK"3C)0'CZ5+38R#&I4;5(&!C&*=0 4444
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M_P"W7_3/_GG^%'^?]-_]NO\ IG_SS_"@":U.+R _ON)%_P!?_K.O_+Q_L_\
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M!% HY!=MH#OQW./Z 'LR;O+7?C?@;L=,TZFQL'B1U&%900*=0 4444 %%%%
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M6^]_K.G?_IA_<]ZZVN0T/<=4382#M/+C,G3O_P!,/[GO75;9_P#GI'_W[/\
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MZ^:O\Q7H&K";^RY]SZ>1@9%XA$74?>YH Y#_ #_IO_MU_P!,_P#GG^%'^?\
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M5/O_ '6^]_K.G?\ Z8?W/>NMH **** "BBB@ JK>ZA:Z>BO=2^6K' .TG)_
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MQ%=:SJ^HV_V&&.TM96A$@GS*KJ<$2(5&W/48)X_"NBH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K.UK2FUG3VM!J%W8JQ!:2U\O<1Z?.K#'X5HT4 <]+X3AN(H%F
MU/4))$4QRRYC5IXSC]VP5 H7@?<"GCKUI5\+R)J4]XGB#5E\T8$*BW"1@= O
M[K< /3./7-=!10!D:'H3:+&Z-JU_?ANGVOROER<D_NT7)/J<FM>BB@ HHHH
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MN^5=QRRI)O 4'W4D5<_X1":+Q7I>K6E_!#9Z?:FUCM#:EF*'K\_F#GC^[^=
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MOD"/.MN ;68/YC#*@KMW#(Y!(P>U26'C7P]J<C1VNHJQ6!KAB\3Q@(IPQ)8
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MA*[2;1K.6X$UEI]V]^9.5 ;#".*-"S$*NXGD]@!P<  [*BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g900407g0404235413831.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g900407g0404235413831.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ B0# 2(  A$! Q$!_\0
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M:QID,%K/+J-HD-VRK;2-.H68MRH0YPQ/;'6I;V_L]-M6NK^[@M;=2 TL\@1
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M>6.:&10R21L&5@>A!'!%25A^%6\S3)YT.ZVGNI9;<YX:,MD$>Q.2/7.>];E
M!146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
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M%L9ZX&:\Y\)?&33/%_B9=#M=+O()B&)DE9=H"]>AS0!Z51110 4444 %%%%
M!1110!2M]8TV[U"YT^VO[:6\M<>? DH+QY_O#M4*>)-"DL)K^/6M.>S@?9-<
M+=(8XVXX9LX!Y'!]:Y"QO=)L?%>J:8E]#+8O%-+<,\@673R2"^6X*(V[C=@@
MC@D?=6*[M;..PNY-4%UX=L[YO)OIIPZ*ABPI:0_>4,64,2>V23S0!V\NIV$,
M]M!+?6T<UUG[/&\JAIL#)V#.6X]*6\U"RT]8FO;RWMEED$49GE5-[GHHR>2?
M2O-H";:RDM;HF.\OH+<:7&YP[!92P5!URN0Q'88)K;\1:GIWVW[3<7<$MH]A
M<V4;+(&4W!(!B&#_ *PXP%ZG!% '7'4;(:@-/-Y;B]:/S1;>:OF%,XW;<YQG
MO1::A97[3K9WEO<-!(8IA#*K^6XZJV#P?8UYZGVE3_93RX\1/>QW"J7_ 'AC
M$ 7S/]P#*YZ9XZUK^$9H+F_M_L+ QVFF1VUVJG_5S!C^[;T=?FR.HW<]: .T
MKQWQSJ^L?\)1J4,=SX@AM;5$$3Z=HZ3QIE 6)D/(//J,5[%7F'C3P?JNJ:I?
MWR:C$8W:)(8)=1E@0*0 5*KQU&??<>E 'I<!S;QDDGY1R>IXJ2F1*4B13@$*
M!P:?0 4444 %%%% '.>)/"$/B:_LKB;4M0LUM8Y4 L9VA=]Y0\L#T&SIWS[5
M5\/> ;/PUJ\-]9ZGJ<\<5J]LL%Y<M,J*2A&S/W<;,8 YX]*V_$)<>&]3,4%Q
M<2"UEVPVSE)9#M.%1@"0Q[$ \USFFZAXRL].GO\ 5-.M638AM=(MY#-= < A
MI3M4D9R>#_O4 =HV=C;0"V. 3@&N%TFRU:"T\1"+1+FTLYD;[/IYDA^:8[MS
M1@-M53E>I&3DX!SGN^W3%% 'GNK^&[G4K+2WN= >[?\ LTV9A>6(/9RG;B3)
M?;@%3DJ2PPI /;5N)+Z2>UGMK*XOKG2'\B=%DB!GWQ8+(2^ 02"0Q4XSQR,]
M;10!P,7AK5;6V;3!;>;'J"0F>Y210MLRL2X()#-P<+@'D<XJS;6]]I#QS7EB
MZVFCI.ZS++$/M6\DKMRXVX4G._;STR.:[6B@#B9]$U&_GDL#:/'9371OA>,R
M8 *?ZLKG=OW>V,=\\5"NCZS,;?4)=-:.?3(X(H[;S8R;K8V793NP 0/EW$'U
M KO** ,GP_:7%K82O=1^5/<SO<-"2"8]QX4D$@D #."1G.,UK444 1>4_P#S
MWD_)?\*/*?\ Y^)/R7_"I:* (O*?_GXD_)?\*Y+QDI6:TS(S_*WWL>WH*[*N
M0\:_ZZS_ -UOZ4 <K1110!T?@]2U_<8=D_==1CU'K78^4_\ S\2?DO\ A7(>
M#/\ D(7'_7+^HKM* (O*?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\ GXD_)?\
M"CRG_P"?B3\E_P *EHH B\I_^?B3\E_PH\I_^?B3\E_PJ6B@"+RG_P"?B3\E
M_P */*?_ )^)/R7_  J6B@"+RG_Y^)/R7_"CRG_Y^)/R7_"I:* (O*?_ )^)
M/R7_  H\I_\ GXD_)?\ "I:* (O*?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\
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M:A2"&R1R1MZ\]*EBTG5-)8W!CMKBWTU)FL4223?,9#G#@1G;M!(^4-GKQTH
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M^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H
MEHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/
M./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_
M^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H
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M@:YY/%]Y<1_;H88([*U2(WL;H6D9G8J0C!@ %P3R#NZ<=:OZ3KU[=ZC#]I6
M6=]YOV18T(>/RSCYR6(;< 3P!CISUH V8M*T^&[6\CLK<7:Q"$7'ECS/+'1=
MW7'MFF)HVE1VMS:IIEFMO=,S7$2P*$F+=2XQAB>^:PKCQ/=VM]-<R)!_94=R
M;/8(SYV\+NW[MV-N?EV[<]\]J@7Q-JZ)%:S+9_;[Y(I+-EB;RXED.,2#?EBO
M!)!7=V H ZZ""&UMX[>WBCAAC4*D<:A54#H !P!4E9NB7\M_9.;@(+F"5X)C
M&I"LRGJ 22 1@XR<9QD]:TJ "BHOM$'_ #VC_P"^A1]I@_Y[1_\ ?8H EKD/
M&O\ KK/_ '6_I75?:8/^>T?_ 'V*Y+QE(DDUIL=6PK9VG/I0!S%%%% '2^#/
M^0A<?]<OZBNTKB?!\B1W]P7=5!B[G'<5V/VF#_GM'_WV* ):*B^TP?\ />/_
M +[%8EQXJMI)VM='C&I72G#%'"PQG_;E/'X#)]J -\D $D@ <DFL)_$9O9&@
MT&U.I2 [6N-VRVC/O)SN^B!CZXJ$:.-2(D\0ZC%>+U%E$VRV7ZKG,G_ CC_9
M%;J2VL4:QQR0HBC"JK  #VH R$\.&]=9]?NO[1<'*VX79;(?:/)W?5RWMBMT
M *H50  , #M4?VF#_GM'_P!]BC[3!_SVC_[[% $M%1?:8/\ GM'_ -]BC[3!
M_P ]H_\ OL4 2T5%]I@_Y[1_]]BC[3!_SVC_ .^Q0!+147VF#_GM'_WV*/M,
M'_/:/_OL4 2T5%]I@_Y[1_\ ?8H^TP?\]H_^^Q0!+147VF#_ )[1_P#?8H^T
MP?\ /:/_ +[% $M%1?:8/^>T?_?8H^TP?\]H_P#OL4 2T5%]I@_Y[1_]]BC[
M3!_SVC_[[% $M%1?:8/^>T?_ 'V*/M,'_/:/_OL4 2U@^+O^0)_VU7^M;/VF
M#_GM'_WV*P_%<T3Z-A)$8^:O 8'UH X>BBB@"Q8_\A"V_P"NJ_S%>HUY=8D#
M4+8DX E7^8KTS[3!_P ]H_\ OL4 2T5%]I@_Y[1_]]BC[3!_SVC_ .^Q0!+1
M47VF#_GM'_WV*/M,'_/:/_OL4 2T5%]I@_Y[1_\ ?8H^TP?\]H_^^Q0!+135
M='&496'J#FG4 9A\.Z(;F\N#I-B9KU=ETY@4F8>C\?,/K4G]B:2=*_LHZ79?
MV=C'V3[.GD]<_<QCKSTJ_10!5ETRPFGMIY;&VDFM<_9Y'B4M#D8.PXRO'I56
M/P[I2P>3+8VUPGVEKM1- A"RDD[@ H (SUQGN23DUJ44 5CIUD=0&H&SMS>K
M'Y0N?*7S F<[=V,XSVHM-/LK!IVL[.WMVGD,LQAB5/,<]6; Y/N:LT4 %>'^
M/-:T^T\;:G"S>%K6[B$;";4=.DN)V8H,,& (&.,#';->X5Y=XAU7Q''XTU"R
MTS3VO+>6+R40K%'")65"&<L-SX&<XR,8'6@#TV EH(R2"2H.1WXJ2FQAA$@;
M&X 9QTS3J "BBB@ HHHH PO&-L]WX1U2--4?3!]FD+W*QA]B[3G(()QCTP?0
MUQ_@'5;S5?$Y-[XAU#56ALG"++H9L8XP70$EB?F8E< >S5WFO2VL'A[4I;Z!
MKBT2UD:>%.LB!3N4<CDC/<5R/@Z70KSQ(U[I&EWL:O9>6EZUV9H90I17&-[#
M.0!O_C*-@G&2 =_5+5;:[N]-FAL;F.WN&7"/+%YB?1ER"1]"#5VJ>J:I:Z/8
M27MX[K$F!A(V=F). %502Q)[ 4 <K)X#N)-'M[$ZI >)?M*R6>^)C(X<M&F\
M>6RD?*Q+8R202<UJW6EZK?S-(MW#:SV<W^A3R6_F;D*;7#J)/FSDX.4.0...
M;<GB72H=)M]2EN'2"X8)$AA<RNY_@$8&\MP?E SP?2K.H:M9Z9:)<W32JCL%
M14@>21B>P106)QSTX .>E &'_P (:L1BAM[[98ND:WD+Q;FN#&200VX;<DG=
MP<CICK3E\/7VG--<VMVD_P!G27^SK=K?_5,YRVXF1=_.0.4P#CGK6H_B#2TN
MK6V-R6DNE5XBD;,F&^Z6<#:NX\#<1D\#-26FM6%]?SV5O,S3P9W Q.JG!P=K
M$;7P2 =I.#P<4 9)\+//?%[F[1K%Y/M+V:Q'/GE=I(?=]SOMVYSSGM44?A"X
M$!:75%DO8!&EE/\ 9R!"L9RH9=_SD_Q'*YQP%K:_MO3_ .U6TSSV^U*,D>4^
MS.,[=^-N['.W.<<XQ4$?B?2);*XNTN9##;D!\V\@9LG"E%*Y<,> 5!#=LT 6
M-(TXZ98^2\WG3N[2S2A=H=V.20,G [ 9/ ')ZU?J"SO(+^TCN;9RT3C@E2I'
M8@@@$$'@@C(-3T %%%% !7(>-?\ 76?^ZW]*Z^N0\:_ZZS_W6_I0!RM%%% %
MNS\4Z9X1CN-2U:22.UVA"R(7()(QP.:V+'XG:+K5EY^B07E\2Q49A,:)C&6=
MVX11D9)_ &N<D\'6WC>RN-)N[J6VAPLA>( MPP]:NZ5X'M? >G+IUG=R7,4K
MM+NG  !X'[['_+'U]\4 ;F(]5^?Q!J@:+J;"V5XX%7^](Q 9U_VCM0^E;D&J
M:1:P)! Z00QC"QK$46-.S8Q\J>C?=]ZY/_/[[_VK_P!.O]VC_/[[_P!J_P#3
MK_=H [6WU.SNI1%#*6D(SMV,#C^]@C[I['H>U6ZY+0?^0JGW_NM][_6=._\
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MZ^^* ,+_ #^^_P#:O_3K_=H_S^^_]J_].O\ =H_S^^_]J_\ 3K_=H_S^^_\
M:O\ TZ_W: -'0]QU1-A(.T\N,R=._P#TP_N>]=5MG_YZ1_\ ?L_XUR^@_P#(
M53[_ -UOO?ZSIW_Z8?W/>NMH BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&I:
M* (ML_\ STC_ ._9_P :-L__ #TC_P"_9_QJ6B@"+;/_ ,](_P#OV?\ &C;/
M_P ](_\ OV?\:EHH BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&I:* (ML_\
MSTC_ ._9_P :-L__ #TC_P"_9_QJ6B@"+;/_ ,](_P#OV?\ &C;/_P ](_\
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MB3S5"^0.S2<_*K=CWH3Q)9MY6^.>'<2)/-4+Y [-)S\H;L>] &GMG_YZ1_\
M?L_XT;9_^>D?_?L_XUFP^(;69X4\BXC>1BKJZ &'^Z7Y^4-_#ZUKT 1;9_\
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MC>*FU1/#UPVD&07(VDF(IY@3(W;-_P N[&<9XK:JGJ=BVHZ?+:I=SVCN,+-
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MOO\ VK_TZ_W: -'0V":HA/F?=/8F7IWQ_P L/[GO75>>G]V3_OVW^%<OH/\
MR%4^_P#=;[W^LZ=_^F']SWKK: (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]
M/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O
M/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"
M+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH
M B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:
M* (O/3^[)_W[;_"L/Q7*KZ-@!_\ 6KU0CU]170U@^+O^0)_VU7^M '"4444
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MGP_:7%K82O=1^5/<SO<-"2"8]QX4D$@D #."1G.,UK4 %%1>4_\ SWD_)?\
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M[&EM]'TRTT\Z?;:=:0V1SFVC@58SGK\H&* //=<M+,ZQX=A:UA@T75[EY[U
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MW.D!I=.MXTF,[QNL..N,-N#>A0MGH10!Z'97EOJ%G%=VL@D@E7<C#N*GKG?
M]A<Z=X6MXKH,LCN\NQLY0,Q('Y&NBH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Catalyst Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001369568<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for the fiscal years ended December&#160;31, <div style="display:inline;">2024</div>, 2023 and 2022, and our financial performance for each such fiscal year: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value of Initial $100</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Fixed Investment Based</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">on (3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Table Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">for PEO ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Actually Paid</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">to PEO ($)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(1)(2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Table Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">for <div style="white-space:nowrap;display:inline;">non-PEO</div></div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="font-weight:bold;display:inline;">Average</div><br/><div style="font-weight:bold;display:inline;">Compensation</div><br/><div style="font-weight:bold;display:inline;">Actually Paid</div><br/><div style="font-weight:bold;display:inline;">to <div style="white-space:nowrap;display:inline;">non-PEO</div></div><br/><div style="font-weight:bold;display:inline;">NEOs (1)(2)</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Shareholder</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Return ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Peer Group</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Shareholder</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Return ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Income</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Product</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Revenue</div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,774,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,896,544</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,723,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,024,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">557</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">163,889</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">489,327</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,146,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,007,034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,256,711</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,952,842</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">448</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">54</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">71,410</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">396,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,923,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17,549,684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,674,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,393,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">496</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">69</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">83,079</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">213,938</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Amounts represent compensation actually paid (&#8220;CAP&#8221;) to our PEO and the average compensation actually paid to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for the relevant fiscal year, as determined under SEC rules (and described below). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fair value or change in fair value, as applicable, of stock options in the &#8220;Compensation Actually Paid&#8221; columns was estimated using a Black-Scholes option pricing model for the purposes of this disclosure in accordance with SEC rules and do not reflect compensation actually earned, realized or received during each applicable year. The calculation of CAP for purposes of this table includes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><div style="white-space:nowrap;display:inline;">point-in-time</div></div> fair values of equity awards and those values will fluctuate based on our stock price and various accounting valuation assumptions. See the Summary Compensation Table for certain other compensation of our PEO and our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs for each applicable fiscal year. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">For the relevant fiscal year, represents our cumulative TSR or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the table immediately above, the columns &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs&#8221; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT</div></div>&#8221;), as adjusted based on the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT&#160;Total&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Minus&#160;SCT</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">New&#160;Unvested</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">12/31 ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Annual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Prior</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">that Remain</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Unvested ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vested and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Granted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">During Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Change</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">in Value of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Prior Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards that</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vest During</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;CAP&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,774,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,338,431</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,922,548</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,488,419</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">49,848</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,896,544</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,146,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">749,999</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">943,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(736,903</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(595,928</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,007,034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,923,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,727,859</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,659,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,460,212</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,234,201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17,549,684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></div></td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,723,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,838,396</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,237,565</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">572,615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">329,407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,024,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,256,711</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,446,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,819,515</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(326,149</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(350,675</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,952,842</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,674,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,939,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,316,864</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,394,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,947,593</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,393,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables illustrate the valuation assumptions as of the vesting date for awards that vested in each of 2024, 2023 and 2022. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">
<tr>
<td style="width:55%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">For Stock Options Vesting in</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">3.85%&#160;-&#8201;4.52%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">3.75%&#160;-&#8201;4.65%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">1.30%&#160;-&#8201;4.00%</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">1.6&#160;-5.0&#160;years</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">4.5&#160;years</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">4.5&#160;years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">54.1% - 60.4%</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">68.0% - 71.0%</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">68.4% - 69.5%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected forfeiture rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">&#8212;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">
<tr>
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="vertical-align:bottom;text-align:center"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted&#160;Average&#160;Fair&#160;Value&#160;of&#160;Full&#160;Value</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Awards Vesting in</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For Restricted Stock Units</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">11.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">11.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">4.65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">Net Product Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s principal executive officer (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div>&#8221;) and our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> named executive officers (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">NEO</div></div>s&#8221;) were as follows for the fiscal years ended December&#160;31, 2024, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:19%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:53%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PEO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2024</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Richard J. Daly</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Michael W. Kalb, Steven R. Miller, Jeffrey Del Carmen, Preethi Sundaram</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Patrick J. McEnany</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2022</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Patrick J. McEnany</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text">For the relevant fiscal year, represents our cumulative TSR or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 7,774,160<span></span>
</td>
<td class="nump">$ 2,146,499<span></span>
</td>
<td class="nump">$ 6,923,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 12,896,544<span></span>
</td>
<td class="nump">1,007,034<span></span>
</td>
<td class="nump">17,549,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the table immediately above, the columns &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs&#8221; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT</div></div>&#8221;), as adjusted based on the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT&#160;Total&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Minus&#160;SCT</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">New&#160;Unvested</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">12/31 ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Annual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Prior</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">that Remain</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Unvested ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vested and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Granted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">During Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Change</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">in Value of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Prior Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards that</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vest During</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;CAP&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,774,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,338,431</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,922,548</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,488,419</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">49,848</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,896,544</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,146,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">749,999</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">943,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(736,903</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(595,928</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,007,034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,923,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,727,859</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,659,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,460,212</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,234,201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17,549,684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></div></td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,723,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,838,396</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,237,565</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">572,615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">329,407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,024,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,256,711</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,446,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,819,515</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(326,149</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(350,675</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,952,842</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,674,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,939,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,316,864</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,394,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,947,593</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,393,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 3,723,348<span></span>
</td>
<td class="nump">2,256,711<span></span>
</td>
<td class="nump">2,674,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 5,024,539<span></span>
</td>
<td class="nump">1,952,842<span></span>
</td>
<td class="nump">7,393,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the table immediately above, the columns &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs&#8221; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#8220;<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT</div></div>&#8221;), as adjusted based on the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">SCT&#160;Total&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Minus&#160;SCT</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">New&#160;Unvested</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">12/31 ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Annual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Prior</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">that Remain</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Unvested ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Value&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vested and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Granted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">During Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Plus&#160;Change</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">in Value of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Prior Year</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Awards that</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Vest During</div></div><br/> <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Year ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;CAP&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,774,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,338,431</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,922,548</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,488,419</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">49,848</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,896,544</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,146,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">749,999</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">943,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(736,903</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(595,928</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,007,034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,923,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,727,859</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,659,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,460,212</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,234,201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">17,549,684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div> NEOs</div></div></td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,723,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,838,396</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,237,565</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">572,615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">329,407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,024,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,256,711</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,446,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,819,515</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(326,149</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(350,675</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,952,842</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,674,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,939,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,316,864</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,394,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,947,593</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,393,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413317.jpg"/> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413608.jpg"/> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413831.jpg"/> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g900407g0404235413317.jpg"/> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2024 Performance <div style="display:inline;">Measures</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following list represents the financial and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-financial</div> performance measures that we consider to have been the most important in linking Compensation Actually Paid to our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs to company performance. The measures in this list are not ranked. Of these measures, we have identified Net Product Revenue as our most important of our financial performance measures used to link Compensation Actually Paid to our PEO and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-PEO</div> NEOs to company performance: </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Net Product Revenue </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Net Income </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Completion of a transformational acquisition </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Quality and Compliance </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 557<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 163,889,000<span></span>
</td>
<td class="nump">$ 71,410,000<span></span>
</td>
<td class="nump">$ 83,079,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">489,327,000<span></span>
</td>
<td class="nump">396,502,000<span></span>
</td>
<td class="nump">213,938,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Richard J. Daly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Net Product Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure:: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Net Income<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure:: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Completion of a transformational acquisition<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=4', window );">Measure:: 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Quality and Compliance<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (6,338,431)<span></span>
</td>
<td class="num">$ (749,999)<span></span>
</td>
<td class="num">$ (5,727,859)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">6,922,548<span></span>
</td>
<td class="nump">943,365<span></span>
</td>
<td class="nump">7,659,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,488,419<span></span>
</td>
<td class="num">(736,903)<span></span>
</td>
<td class="nump">3,460,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">49,848<span></span>
</td>
<td class="num">(595,928)<span></span>
</td>
<td class="nump">5,234,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,838,396)<span></span>
</td>
<td class="num">(1,446,560)<span></span>
</td>
<td class="num">(1,939,664)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">3,237,565<span></span>
</td>
<td class="nump">1,819,515<span></span>
</td>
<td class="nump">2,316,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">572,615<span></span>
</td>
<td class="num">(326,149)<span></span>
</td>
<td class="nump">2,394,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 329,407<span></span>
</td>
<td class="num">$ (350,675)<span></span>
</td>
<td class="nump">$ 1,947,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>31</ContextCount>
  <ElementCount>27</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="d900407ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d900407ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d900407ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cprx-20241231.xsd</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="d900407ddef14a.htm">d900407ddef14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g900407g0404235412721.jpg</File>
    <File>g900407g0404235412946.jpg</File>
    <File>g900407g0404235413317.jpg</File>
    <File>g900407g0404235413608.jpg</File>
    <File>g900407g0404235413831.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="74">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d900407ddef14a.htm": {
   "nsprefix": "cprx",
   "nsuri": "http://www.catalystpharma.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "cprx-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "inline": {
     "local": [
      "d900407ddef14a.htm"
     ]
    }
   },
   "keyStandard": 27,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 7,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 31,
   "entityCount": 1,
   "segmentCount": 7,
   "elementCount": 266,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 74,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900407ddef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-25-079097-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-079097-xbrl.zip
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M=&WLO6ESVU:R/_P^GP*E3.;:591$:K7EQ/>A)3G1Q%JN)"<SSYL4"!Z*&(,
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M(GJ!R>.HHO@XL3;JGI4YYT\MB'6I4&91:D1MF6OQ.(V-RH%]/6#NSUQ 5EF
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MT7AB&1UX+T+I(NB;9J1C@ 3B;C;M7%@GP8: 49*Q:PF#ST&8VR[!N@]2R )
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M"9 MLRND<GTJOHWW?)6:N\94WRKQ#IFR];.5&3XI<.]-<H.CP"'1_A[F<+=
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M.FC.O@8K#:KX3N..7\*-T>H9*(#":!PW=\/@)6>HQ8=49WZ+!]556-Q**J)
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MU/PBIKDX3L[*.VLG8GB#?F^I!NMQZZ.<4W,E_N0 ;]FR>I*Y SL3<@>>?>:
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MU"4S I>O\"?F[/1-KV!A>KTTD8YK CJ=]1%:,?,C:OU6@0T=%@1'&5 SQ*$
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MM@=;.U_%[MT7A6MEDSTJ>KR13]19QBA+@@C?T4J+U1> =[Q7G;1 GQO]F#B
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M+8A ,XPL!A1#XN#A4$4;L*IT]%6H'8PUS?]T,=>0JCX.@8I(A))3)TVB95^
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M> <(%P1_M9&.(N5?F.N(^=VL,)>INFX50)""/'M#K2I,R99^E=$BP%!!GZM
M*A%A*U8IG$!\3L4SZ4B[(0(PZO/B_['WILUM&TO#Z'?_BBF=Y"VY"J*Y+W:B
M*EF2$^58EAY)3F[NK5NG('(HXA@$&"R2^?SZM[MG!AB ($5*W#VIE"R1P"P]
MO4\O4I;+#BMX)V/E;F20L.*0^BTE$]J]'EI2:)L#(GF6 "-.Z/H4JIP[A%4C
M=:Z.P&3-/[RN!]M_,JN0[,P5X_5D_I<H4(B>00>D]6^(9'(I=,+"9G@ 2RH@
MY<WSG\<6#=R*>>OA3JCG"YL/'4\I'24(GI18S^728DU2W_M'91+FOBTL1)+Q
MI27Q6TFB4FIT*H,F37":Z0A4H1;3\YI6&#SSW"&>RWWJYYB-:/>FP%A!P<9S
M)%(5,K-/+F6D_:#HP(GH,0'121V/LLZ-O)G Z#(@@!#/3>\!(UR<R9.IM:(C
M3(I]E&>3[ 2?F[(/0%.\30G44:+78 B0&N0#=K2Z:PD_+PC3T6HH$4..]8*,
MN5P@T$X><$%T@TO!>E0EA1:)I=J&\5 P54<YP@Y#/G?%<6VP2SG87>(/S]1&
M?EMB7].X*#V?82H561.P)\4A/0 L8/O@ 9ZF77@D'LC(+)$L($)V)>V+%("9
MD?\:2<GS1_VT.-A?3D&Q6-)&U!<LHRBRM"Y((+_D9#.](@]T9A28R,Y,,QN.
M10$55*;E":].4))J"(6X@#/*4# 1+OK$-:@G><IZ""A:P!C7Z0MQWE/N]#6E
MW!80"6Y$N)^51T<>:5=6]]2]F!-8Z>5AES_L.).8,W)CJIPFE&1[3M1.DUER
MR)!FJ&A848!>V47(N^_-L_PS)Q3;ID! ^ OX,=V9)#+@8H*YH3HEV/;,L@'I
M\<6%W&2J+-$#<AQ/NY'ZSOK(C_5KF[=)Y:DG7Z:5)[?'/5ER/S5_IDR(Y8R5
M,8<A%6)$C/&A-(/TKD>YDK6-%^@IL[!U^BJL/ ?KI8?Q<NZ:8:BHH]#B<P%)
M*:.EC/<TTCNAT +F^UQN54YIFL)VR<TW-< ^[=#;C7 ?V-HMP4A1WT 2)FB$
MHL()>1N5$J*#\#!5'B:OP.ER4?Z.D[PEF/!>.$WT3-M]5LLK( J5+5_,)!)5
M=*9838_;SJQ:<;646:6G6TC( )(8[7@P>=*&%1F@30>T$^9TWOD.7-YSTH2)
MRS?9!7Z\TU[9BO'*[KY7]GFQ>442:HJXM%\O+.=4NTEY3KB=)A>?91P9MD$^
MCS"<H8KW'"P*2X;Y/8^>5)IU$:L6BAQ&/DBO"]Z@W8-8>)O3[L"<[Z5UM0MY
M#,%"XT<E=J+N=PLW<$BW@%1PON!;34$C*='+Z#XZVWOI44US0!0!(]'TTSA!
M6J@*(125?<GAABH,ESK13.%";0LP%8L,[[3H3J+*9'6C3$H7OJI=W!<H-IO7
M5F<;L8 =4RQF=)6J"]R^ZD,G9%82/R-Q3VKF&?F?E:<P( RFW3XH!T?&-A?6
M&%U^3UD4"4C-12$#.@'VY"93?6QE&;3"2=@AWJZ@XT55!7[.9?!V.I#(SRHT
MVBG#R!MP5"Q+[#>U<DM?F_8(E7&E*%,N\)$V3>5'N8I-55V-(ZQ7KZ5G*GZ#
MT22I4C1E6:O'RT]4'G?*,4H?EF"Y(6S0+F+BTZT==80S^'S*+61U<%&[]]E3
MLE+^*I$VV^; UDSO#+]_UG]97#U:Y*B@_=*7M_?DSHV>!9[F%'-FVYLSS+BD
MLR,]1/Q.T\VM62BD4+9K>R(ZI4M-3]"Y+'R2B>30/9K9XT\R$1-?I"Y2L#U+
MF-JR R?H'>$>QUF')PZ?"5,7$FRFN%*JO0K3F2[72%T0@$E-[.G 4L',B5TP
M;=@PWYIK'@:R!F]3P&6-Y^=NV$13FJ5?+?@Y4WANM\=46(?(P#4_09Y4$DP-
M)UP!B>R?VZ?[Q*=X$ N@F;@1BXW0_&)"7R<JTA:37GY"0<H3U).Z"1#-F ).
M*1JH'FFY$ND@LLO?W82<GQ-:&51X1E<DQOB<%C_MW M+&^A7&Y3S@BM!ZO&H
M*(ZX/=8[Q60JK5>:U</AVS3TK9<V A @M%4"C90 1<"T7N%*SO!@1_? 92#7
M1>\#-1<65:G37DYB00H:$^7B;WGPZ'1%IO,,YSPZW^$)_<0G*'Q.8BA<I7*^
M)PK/A'^>2YL$9*^83:1:I+IC4K@H_39]]^U$$8;9FYWM<X9)IK.J;;O=+J[@
MMHZ;[E1L9"ZOBR1&'M[ [F<*$<DC]*V)X">*-)+3644>@*EOBJ".9\U])7MG
MNH>S]VTTY6L<P%/7+ >E&!/A+$QJIR?7-F-13D(S,O*DH-6^?II!FK+ZCE#8
MGJAA.JFF8.QPV46>[M9DT&VH>4 R'>&F4QYF(N\D\T[RE/EW#/#E&O_.X,4T
MY$G<-).L9Z=]N%7CP]T['^X,@5-0Z6X=<D96LLDZB[&]'WZ6X0CMVN']6\9=
M+EV[]H2>.\D=M18?X7,EUJS<(H1W@ K#4!T*3X_01T,OE2M?2[>EJ?Q!AB,D
MK]WS)&G)UGB-?NTI)LP%V(+N1?6FDH6(/N48N2430?0,(EV5MO4, HRKH0KG
M0(I][J"_++_SO),\VVY@4F*F-@[JF6EAK:3YE0Z"*=LGF]QUOJG1<+=<JU:$
M6PRS.^QBWF4H0R47VNX"835B]IR4Q\7(E H*G\#^DADK:.;\A;$X:0!%@0:;
M]*K,I(CD$:U %2/ R\>[KNT,1<TW'?#48'Y&3!HL!Z.UON;N('*>,'74EN:M
MF;QO*-A:$JV25J0KNK5(77B%=QKSWR*05JG?(V0JR>&=@;:K:=<'F1 X#1D6
M1(35.W\2=R) ON]0MM5,KIJ&;DTU-F582$W6[\IU+U!1G#F6DM;#*&".7>KI
MWDTT15732]6UE >?HFQ!,XO)R' 93'JAR@A1D-,S44PY7)4OY@E*+@1Y/1%'
MJE>^(&Q/UF(K7OXK.05Y1$5TI3I?)Q1Y'W0KDWF3/*?B-"6&A@RCX6% )!5I
M8'DH4_NQ2':9/!'%V?LY0R:MQ*Y[[F5!Y$DL69=OU-A5:%<M9E,E%WJYN,NT
M%-=&K"ZTKD<.I>X4B2I9^SOSY#-11$JVS!,!$')7I+(&PA\GI4@\3,A<"\1,
M^A_(12ERQI!,<56J[O\39F1/<DZ149I6=V"'6.=*R*+D?&7C(JH15B@P243F
MZO1,OW(7M^NPF/DOUR?BG$/,@P_C8!W-;5YL^^3JIZ[#$-)X419+B1HG#)D8
M5BB%!WP#E!-+U@1DB#4J"KC%)#.HESLG&5: %[P>B2YQ&0.#S'XA1T(3XCUW
M1Z,BFO7RF45ZZW/1\/,5Q"_03V7U[)3(]/B\%.8. 4$D:RM9)D:2H4VSSH-2
MR!*6/1-^EK[&C DS:P)*D4CXJZ@ H0.46 /5YLO7Y*-TE/!]TN&QBWGD/2!:
MHE7D(-3Q^*T%' W.0S!\(NA0J']8O\:.!MA^+TQ"/$1%LWQ5!()4TK5%W'*(
MTKJRV#*U$) M7@7XIVY9K_VA9WO"S/(^BHXIC[L+$P!%Q-N]GJ./@((N2JI1
MY"[H"F6*_R3,=#D08&^U_'-B95&4B4=U"7A %=T])5!1?7A"SGBG#YH+*E,(
MJ=3?Q.+(</@DVER+/R@.[DINZ^B@9Z/>E.2"E![[:6?,1)[-T+*?5/6#4-7I
MULKJODKQ00BG=0]7Z6#.1:'G51V/%=X/3_&@_"C>Y9KQ+O](WN5)KKL>K>JB
MK]5@*2CAOI"LQA"U)'$Z7W1@03FCVS9"*K/)Z ^L7I#T@0+$=)TD,D8]J%K>
MXG/ =&,W*8I'Y>T37J_)(B%GZ#Z>P]^1@UJ-5EQ=Z&=Q\) HE#2LVJDC(KZH
MVKT?A+*PJ/*&J33UI$39;/U1\#]'^A>VZ/[]VD>J1;_=YT2(,%'YA]K.G:7E
M]]:#R<\)KU0 H6J&"E\H!5?6UYOSYFM^JI\J8G"8WZ6*2*@:9T+KR;X3N9Q4
MRQ4F(TM0*R:D&C5C]VJZ#N_&HIZ8:-PLL%6&_PD]4";N=GVAO":.%YF,6V)8
M@>6>JH10.IAL^TPC36US$'$O05Y'D?TH.5.LN]*-INH$LM^G])45\0UD!;)Y
MLZ!^55H*+_J1<N4 *-&U&FYBQU*E3336/(PB4=,PC;Q.3Y TFBGKGD4\U?H*
MZHT4"';F]("L_&ZG7*Z76_]I R']$@ZQ:F-!2K;C 30<*4Q%B'OLA3SZ,$F7
M\"F8Z5?75[<GGX'><,1C=K>\H7^_.3]/QB5]N_*!G2QO_+,_+VZO;OY.IECB
MT-?7-U=_:E!9WLA7GU8PZ-WO*:!/E[C6R^OS+[<G=Q=77U8+B2_+&_7D\OPL
M&?=\>>/^/^>G7^\N_DSA?+6\L3]]NC@]O[E-8;SR3C>*^9[YO=[1IP#+D/^%
MF[D%FYQ'[(:3NTM( P^+Y@7L.@!.+QCFB6#SP+G+(HUSOCH1VF0PPD0C[WR-
M+-*8=*OO$1:@O%\GHO7:):Q6E(I7(;U*AQI+J6&[2J)GA+3,,O!L*L:8EQ9)
M6A58_:H8Y&1-I(EL[,P,\G5*L(G=-,/@]OP4-,/<FUG06*GU+JM'T]9]7:YE
M50YQ!Z)V+I]V9::0DY3&O'<2'W0L+OY5(;;5^XU/7*R*]J 4>U)_)4AHO<X<
MY;FQ$*[<@Y44P84M3%%9</.B%)IP7]*ET,CQE.\B!^4PO=K/J#A^'(ED!6VU
MY&,9VM0?029(94^?=X7/A,H\IR8(^?:QS.=8F122=C);.$N+2N&23CPL@^HH
M[8V%/'&C%-?J0IA,015X%M2HH? *A:!E2(]*%&$):DRX(C42IQWZD6@ID%9T
MDWT/PICND4'54NY*O'$*'+K#(2<1MWNB!B_>_RC+!>:1GBA5_DMV4*17DL""
MY!I+:[?@<8H#$*VJJ>=(CD#P@"F2&FVL[*E2S)+=6QFT10BZ.F/*$NHA%%TV
MP$8:,\["!WU?%2"G6JF]F%*@J &!O% .E.HM#DI]I\K"QR+HX6XPM9JJ\L )
M2KB' ^"D8 ,GG0-/ %?[0!&D,X>J$0YQE5#S%EKB9>#5E/N%ZW8%;@F7<AQD
M:IBK)>F?28Z<+&>VW;H4EB3C[NWPFRBK&$S@#6)^5U:>=,0=-"8/]"7KG"(^
MLI#,N""FB!)9)0\^'?DA!FJ+]#?@$M^ ]WDBONA9]OCL Q+[0WM\!)QT9(\E
MCB?6=M+U1B[C@8AO$C+$2!$4Z,8FFI35PR6@'AW^%"HBGR9D5;"V#BT)""41
MJ)ZGAOVJLA[5XE:%^C#%$]%''T<XEH!2U#TK6L(V<?9%M "%IP,'1+D_&N"-
M<I9HJ6X_G^N(3[I=\D0_4&P$X5U*AAGXTO;G4ZH^7=WD"FUE;Z< 7%BX&K7-
M%Q2HU)VA]9]?G7*=;;!Y?GOU^4_2UG'YLHO2[)K?:7)+1FP+_X E+GU2/8BN
M=BSI9:C6)\X>OYAV]M:$"CCGRJ[IV&\3)5'=+,$*&CFU=:<O&^KFLF'W+QL*
MP/ G\IX;%9>UAIJV-E <T!-1G[!<\'9P:/_7#Z2[6VK=% SD/Z5-LO!I#&T%
MFM0&$3TC//Z0_.6I>TR2:EH;[33X3+D8R=V>L:.RKOA%6 AP_/N0O*-H;^BQ
MZE1 F2:6W0OPWN)>EK&E8.AT9WXJ3L3R$R.%VJUXOJR0G-]FB7T,_&]\COY%
M:%71A$K^3QT]LXR0W=,$:00Y/(Z1HS(8A;+=\^:[KR(4U3 JI?<^Y%(+E">-
M%2H"=1V0Q#\E_3,P(,#CP28*AV1;:B2:=>S9GC,4$9EX&X\!N-CA16P<Y+2Z
MR]E2KT12ZF3S'N]CX[B;HP2XZU#+JC[&(8<Y6TY'F5P4-"%-3DL12A*:ZEWD
MN7I>]9B)&YE8Y@NHZ)*Q:J<AYYI0+[6=55-59JIFD]%DWOPBVFAV.9B>N"CO
MX=>#\@']/<)K5_FWG.KCU<W9^<W1Z=7GSR?7M^?OU2^S$3$/>TV+N =%G0='
M<NKW9;G<]V4ED=_@$H-C^J>7E?3U\L^H>F2^P<8EJ"Q*-!>[5A/BXP7CU%K+
M&6=)PU1J^,4O[V#7M'?UK::_.>0T>V\_^DZ/S0U[TF(S$TKH2]RHE,JH^((9
M Z/^JTS_?9BR@P+I-K?N5,F28WMQU>D+\&U$7P!2[_AY@"N,5WB??^G%8"A@
MJ&N#0M'DUS)FXC!\:\ S.?G)P\YC37D%8#E7PFPAVW85!W0EW7JW6&8E.2IB
MA5(0+(T95LH3W#!W6K#O@^,;$,ZH<_Y18F>V.UX2ZA3-="9C0RQ0&60C%Z$'
MG%(P2G)(3 )I94LI.IAF?:W3_6%[,5Y!H#,I18$, F@G.7&0TF$!AG->PFK?
M@+J.&H_WZT%UR4^M0'3/B:VW$4;CL9L2NP3+$E,GKP>EL](*L39%RS\Q>4A#
M78&V5Z+%,RC1$FUUG+[M8H XN98W@M2UM4YW,@H<C*4OMPQ*SX_2E\B N<O^
M*K%_V^X]X-7UR4;P&5MZHCF?P>!/2;?W32!PPW#E74#AWQ!H%]X#]YS(M]@E
M<.35,V:!GY<<KU6%*_-&].]"?^M&N&UGO<@:>Q3RVC"8.C^F?@P<VV/G;GC/
M ^P-^<<Z<!2C*5R'0A.NM#AK\>5G:N^\$7RMK'6Z3_P^D-RUTC0X.S_._L'[
M_8!C3H/+3NU@R+T-JKL8#(0U]'X0A4#PV&K9X.O\^'J-@;\#A]W&F+ML#]>E
M"MQ&&,[VL!GA7U^W\'=)3:T8Q%Q 30WXPP.[B</07SDR_A[#&D$C#?TXP*"N
MC0CXZJ8$?%532M_ 3[R!6V^KY0EO8A(C^%'%!)^G@<9K[TN;#5_+NF!+*G@"
M[V@SA7CD:OT^R[W"J"NA+-TD<E,=3X7]?53)><H!&Y94@-^&(QZF>O-D&-_
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MM6O8&7)9N&_2^^9VXL&9<\>3VTR"&LZR;J9K.[ ?0("!5AT*=WO(N+P%HJ9
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M0,L*Y+)40R8;;TJTR! 000$-5Q!3)>DJ?QLI%U_I('<1*NG4U3X#H3[[R,>
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M=O-:M<#MP*23GC]*U 9O&2P1RP6R[KCK<CUP+50):QC)J*Z+)QO'JF^24J2
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M6O]9:QS%XBP'D57L'4H^/'?#>QYX0+%GZJ,+X$V>$_G:1Y>RH67R09HZEW%
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M2GTE>Q-J^2O3G#:"/2;;<159@?/U2?OJ)>X)O6\:._S76_K[/#7&]RN)<)E
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M7YV6:,J [Q.E&)@8F.P33(S+<*N.8\=A8JI][Q."F&K?JR(34^U[ORC%P,3
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M>+8[#AU\\Y_8">#-^S&[B/B0U<O5P_NW>*E^PQ]B5XR2B1PHNGF\/?JW#!;
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M][,6&K-824+9XQ_VZS;3(Z(Q'-&*/455Y-;[S5[J]?O(2$P0-UO*#FVI)\W
MLRM)AO4. XTDJ?3CZTGZ$QEL9,_^+1#^X4H>5=)?&<!,AZ#T?3\S=.G),%FJ
MFVZ4.I)FO<[%CI,X$KG:Y.7!EQ)49DS+?6C[Z:,XLPC@]W(TRB,G+F>[U-2F
ME8JYNL[&B'7*J <%3\5,(T^>K11)N)B$-X23$WQKC^[IO(N\> !!WOUS"=^U
MWS.'>>R<L.N#G20P3%=Z!7JJ2G))]68/+S[+*F>OVJ$#;@$4.3WL.O<6 /^R
MC1W8.*T50(&3O=8\]^>4W4M]63$0?B:Q,2V;>V&DWR[TZK6Z;,&R[VZ&%^+]
M,"],+DG\=@Q.)?=G/:"4#IR]M3IK,JT>QBLJ-"<^A&&7QCE/]%[I&V"<G+B[
M\%7JYV(!O0QK,)5=J5U+_]>-;CDUFA7-OOD%PN,B*$WI2JS:Z YU/&BDLK5E
M2!#ZYH;&:Z$TPX8P-.&<AJR_MS;UD00 (KAP0';GW8^"7RKQQ&@FH3 /S(CF
MO%\T*=BS+,HU!8'@Z*7^=U=22]T3;_T<-6Z!&(83F^FEZO),CW1VA^Z^/B^
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M'4_\S^ZG>VN8JZ+:HLZQM8P4.<']E=!F-;/N#F-)B_HA72UNU1;=$/^/7T&
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MRV0N[O+3"MV+QG6/AZQDKL,/L9!#0Y^L'@^:9%GVC#FZ92M\?U5%>P>0@>U
MJM-)47_:)RRV,Y&"W1]84%G^B"/!_@>TVN!D1=QJ.$*>64X7,/A0"?_@&+=
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M7,C+"8N(/B(Y=(&&J!R)Q::/EDC:82R9B&&%A=;N>K(1R0V1$]I3HQ%5<0(
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M6LLSU]N0$WY?7*"OE^L__V-(XX5S^$S@%SI7D#C;&^D8@<K\68; @MD!]YL
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MP1Z&E4+@P( HR]VU_'U5# H<Z'6]NGN20TYB\WMC8NM-[-/OSS) $VR^X7
M05T*VX%TV[E<Y;F!]1A2A-4QN8Y$\&L&VG ,5<$ND2\WQ3;83QGN=+#LS>'
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M,%IEN*D*F;SYS/.W\L"M=O5?;Y)<((Q'GR6>ME34I6E,L$]-":MADL^1?MS
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MU#*A2>K(/=W<95_KH J;9X=M0T![M.]3&J>Y @,72S?J7B&V__V*#425=,E
M_N+W^P!1-LV0I>[?>G(6)CD,J !*FUA@8SZU]4-\F='BSO/[W'<D'DL.LR1\
M3]9.AB2<=8,7$,00HM+/,[&_5D$E**N;HOH7#$M>X#MM1/,.4)-Z&/A\^)HJ
MD$@-'2RR2K)Q</TUC<^.06"RJ!SQ/O0PM;WN6'P1>C;-PT@[J[Z0)A[ N^6
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MB=]2 </).%G../]4/72E_R S"FY8[F]0)8 #/3F2N^ I#SB@/O[P:"C&)?6
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MU2[9&60N9(?0P6F;2&5]C?Z01+#6Y-H8['.XU<'FMPL9!X=:GW0"I_I$*8#
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M*B7H>R/5)\SV<5*:&C1.-.S+.):5N]Z;+]=_RP-Z4]3 D25[N >N]/.\'Q:
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ME;4X03GWSSSZ9 %5=@J6T*?E[_D-D)NRC!/G]^8.R"Z![KF+:.:=5.BHS"7
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MO11>C:KR6G7FVR"7\&X8/Q7&@UNN%/@Q>B!$:IME 6$Q'36FFSO(<HJ53V6
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M5.4G,>,6+[]OU13TTQQ+/2PG$UT"W6K!>'@;-+^DE13?6@L&A %H6[/5.8&
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MO-AX^]VK7-B8F)AVSQ,^^7GE#/!XDB/I:*Y487)_CL7>X-AU5:'L14RBT(E
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MM@AO?5-%93.7W$G4R3.L](C50(E$(=0S[WN?[P3R]S2^N?(GX2-UI&W0TYJ
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MZ/>P"+&Q,#&QR CNXQ)2D=-04Y%34M+2LS/2/F2EHZ1DXGO,^I2#FYN;AE%
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M.V<5Q9Y:N;0LI7IIYB;LC#.MQV*H\$6MHES8H?'+7QBT1$>V\'?Q4XZ.4S^
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M5)!Q9]?F;$# <2BGK>B$E&3-GMVBWNL3%X;P)4L+I.'ZG>'_B//"?W9C_Z^
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M44]KPMHH+ASD;*<E_RDL;9E-8EAFL<Y:GB%*J'M@BM28.$PBERVT#7LZ!^U
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MCODH*-Y+*(,BJ>]#UF1"J;K)2#QA0D#FP1%NL>Q-8%8*RQ73AHO^U&37E.A
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MG=SU_%,J'_D9K./"RY)2ZCA">FU%5^Z]"@I/[_J9A>C0[P4 $!TEZ#'!AG&
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M,V;+CLHGX]/'5&/+H/J$HX?L0G5?QD!@5QKP=:EZ8XDMU:5:3:+EO-JX6D^
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MRJJ#.@[9E8,B,4O-=+4J+>^YE30&]?C0U;'_OS\1_@>E?O'U'U!+ 0(4 Q0
M   ( *^ BUK^$)Z <P(  -\)   1              "  0    !C<')X+3(P
M,C0Q,C,Q+GAS9%!+ 0(4 Q0    ( *^ BUIR0_U![?\  "Y("@ 2
M      "  :("  !D.3 P-# W9&1E9C$T82YH=&U02P$"% ,4    " "O@(M:
M@(75 UL8  #V&   &0              @ &_ @$ 9SDP,#0P-V<P-# T,C,U
M-#$R-S(Q+FIP9U!+ 0(4 Q0    ( *^ BUHLEW6$)@L   4,   9
M      "  5$; 0!G.3 P-# W9S T,#0R,S4T,3(Y-#8N:G!G4$L! A0#%
M  @ KX"+6H@>@,AS70  :VX  !D              ( !KB8! &<Y,# T,#=G
M,#0P-#(S-30Q,S,Q-RYJ<&=02P$"% ,4    " "O@(M:[C61A I5  "M:0
M&0              @ %8A $ 9SDP,#0P-V<P-# T,C,U-#$S-C X+FIP9U!+
M 0(4 Q0    ( *^ BUI4E]^Y%E0  +%F   9              "  9G9 0!G
M.3 P-# W9S T,#0R,S4T,3,X,S$N:G!G4$L%!@     '  < X@$  .8M @
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d900407ddef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cprx-20241231.xsd" xlink:type="simple"/>
    <context id="P01_01_2024To12_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_2TypedMemberecdMeasureAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_3TypedMemberecdMeasureAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_4TypedMemberecdMeasureAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_1TypedMemberecdMeasureAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001369568</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="P01_01_2024To12_31_2024" id="hidden137734544">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2024To12_31_2024" id="ixv-7190">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2024To12_31_2024" id="ixv-7191">0001369568</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P01_01_2024To12_31_2024" id="ixv-7467">Catalyst Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="P01_01_2024To12_31_2024" id="ixv-1252">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-5271">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s principal executive officer (&#x201c;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&#x201d;) and our &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; named executive officers (&#x201c;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NEO&lt;/div&gt;&lt;/div&gt;s&#x201d;) were as follows for the fiscal years ended December&#160;31, 2024, 2023 and 2022: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:19%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:26%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:53%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Year&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;PEO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;2024&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Richard J. Daly&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Michael W. Kalb, Steven R. Miller, Jeffrey Del Carmen, Preethi Sundaram&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;2023&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Patrick J. McEnany&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:6pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;2022&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Patrick J. McEnany&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;Alicia Grande, Steven R. Miller, Gary Ingenito, Jeffrey Del Carmen&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="P01_01_2024To12_31_2024" id="ixv-7474">Richard J. Daly</ecd:PeoName>
    <ecd:PvpTableTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-5326">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table sets forth information concerning the compensation of our PEO and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs for the fiscal years ended December&#160;31, &lt;div style="display:inline;"&gt;2024&lt;/div&gt;, 2023 and 2022, and our financial performance for each such fiscal year: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value of Initial $100&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fixed Investment Based&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;on (3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Table Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;for PEO ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Actually Paid&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;to PEO ($)&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1)(2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Table Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;for &lt;div style="white-space:nowrap;display:inline;"&gt;non-PEO&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Actually Paid&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;to &lt;div style="white-space:nowrap;display:inline;"&gt;non-PEO&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NEOs (1)(2)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shareholder&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Return ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peer Group&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shareholder&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Return ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;thousands)&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Product&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;thousands)&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;2024&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,774,160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;12,896,544&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,723,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,024,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;557&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;88&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;163,889&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;489,327&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;2023&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,146,499&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,007,034&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,256,711&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,952,842&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;448&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;54&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;71,410&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;396,502&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;2022&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,923,782&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;17,549,684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,674,788&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,393,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;496&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;69&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;83,079&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;213,938&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Amounts represent compensation actually paid (&#x201c;CAP&#x201d;) to our PEO and the average compensation actually paid to our &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs for the relevant fiscal year, as determined under SEC rules (and described below). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Fair value or change in fair value, as applicable, of stock options in the &#x201c;Compensation Actually Paid&#x201d; columns was estimated using a Black-Scholes option pricing model for the purposes of this disclosure in accordance with SEC rules and do not reflect compensation actually earned, realized or received during each applicable year. The calculation of CAP for purposes of this table includes &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;point-in-time&lt;/div&gt;&lt;/div&gt; fair values of equity awards and those values will fluctuate based on our stock price and various accounting valuation assumptions. See the Summary Compensation Table for certain other compensation of our PEO and our &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs for each applicable fiscal year. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;For the relevant fiscal year, represents our cumulative TSR or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In the table immediately above, the columns &#x201c;Compensation Actually Paid to PEO&#x201d; and &#x201c;Average Compensation Actually Paid to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs&#x201d; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#x201c;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&lt;/div&gt;&lt;/div&gt;&#x201d;), as adjusted based on the following: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&#160;Total&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Minus&#160;SCT&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;New&#160;Unvested&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&#160;as&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12/31 ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Annual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Prior&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;that Remain&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vested and&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Change&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;in Value of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Prior Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards that&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vest During&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&#160;CAP&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,774,160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,338,431&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,922,548&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;4,488,419&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;49,848&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;12,896,544&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,146,499&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;749,999&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;943,365&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(736,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(595,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,007,034&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,923,782&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,727,859&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,659,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,460,212&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,234,201&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;17,549,684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td colspan="8" style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,723,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,838,396&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,237,565&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;572,615&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;329,407&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,024,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,256,711&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,446,560&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,819,515&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(326,149&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(350,675&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,952,842&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,674,788&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,939,664&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,316,864&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,394,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,947,593&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,393,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following tables illustrate the valuation assumptions as of the vesting date for awards that vested in each of 2024, 2023 and 2022. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:55%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For Stock Options Vesting in&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;3.85%&#160;-&#x2009;4.52%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;3.75%&#160;-&#x2009;4.65%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;1.30%&#160;-&#x2009;4.00%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected term&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;1.6&#160;-5.0&#160;years&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;4.5&#160;years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;4.5&#160;years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;54.1% - 60.4%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;68.0% - 71.0%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;68.4% - 69.5%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected forfeiture rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#x2014;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:74%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;Average&#160;Fair&#160;Value&#160;of&#160;Full&#160;Value&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards Vesting in&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;For Restricted Stock Units&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;11.19&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;11.25&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right"&gt;4.65&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:CoSelectedMeasureName contextRef="P01_01_2024To12_31_2024" id="ixv-5513">Net Product Revenue</ecd:CoSelectedMeasureName>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7475"
      unitRef="Unit_USD">7774160</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7476"
      unitRef="Unit_USD">12896544</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7477"
      unitRef="Unit_USD">3723348</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7478"
      unitRef="Unit_USD">5024539</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7479"
      unitRef="Unit_USD">557</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7480"
      unitRef="Unit_USD">88</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2024To12_31_2024"
      decimals="-3"
      id="ixv-7481"
      unitRef="Unit_USD">163889000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="-3"
      id="ixv-7482"
      unitRef="Unit_USD">489327000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7483"
      unitRef="Unit_USD">2146499</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7484"
      unitRef="Unit_USD">1007034</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7485"
      unitRef="Unit_USD">2256711</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7486"
      unitRef="Unit_USD">1952842</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7487"
      unitRef="Unit_USD">448</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7488"
      unitRef="Unit_USD">54</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To12_31_2023"
      decimals="-3"
      id="ixv-7489"
      unitRef="Unit_USD">71410000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="-3"
      id="ixv-7490"
      unitRef="Unit_USD">396502000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7491"
      unitRef="Unit_USD">6923782</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7492"
      unitRef="Unit_USD">17549684</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7493"
      unitRef="Unit_USD">2674788</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7494"
      unitRef="Unit_USD">7393846</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7495"
      unitRef="Unit_USD">496</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7496"
      unitRef="Unit_USD">69</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      id="ixv-7497"
      unitRef="Unit_USD">83079000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      id="ixv-7498"
      unitRef="Unit_USD">213938000</ecd:CoSelectedMeasureAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-7499">For the relevant fiscal year, represents our cumulative TSR or the cumulative TSR of the Nasdaq Biotechnology Index, in each case assuming an initial investment of $100 as described under the Narrative Disclosure to Pay Versus Performance heading below. We have never declared or paid a dividend on our common stock and do not anticipate doing so in the foreseeable future.</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-5678">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In the table immediately above, the columns &#x201c;Compensation Actually Paid to PEO&#x201d; and &#x201c;Average Compensation Actually Paid to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs&#x201d; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#x201c;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&lt;/div&gt;&lt;/div&gt;&#x201d;), as adjusted based on the following: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&#160;Total&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Minus&#160;SCT&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;New&#160;Unvested&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&#160;as&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12/31 ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Annual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Prior&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;that Remain&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vested and&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Change&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;in Value of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Prior Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards that&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vest During&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&#160;CAP&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,774,160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,338,431&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,922,548&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;4,488,419&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;49,848&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;12,896,544&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,146,499&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;749,999&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;943,365&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(736,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(595,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,007,034&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,923,782&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,727,859&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,659,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,460,212&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,234,201&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;17,549,684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td colspan="8" style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,723,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,838,396&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,237,565&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;572,615&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;329,407&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,024,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,256,711&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,446,560&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,819,515&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(326,149&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(350,675&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,952,842&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,674,788&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,939,664&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,316,864&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,394,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,947,593&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,393,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-5679">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In the table immediately above, the columns &#x201c;Compensation Actually Paid to PEO&#x201d; and &#x201c;Average Compensation Actually Paid to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs&#x201d; reflect the Total Compensation reported in the 2024 Summary Compensation Table (&#x201c;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&lt;/div&gt;&lt;/div&gt;&#x201d;), as adjusted based on the following: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SCT&#160;Total&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Minus&#160;SCT&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;New&#160;Unvested&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&#160;as&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12/31 ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Annual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Prior&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;that Remain&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Value&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vested and&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Plus&#160;Change&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;in Value of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Prior Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Awards that&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vest During&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&#160;CAP&#160;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,774,160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,338,431&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,922,548&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;4,488,419&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;49,848&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;12,896,544&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,146,499&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;749,999&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;943,365&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(736,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(595,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,007,034&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;6,923,782&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,727,859&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,659,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,460,212&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,234,201&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;17,549,684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td colspan="8" style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,723,348&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,838,396&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3,237,565&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;572,615&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;329,407&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,024,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,256,711&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,446,560&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,819,515&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(326,149&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(350,675&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,952,842&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,674,788&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,939,664&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,316,864&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2,394,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,947,593&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;7,393,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7501"
      unitRef="Unit_USD">7774160</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7502"
      unitRef="Unit_USD">-6338431</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7503"
      unitRef="Unit_USD">6922548</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7504"
      unitRef="Unit_USD">4488419</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7505"
      unitRef="Unit_USD">49848</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7506"
      unitRef="Unit_USD">12896544</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7507"
      unitRef="Unit_USD">2146499</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7508"
      unitRef="Unit_USD">-749999</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7509"
      unitRef="Unit_USD">943365</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7510"
      unitRef="Unit_USD">-736903</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7511"
      unitRef="Unit_USD">-595928</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7512"
      unitRef="Unit_USD">1007034</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7513"
      unitRef="Unit_USD">6923782</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7514"
      unitRef="Unit_USD">-5727859</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7515"
      unitRef="Unit_USD">7659348</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7516"
      unitRef="Unit_USD">3460212</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7517"
      unitRef="Unit_USD">5234201</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7518"
      unitRef="Unit_USD">17549684</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7519"
      unitRef="Unit_USD">3723348</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7520"
      unitRef="Unit_USD">-2838396</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7521"
      unitRef="Unit_USD">3237565</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7522"
      unitRef="Unit_USD">572615</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7523"
      unitRef="Unit_USD">329407</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-7524"
      unitRef="Unit_USD">5024539</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7525"
      unitRef="Unit_USD">2256711</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7526"
      unitRef="Unit_USD">-1446560</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7527"
      unitRef="Unit_USD">1819515</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7528"
      unitRef="Unit_USD">-326149</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7529"
      unitRef="Unit_USD">-350675</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-7530"
      unitRef="Unit_USD">1952842</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7531"
      unitRef="Unit_USD">2674788</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7532"
      unitRef="Unit_USD">-1939664</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-7533"
      unitRef="Unit_USD">2316864</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7534"
      unitRef="Unit_USD">2394265</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-7535"
      unitRef="Unit_USD">1947593</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-7536"
      unitRef="Unit_USD">7393846</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TabularListTableTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-6196">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2024 Performance &lt;div style="display:inline;"&gt;Measures&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following list represents the financial and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-financial&lt;/div&gt; performance measures that we consider to have been the most important in linking Compensation Actually Paid to our PEO and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs to company performance. The measures in this list are not ranked. Of these measures, we have identified Net Product Revenue as our most important of our financial performance measures used to link Compensation Actually Paid to our PEO and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-PEO&lt;/div&gt; NEOs to company performance: &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt;Net Product Revenue &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt;Net Income &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt;Completion of a transformational acquisition &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt;Quality and Compliance &lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName
      contextRef="P01_01_2024To12_31_2024_1TypedMemberecdMeasureAxis"
      id="ixv-7537">Net Product Revenue</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="P01_01_2024To12_31_2024_2TypedMemberecdMeasureAxis"
      id="ixv-7538">Net Income</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="P01_01_2024To12_31_2024_3TypedMemberecdMeasureAxis"
      id="ixv-7539">Completion of a transformational acquisition</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="P01_01_2024To12_31_2024_4TypedMemberecdMeasureAxis"
      id="ixv-7540">Quality and Compliance</ecd:MeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-6222">&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g900407g0404235413317.jpg"/&gt; &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-6223">&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g900407g0404235413317.jpg"/&gt; &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-6230">&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g900407g0404235413608.jpg"/&gt; &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-6244">&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g900407g0404235413831.jpg"/&gt; &lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
